The O
present O
study O
was O
designed O
to O
determine O
the O
effect O
of O
a O
new O
( B
25 I
) I
Mg I
( I
2 I
+ I
) I
- O
carrying O
nanoparticle O
( O
( B
25 I
) I
MgPMC16 I
) O
on O
energy O
depletion O
, O
oxidative O
stress O
, O
and O
electrocardiographic O
( O
ECG O
) O
parameters O
on O
heart O
tissue O
of O
the O
rats O
poisoned O
by O
aluminum B
phosphide I
( O
AlP B
) O
. O

( B
25 I
) I
MgPMC16 I
at O
doses O
of O
0 O
. O
025 O
, O
0 O
. O
05 O
, O
and O
0 O
. O
1 O
median O
lethal O
dose O
( O
LD50 O
= O
896 O
mg O
/ O
kg O
) O
was O
administered O
intravenously O
( O
iv O
) O
30 O
min O
after O
a O
single O
intragastric O
administration O
of O
AlP B
( O
0 O
. O
25 O
LD50 O
) O
. O

( B
25 I
) I
MgPMC16 I
significantly O
increased O
the O
BP O
and O
HR O
at O
all O
doses O
used O
. O

We O
found O
a O
considerable O
increase O
in O
antioxidant O
power O
, O
Mg B
level O
in O
the O
plasma O
and O
the O
heart O
and O
a O
reduction O
in O
lipid O
peroxidation O
and O
ADP B
/ O
ATP B
ratio O
at O
various O
doses O
of O
( B
25 I
) I
MgPMC16 I
, O
but O
( B
25 I
) I
MgPMC16 I
- O
0 O
. O
025 O
+ O
Bicarb B
was O
the O
most O
effective O
combination O
therapy O
. O

We O
found O
a O
considerable O
increase O
in O
antioxidant O
power O
, O
Mg B
level O
in O
the O
plasma O
and O
the O
heart O
and O
a O
reduction O
in O
lipid O
peroxidation O
and O
ADP B
/ O
ATP B
ratio O
at O
various O
doses O
of O
( B
25 I
) I
MgPMC16 I
, O
but O
( B
25 I
) I
MgPMC16 I
- O
0 O
. O
025 O
+ O
Bicarb B
was O
the O
most O
effective O
combination O
therapy O
. O

The O
results O
of O
this O
study O
support O
that O
( B
25 I
) I
MgPMC16 I
can O
increase O
heart O
energy O
by O
active O
transport O
of O
Mg B
inside O
the O
cardiac O
cells O
. O
( B
25 I
) I
MgPMC16 I
seems O
ameliorating O
AlP B
- O
induced O
toxicity O
and O
cardiac O
failure O
necessitating O
further O
studies O
. O

The O
results O
of O
this O
study O
support O
that O
( B
25 I
) I
MgPMC16 I
can O
increase O
heart O
energy O
by O
active O
transport O
of O
Mg B
inside O
the O
cardiac O
cells O
. O
( B
25 I
) I
MgPMC16 I
seems O
ameliorating O
AlP B
- O
induced O
toxicity O
and O
cardiac O
failure O
necessitating O
further O
studies O
. O

The O
main O
isolated O
compounds O
were O
triterpenes B
( O
alpha B
- I
amyrin I
, O
beta B
- I
amyrin I
, O
lupeol B
, O
betulin B
, O
betulinic B
acid I
, O
uvaol B
, O
erythrodiol B
and O
oleanolic B
acid I
) O
and O
phenolic B
acid I
derivatives O
from O
4 B
- I
hydroxybenzoic I
acid I
( O
gallic B
and I
protocatechuic I
acids I
and O
isocorilagin B
) O
. O

The O
main O
isolated O
compounds O
were O
triterpenes B
( O
alpha B
- I
amyrin I
, O
beta B
- I
amyrin I
, O
lupeol B
, O
betulin B
, O
betulinic B
acid I
, O
uvaol B
, O
erythrodiol B
and O
oleanolic B
acid I
) O
and O
phenolic B
acid I
derivatives O
from O
4 B
- I
hydroxybenzoic I
acid I
( O
gallic B
and I
protocatechuic I
acids I
and O
isocorilagin B
) O
. O

Increased O
levels O
of O
ALA B
and O
oleic B
acid I
, O
and O
decrease O
in O
linoleic B
and I
palmitic I
acids I
at O
late O
ripening O
stages O
of O
Primula O
sibthorpii O
, O
and O
slightly O
fluctuations O
of O
all O
examined O
fatty B
acids I
in O
Echium O
italicum O
were O
observed O
. O

) O
, O
( B
22E I
, I
24R I
) I
- I
3 I
beta I
- I
hydroxy I
- I
ergosta I
- I
5 I
, I
22 I
- I
dien I
- I
7 I
- I
one I
( O
6 O
) O
, O
benzoic B
acid I
( O
7 O
) O
, O
methyl B
p I
- I
hydroxybenzoate I
( O
8 O
) O
and O
3 B
, I
4 I
- I
dihydroxybenzoic I
acid I
( O
9 O
) O
. O

A O
new O
triterpenoid B
, O
2 B
alpha I
, I
24 I
- I
diacetoxy I
- I
3 I
beta I
- I
hydroxyolean I
- I
12 I
- I
en I
- I
28 I
- I
oic I
acid I
( O
1 O
) O
, O
was O
characterised O
from O
the O
rhizomes O
of O
Nelumbo O
nucifera O
Gaertn O
by O
spectroscopic O
and O
chemical O
methods O
along O
with O
four O
known O
compounds O
, O
hyptatic B
acid I
- I
A I
( O
2 B
alpha I
, I
3 I
beta I
, I
24 I
- I
trihydroxyolean I
- I
12 I
- I
en I
- I
28 I
- I
oic I
acid I
) O
( O
2 O
) O
, O
maslinic B
acid I
( O
2 B
alpha I
, I
3 I
beta I
- I

Furthermore O
, O
CA O
- O
induced O
vasorelaxation O
was O
inhibited O
by O
the O
PKG O
inhibitor O
KT5823 B
( O
0 O
. O
3 O
mu O
M O
) O
and O
the O
Ca B
( I
2 I
+ I
) I
- O
activated O
K B
( I
+ I
) I
channel O
inhibitor O
tetraethylammonium B
( O
10 O
( O
- O
3 O
) O
M O
) O
. O

In O
vivo O
microdialysis O
studies O
indicated O
that O
systemic O
or O
intra O
- O
NAc O
administration O
of O
AMN082 B
significantly O
decreased O
extracellular O
gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
and O
elevated O
extracellular O
glutamate B
, O
but O
had O
no O
effect O
on O
extracellular O
dopamine B
in O
the O
NAc O
, O
suggesting O
that O
a O
non O
- O
dopaminergic O
mechanism O
underlies O
the O
effects O
of O
AMN082 B
on O
the O
actions O
of O
cocaine B
. O

Drinking O
rate O
, O
measured O
with O
radiolabeled O
polyethylene B
glycol I
- I
4000 I
, O
was O
about O
25 O
times O
greater O
in O
16ppt O
- O
acclimated O
killifish O
relative O
to O
FW O
- O
acclimated O
animals O
. O

The O
selective O
mGluR2 O
/ O
3 O
agonist O
LY379268 B
inhibited O
the O
K B
( I
+ I
) I
- O
evoked O
overflow O
of O
[ B
( I
3 I
) I
H I
] I
glycine I
in O
a O
concentration O
- O
dependent O
manner O
( O
EC O
( O
50 O
) O
about O
0 O
. O
2 O
nM O
) O
. O

Mounting O
evidence O
suggests O
a O
possible O
role O
for O
gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
in O
the O
neuropathophysiology O
of O
autism O
spectrum O
disorders O
( O
ASD O
) O
, O
but O
the O
extent O
of O
this O
impairment O
is O
unclear O
. O

Disorders O
of O
coenzyme B
Q I
( I
10 I
) I
( O
CoQ B
( I
10 I
) I
) O
biosynthesis O
represent O
the O
most O
treatable O
subgroup O
of O
mitochondrial O
diseases O
. O

Neurological O
involvement O
is O
frequently O
observed O
in O
CoQ B
( I
10 I
) I
deficiency O
, O
typically O
presenting O
as O
cerebellar O
ataxia O
and O
/ O
or O
seizures O
. O

The O
aetiology O
of O
the O
neurological O
presentation O
of O
CoQ B
( I
10 I
) I
deficiency O
has O
yet O
to O
be O
fully O
elucidated O
and O
therefore O
in O
order O
to O
investigate O
these O
phenomena O
we O
have O
established O
a O
neuronal O
cell O
model O
of O
CoQ B
( I
10 I
) I
deficiency O
by O
treatment O
of O
neuronal O
SH O
- O
SY5Y O
cell O
line O
with O
para B
- I
aminobenzoic I
acid I
( O
PABA B
) O
. O

The O
aetiology O
of O
the O
neurological O
presentation O
of O
CoQ B
( I
10 I
) I
deficiency O
has O
yet O
to O
be O
fully O
elucidated O
and O
therefore O
in O
order O
to O
investigate O
these O
phenomena O
we O
have O
established O
a O
neuronal O
cell O
model O
of O
CoQ B
( I
10 I
) I
deficiency O
by O
treatment O
of O
neuronal O
SH O
- O
SY5Y O
cell O
line O
with O
para B
- I
aminobenzoic I
acid I
( O
PABA B
) O
. O

The O
aetiology O
of O
the O
neurological O
presentation O
of O
CoQ B
( I
10 I
) I
deficiency O
has O
yet O
to O
be O
fully O
elucidated O
and O
therefore O
in O
order O
to O
investigate O
these O
phenomena O
we O
have O
established O
a O
neuronal O
cell O
model O
of O
CoQ B
( I
10 I
) I
deficiency O
by O
treatment O
of O
neuronal O
SH O
- O
SY5Y O
cell O
line O
with O
para B
- I
aminobenzoic I
acid I
( O
PABA B
) O
. O

PABA B
is O
a O
competitive O
inhibitor O
of O
the O
CoQ B
( I
10 I
) I
biosynthetic O
pathway O
enzyme O
, O
COQ2 O
. O

PABA B
treatment O
( O
1 O
mM O
) O
resulted O
in O
a O
54 O
% O
decrease O
( O
46 O
% O
residual O
CoQ B
( I
10 I
) I
) O
decrease O
in O
neuronal O
CoQ B
( I
10 I
) I
status O
( O
p O
< O
0 O
. O
01 O
) O
. O

PABA B
treatment O
( O
1 O
mM O
) O
resulted O
in O
a O
54 O
% O
decrease O
( O
46 O
% O
residual O
CoQ B
( I
10 I
) I
) O
decrease O
in O
neuronal O
CoQ B
( I
10 I
) I
status O
( O
p O
< O
0 O
. O
01 O
) O
. O

Reduction O
of O
neuronal O
CoQ B
( I
10 I
) I
status O
was O
accompanied O
by O
a O
progressive O
decrease O
in O
mitochondrial O
respiratory O
chain O
enzyme O
activities O
, O
with O
a O
67 O
. O
5 O
% O
decrease O
in O
cellular O
ATP B
production O
at O
46 O
% O
residual O
CoQ B
( I
10 I
) I
. O

Reduction O
of O
neuronal O
CoQ B
( I
10 I
) I
status O
was O
accompanied O
by O
a O
progressive O
decrease O
in O
mitochondrial O
respiratory O
chain O
enzyme O
activities O
, O
with O
a O
67 O
. O
5 O
% O
decrease O
in O
cellular O
ATP B
production O
at O
46 O
% O
residual O
CoQ B
( I
10 I
) I
. O

Mitochondrial O
oxidative O
stress O
increased O
four O
- O
fold O
at O
77 O
% O
and O
46 O
% O
residual O
CoQ B
( I
10 I
) I
. O

A O
40 O
% O
increase O
in O
mitochondrial O
membrane O
potential O
was O
detected O
at O
46 O
% O
residual O
CoQ B
( I
10 I
) I
with O
depolarisation O
following O
oligomycin O
treatment O
suggesting O
a O
reversal O
of O
complex O
V O
activity O
. O

This O
neuronal O
cell O
model O
provides O
insights O
into O
the O
effects O
of O
CoQ B
( I
10 I
) I
deficiency O
on O
neuronal O
mitochondrial O
function O
and O
oxidative O
stress O
, O
and O
will O
be O
an O
important O
tool O
to O
evaluate O
candidate O
therapies O
for O
neurological O
conditions O
associated O
with O
CoQ B
( I
10 I
) I
deficiency O
. O

This O
neuronal O
cell O
model O
provides O
insights O
into O
the O
effects O
of O
CoQ B
( I
10 I
) I
deficiency O
on O
neuronal O
mitochondrial O
function O
and O
oxidative O
stress O
, O
and O
will O
be O
an O
important O
tool O
to O
evaluate O
candidate O
therapies O
for O
neurological O
conditions O
associated O
with O
CoQ B
( I
10 I
) I
deficiency O
. O

We O
have O
previously O
described O
a O
novel O
mGlu O
5 O
positive O
allosteric O
modulator O
( O
PAM O
) O
, O
LSN2463359 B
and O
provided O
evidence O
of O
its O
ability O
to O
attenuate O
aspects O
of O
the O
behavioural O
response O
to O
administration O
of O
the O
competitive O
NMDA B
receptor O
antagonist O
, O
SDZ B
220 I
, I
581 I
. O

In O
the O
present O
study O
, O
the O
interactions O
between O
this O
mGlu O
5 O
PAM O
and O
the O
NMDA B
receptor O
were O
explored O
further O
by O
assessing O
the O
effects O
of O
LSN2463359 B
against O
some O
of O
the O
motor O
, O
instrumental O
and O
cognitive O
effects O
induced O
by O
the O
non O
- O
competitive O
NMDA B
receptor O
antagonists O
PCP B
and O
MK B
- I
801 I
, O
the O
competitive O
NMDA B
receptor O
antagonist O
SDZ B
220 I
, I
581 I
and O
the O
GluN2B O
selective O
NMDA B
receptor O
antagonist O
, O
Ro B
63 I
- I
1908 I
. O

In O
the O
present O
study O
, O
the O
interactions O
between O
this O
mGlu O
5 O
PAM O
and O
the O
NMDA B
receptor O
were O
explored O
further O
by O
assessing O
the O
effects O
of O
LSN2463359 B
against O
some O
of O
the O
motor O
, O
instrumental O
and O
cognitive O
effects O
induced O
by O
the O
non O
- O
competitive O
NMDA B
receptor O
antagonists O
PCP B
and O
MK B
- I
801 I
, O
the O
competitive O
NMDA B
receptor O
antagonist O
SDZ B
220 I
, I
581 I
and O
the O
GluN2B O
selective O
NMDA B
receptor O
antagonist O
, O
Ro B
63 I
- I
1908 I
. O

LSN2463359 B
had O
either O
no O
or O
minor O
impact O
on O
locomotor O
hyperactivity O
induced O
by O
either O
PCP B
or O
SDZ B
220 I
, I
581 I
. O

However O
, O
in O
rats O
lever O
pressing O
for O
food O
rewards O
under O
a O
variable O
interval O
30s O
schedule O
of O
instrumental O
responding O
, O
the O
drug O
clearly O
attenuated O
not O
only O
the O
suppression O
of O
response O
rate O
induced O
by O
SDZ B
220 I
, I
581 I
but O
also O
the O
stimulation O
of O
response O
rate O
induced O
by O
Ro B
63 I
- I
1908 I
. O

However O
, O
in O
rats O
lever O
pressing O
for O
food O
rewards O
under O
a O
variable O
interval O
30s O
schedule O
of O
instrumental O
responding O
, O
the O
drug O
clearly O
attenuated O
not O
only O
the O
suppression O
of O
response O
rate O
induced O
by O
SDZ B
220 I
, I
581 I
but O
also O
the O
stimulation O
of O
response O
rate O
induced O
by O
Ro B
63 I
- I
1908 I
. O

In O
addition O
, O
although O
PCP B
and O
SDZ B
220 I
, I
581 I
induced O
similar O
deficits O
in O
a O
discrimination O
and O
reversal O
learning O
task O
, O
LSN2463359 B
was O
again O
only O
able O
to O
reverse O
the O
deficit O
induced O
by O
SDZ B
220 I
, I
581 I
. O

In O
addition O
, O
although O
PCP B
and O
SDZ B
220 I
, I
581 I
induced O
similar O
deficits O
in O
a O
discrimination O
and O
reversal O
learning O
task O
, O
LSN2463359 B
was O
again O
only O
able O
to O
reverse O
the O
deficit O
induced O
by O
SDZ B
220 I
, I
581 I
. O

Wake O
- O
promoting O
doses O
of O
LSN2463359 B
and O
LSN2814617 B
attenuated O
deficits O
in O
performance O
induced O
by O
the O
competitive O
NMDA B
receptor O
antagonist O
SDZ B
220 I
, I
581 I
in O
two O
tests O
of O
operant O
behaviour O
: O
the O
variable O
interval O
30 O
s O
task O
and O
the O
DMTP O
task O
. O

However O
, O
the O
improvements O
in O
response O
accuracy O
induced O
by O
the O
mGlu O
5 O
potentiators O
in O
SDZ B
220 I
, I
581 I
- O
treated O
rats O
were O
not O
delay O
- O
dependent O
and O
, O
therefore O
, O
perhaps O
more O
likely O
reflected O
optimization O
of O
general O
arousal O
than O
specific O
beneficial O
effects O
on O
discrete O
cognitive O
processes O
. O

Size O
of O
TiO B
( I
2 I
) I
nanoparticles O
influences O
their O
phototoxicity O
: O
an O
in O
vitro O
investigation O
. O

To O
uncover O
the O
size O
influence O
of O
TiO B
( I
2 I
) I
nanoparticles O
on O
their O
potential O
toxicity O
, O
the O
cytotoxicity O
of O
different O
- O
sized O
TiO B
( I
2 I
) I
nanoparticles O
with O
and O
without O
photoactivation O
was O
tested O
. O

To O
uncover O
the O
size O
influence O
of O
TiO B
( I
2 I
) I
nanoparticles O
on O
their O
potential O
toxicity O
, O
the O
cytotoxicity O
of O
different O
- O
sized O
TiO B
( I
2 I
) I
nanoparticles O
with O
and O
without O
photoactivation O
was O
tested O
. O

It O
was O
demonstrated O
that O
without O
photoactivation O
, O
TiO B
( I
2 I
) I
nanoparticles O
were O
inert O
up O
to O
100 O
mu O
g O
/ O
ml O
. O

On O
the O
contrary O
, O
with O
photoactivation O
, O
the O
toxicity O
of O
TiO B
( I
2 I
) I
nanoparticles O
significantly O
increased O
, O
which O
correlated O
well O
with O
the O
specific O
surface O
area O
of O
the O
particles O
. O

Our O
results O
also O
suggest O
that O
the O
generation O
of O
hydroxyl B
radicals O
and O
reactive O
oxygen B
species O
( O
ROS O
) O
- O
mediated O
damage O
to O
the O
surface O
- O
adsorbed O
biomolecules O
could O
be O
the O
two O
major O
reasons O
for O
the O
cytotoxicity O
of O
TiO B
( I
2 I
) I
nanoparticles O
after O
photoactivation O
. O

To O
further O
investigate O
the O
influence O
of O
the O
generation O
of O
hydroxyl B
radicals O
and O
adsorption O
of O
protein O
, O
poly B
( I
ethylene I
- I
alt I
- I
maleic I
anhydride I
) I
( O
PEMA B
) O
and O
chitosan O
were O
used O
to O
coat O
TiO B
( I
2 I
) I
nanoparticles O
. O

The O
results O
confirmed O
that O
surface O
coating O
of O
TiO B
( I
2 I
) I
nanoparticles O
could O
reduce O
such O
toxicity O
after O
photoactivation O
, O
by O
hindering O
adsorption O
of O
biomolecules O
and O
generation O
of O
hydroxyl B
radical O
( O
. B
OH I
) O
during O
photoactivation O
. O

Vitamin B
D I
is O
a O
potent O
stimulator O
of O
monocyte O
innate O
immunity O
, O
and O
this O
effect O
is O
mediated O
via O
intracrine O
conversion O
of O
25 B
- I
hydroxyvitamin I
D I
( O
25OHD B
) O
to O
1 B
, I
25 I
- I
dihydroxyvitamin I
D I
( O
1 B
, I
25 I
( I
OH I
) I
( I
2 I
) I
D I
) O
. O

Furthermore O
, O
N B
- I
feruloyl I
serotonin I
( O
5 O
) O
and O
N B
- I
isoferuloyl I
serotonin I
( O
6 O
) O
were O
converted O
into O
, O
two O
new O
compounds O
, O
N B
- I
feruloyl I
serotonin I
- I
4 I
' I
- I
O I
- I
beta I
- I
D I
- I
glucopyranoside I
( O
8 O
) O
and O
N B
- I
isoferuloyl I
serotonin I
- I
3 I
' I
- I
O I
- I
beta I
- I
D I
- I
glucopyranoside I
( O
9 O
) O
, O
respectively O
. O

Furthermore O
, O
N B
- I
feruloyl I
serotonin I
( O
5 O
) O
and O
N B
- I
isoferuloyl I
serotonin I
( O
6 O
) O
were O
converted O
into O
, O
two O
new O
compounds O
, O
N B
- I
feruloyl I
serotonin I
- I
4 I
' I
- I
O I
- I
beta I
- I
D I
- I
glucopyranoside I
( O
8 O
) O
and O
N B
- I
isoferuloyl I
serotonin I
- I
3 I
' I
- I
O I
- I
beta I
- I
D I
- I
glucopyranoside I
( O
9 O
) O
, O
respectively O
. O

Potassium B
permanganate I
( O
KMnO B
( I
4 I
) I
) O
is O
used O
to O
control O
iron O
concentrations O
and O
to O
reduce O
the O
levels O
of O
nuisance O
materials O
that O
affect O
odor O
or O
taste O
of O
finished O
drinking O
water O
. O

Manganese B
( O
Mn B
) O
is O
recognized O
an O
essential O
nutrient O
, O
permanganate B
( O
MnO4 B
( I
- I
) I
) O
and O
manganous B
( O
Mn B
( I
+ I
2 I
) I
) O
ions O
are O
caustic O
, O
and O
the O
acute O
toxicity O
of O
KMnO B
( I
4 I
) I
is O
defined O
by O
its O
oxidant O
/ O
irritant O
properties O
and O
by O
the O
toxicity O
of O
Mn B
. O

Manganese B
( O
Mn B
) O
is O
recognized O
an O
essential O
nutrient O
, O
permanganate B
( O
MnO4 B
( I
- I
) I
) O
and O
manganous B
( O
Mn B
( I
+ I
2 I
) I
) O
ions O
are O
caustic O
, O
and O
the O
acute O
toxicity O
of O
KMnO B
( I
4 I
) I
is O
defined O
by O
its O
oxidant O
/ O
irritant O
properties O
and O
by O
the O
toxicity O
of O
Mn B
. O

Ingestion O
of O
small O
amounts O
( O
4 O
- O
20 O
mg O
/ O
kg O
) O
of O
aqueous O
KMnO B
( I
4 I
) I
solutions O
that O
are O
above O
200 O
mg O
/ O
L O
causes O
gastrointestinal O
distress O
, O
while O
bolus O
ingestion O
has O
caused O
respiratory O
arrest O
following O
coagulative O
necrosis O
and O
hemorrhage O
in O
the O
esophagus O
, O
stomach O
, O
or O
liver O
. O

Dilute O
KMnO B
( I
4 I
) I
solutions O
( O
1 O
- O
100 O
mg O
/ O
L O
) O
are O
used O
as O
a O
topical O
antiseptics O
and O
astringents O
, O
but O
> O
1 O
: O
5000 O
( O
200 O
mg O
/ O
L O
) O
dilutions O
can O
irritate O
or O
discolor O
sensitive O
mucous O
membranes O
and O
direct O
skin O
or O
ocular O
contact O
with O
concentrated O
KMnO B
( I
4 I
) I
can O
perforate O
tissues O
. O

Dilute O
KMnO B
( I
4 I
) I
solutions O
( O
1 O
- O
100 O
mg O
/ O
L O
) O
are O
used O
as O
a O
topical O
antiseptics O
and O
astringents O
, O
but O
> O
1 O
: O
5000 O
( O
200 O
mg O
/ O
L O
) O
dilutions O
can O
irritate O
or O
discolor O
sensitive O
mucous O
membranes O
and O
direct O
skin O
or O
ocular O
contact O
with O
concentrated O
KMnO B
( I
4 I
) I
can O
perforate O
tissues O
. O

Based O
on O
clinical O
experience O
with O
200 O
mg O
/ O
L O
KMnO B
( I
4 I
) I
, O
a O
Do O
Not O
Consume O
concentration O
of O
7 O
mg O
/ O
L O
KMnO B
( I
4 I
) I
( O
equivalent O
to O
2 O
mg O
Mn B
/ O
L O
) O
is O
recommended O
. O

Based O
on O
clinical O
experience O
with O
200 O
mg O
/ O
L O
KMnO B
( I
4 I
) I
, O
a O
Do O
Not O
Consume O
concentration O
of O
7 O
mg O
/ O
L O
KMnO B
( I
4 I
) I
( O
equivalent O
to O
2 O
mg O
Mn B
/ O
L O
) O
is O
recommended O
. O

OCPs O
( O
hexachlorocyclohexan B
( O
HCH B
) O
, O
aldrin B
, O
dieldrin B
, O
endosulfan B
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDE I
) O
, O
op B
' I
- I
DDE I
, O
pp B
' I
- I
dichlorodiphenyltric I
( O
pp B
' I
- I
DDT I
) O
, O
op B
' I
- I
DDT I
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDD I
) O
and O
op B
' I
- I
DDD I
) O
were O
extracted O
from O
blood O
and O
quantitatively O
estimated O
using O
gas O
chromatography O
. O

OCPs O
( O
hexachlorocyclohexan B
( O
HCH B
) O
, O
aldrin B
, O
dieldrin B
, O
endosulfan B
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDE I
) O
, O
op B
' I
- I
DDE I
, O
pp B
' I
- I
dichlorodiphenyltric I
( O
pp B
' I
- I
DDT I
) O
, O
op B
' I
- I
DDT I
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDD I
) O
and O
op B
' I
- I
DDD I
) O
were O
extracted O
from O
blood O
and O
quantitatively O
estimated O
using O
gas O
chromatography O
. O

OCPs O
( O
hexachlorocyclohexan B
( O
HCH B
) O
, O
aldrin B
, O
dieldrin B
, O
endosulfan B
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDE I
) O
, O
op B
' I
- I
DDE I
, O
pp B
' I
- I
dichlorodiphenyltric I
( O
pp B
' I
- I
DDT I
) O
, O
op B
' I
- I
DDT I
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDD I
) O
and O
op B
' I
- I
DDD I
) O
were O
extracted O
from O
blood O
and O
quantitatively O
estimated O
using O
gas O
chromatography O
. O

OCPs O
( O
hexachlorocyclohexan B
( O
HCH B
) O
, O
aldrin B
, O
dieldrin B
, O
endosulfan B
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDE I
) O
, O
op B
' I
- I
DDE I
, O
pp B
' I
- I
dichlorodiphenyltric I
( O
pp B
' I
- I
DDT I
) O
, O
op B
' I
- I
DDT I
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDD I
) O
and O
op B
' I
- I
DDD I
) O
were O
extracted O
from O
blood O
and O
quantitatively O
estimated O
using O
gas O
chromatography O
. O

OCPs O
( O
hexachlorocyclohexan B
( O
HCH B
) O
, O
aldrin B
, O
dieldrin B
, O
endosulfan B
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDE I
) O
, O
op B
' I
- I
DDE I
, O
pp B
' I
- I
dichlorodiphenyltric I
( O
pp B
' I
- I
DDT I
) O
, O
op B
' I
- I
DDT I
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDD I
) O
and O
op B
' I
- I
DDD I
) O
were O
extracted O
from O
blood O
and O
quantitatively O
estimated O
using O
gas O
chromatography O
. O

OCPs O
( O
hexachlorocyclohexan B
( O
HCH B
) O
, O
aldrin B
, O
dieldrin B
, O
endosulfan B
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDE I
) O
, O
op B
' I
- I
DDE I
, O
pp B
' I
- I
dichlorodiphenyltric I
( O
pp B
' I
- I
DDT I
) O
, O
op B
' I
- I
DDT I
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDD I
) O
and O
op B
' I
- I
DDD I
) O
were O
extracted O
from O
blood O
and O
quantitatively O
estimated O
using O
gas O
chromatography O
. O

OCPs O
( O
hexachlorocyclohexan B
( O
HCH B
) O
, O
aldrin B
, O
dieldrin B
, O
endosulfan B
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDE I
) O
, O
op B
' I
- I
DDE I
, O
pp B
' I
- I
dichlorodiphenyltric I
( O
pp B
' I
- I
DDT I
) O
, O
op B
' I
- I
DDT I
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDD I
) O
and O
op B
' I
- I
DDD I
) O
were O
extracted O
from O
blood O
and O
quantitatively O
estimated O
using O
gas O
chromatography O
. O

OCPs O
( O
hexachlorocyclohexan B
( O
HCH B
) O
, O
aldrin B
, O
dieldrin B
, O
endosulfan B
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDE I
) O
, O
op B
' I
- I
DDE I
, O
pp B
' I
- I
dichlorodiphenyltric I
( O
pp B
' I
- I
DDT I
) O
, O
op B
' I
- I
DDT I
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDD I
) O
and O
op B
' I
- I
DDD I
) O
were O
extracted O
from O
blood O
and O
quantitatively O
estimated O
using O
gas O
chromatography O
. O

OCPs O
( O
hexachlorocyclohexan B
( O
HCH B
) O
, O
aldrin B
, O
dieldrin B
, O
endosulfan B
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDE I
) O
, O
op B
' I
- I
DDE I
, O
pp B
' I
- I
dichlorodiphenyltric I
( O
pp B
' I
- I
DDT I
) O
, O
op B
' I
- I
DDT I
, O
pp B
' I
- I
dichlorodiphenyldich I
( O
pp B
' I
- I
DDD I
) O
and O
op B
' I
- I
DDD I
) O
were O
extracted O
from O
blood O
and O
quantitatively O
estimated O
using O
gas O
chromatography O
. O

A O
Mann O
- O
Whitney O
U O
test O
revealed O
significant O
difference O
in O
beta B
- I
HCH I
levels O
( O
U O
= O
1237 O
. O
00 O
, O
W O
= O
4087 O
. O
00 O
, O
z O
= O
- O
6 O
. O
296 O
, O
p O
= O
0 O
. O
000 O
, O
r O
= O
- O
0 O
. O
71 O
) O
, O
dieldrin B
levels O
( O
U O
= O
1449 O
. O
00 O
, O
W O
= O
4299 O
. O
00 O
, O
z O
= O
- O
5 O
. O
809 O
, O
p O
= O
0 O
. O
000 O
, O
r O
= O
- O
0 O
. O
68 O
) O
and O
pp B
' I
- I
DDE I
levels O
( O
U O
= O
2062 O
. O
00 O
, O
W O
= O
4912 O
. O
00 O
, O
z O
= O
- O
2 O
. O
698 O
, O
p O
= O

In O
conclusion O
, O
this O
study O
supports O
epidemiological O
studies O
that O
associate O
exposure O
to O
pesticides O
with O
increased O
risk O
of O
AD O
, O
and O
we O
identified O
the O
specific O
pesticides O
beta B
- I
HCH I
, O
dieldrin B
and O
pp B
' I
- I
DDE I
that O
are O
associated O
with O
the O
risk O
of O
AD O
in O
the O
north O
Indian O
population O
. O

However O
, O
despite O
the O
four O
formulations O
studied O
did O
not O
present O
any O
acute O
phototoxicity O
potential O
, O
the O
combination O
2 O
containing O
octyl B
methoxycinnamate I
( O
OMC B
) O
, O
avobenzone B
( O
AVB B
) O
and O
4 B
- I
methylbenzilidene I
camphor I
( O
MBC B
) O
presented O
an O
indication O
of O
phototoxicity O
that O
should O
be O
better O
investigated O
in O
terms O
of O
the O
frequency O
of O
photoallergic O
or O
chronic O
phototoxicity O
in O
humans O
, O
once O
these O
tests O
are O
scientifically O
validated O
only O
to O
detect O
phototoxic O
potential O
with O
the O
aim O
of O
preventing O
phototoxic O
reactions O
in O
the O
general O
population O
, O
and O
positive O
results O

Nowadays O
valganciclovir B
( O
V B
- I
GCV I
) O
, O
a O
mono B
- I
valyl I
ester I
pro O
- O
drug O
of O
GCV B
, O
is O
available O
as O
an O
oral O
syrup O
. O

Lyral B
and O
lilial B
: O
( O
a O
) O
decreased O
the O
viability O
of O
HaCat O
cells O
with O
a O
50 O
% O
cell O
death O
at O
100 O
and O
60 O
nM O
respectively O
; O
( O
b O
) O
decreased O
significantly O
in O
a O
dose O
dependant O
manner O
the O
intracellular O
ATP B
level O
following O
12 O
- O
h O
of O
treatment O
; O
( O
c O
) O
inhibited O
complexes O
I O
and O
II O
of O
electron O
transport O
chain O
in O
liver O
sub O
- O
mitochondrial O
particles O
; O
and O
( O
d O
) O
increased O
reactive O
oxygen B
species O
generation O
that O
was O
reversed O
by O
N B
- I
acetyl I
cysteine I
and O
trolox B
and O
the O
natural O
antioxidant O
lipoic B
acid I
, O
without O
influencing O
the O
level O
of O
free O

Here O
, O
we O
found O
that O
mice O
lacking O
A O
( O
1 O
) O
AR O
were O
resistant O
to O
alpha B
- I
naphthyl I
isothiocyanate I
( O
ANIT B
) O
- O
induced O
liver O
injury O
, O
as O
evidenced O
by O
lower O
serum O
liver O
enzyme O
levels O
and O
reduced O
extent O
of O
histological O
necrosis O
. O

The O
interfacial O
tension O
values O
and O
the O
molecular O
area O
values O
for O
PEH B
( I
+ I
) I
and O
PEOH B
( I
- I
) I
forms O
of O
phosphatidylethanola B
were O
calculated O
. O

The O
interfacial O
tension O
values O
and O
the O
molecular O
area O
values O
for O
PEH B
( I
+ I
) I
and O
PEOH B
( I
- I
) I
forms O
of O
phosphatidylethanola B
were O
calculated O
. O

acai O
, O
alpha B
- I
lipoic I
acid I
, O
tocotrienols B
, O
and O
apocynin B
) O
have O
made O
it O
possible O
to O
modulate O
various O
biochemical O
aspects O
of O
COPD O
. O

Activity O
- O
guided O
fractionation O
of O
seeds O
of O
Solanum O
indicum O
for O
anti O
- O
HBV O
activity O
led O
to O
the O
isolation O
of O
two O
novel O
coumarinolignoid B
alkaloids I
( O
indicumines B
A I
- I
B I
, O
1 O
- O
2 O
) O
and O
two O
new O
coumarinolignoids B
( O
indicumines B
C I
- I
D I
, O
3 O
- O
4 O
) O
, O
together O
with O
four O
known O
coumarins B
( O
5 O
- O
8 O
) O
. O

Activity O
- O
guided O
fractionation O
of O
seeds O
of O
Solanum O
indicum O
for O
anti O
- O
HBV O
activity O
led O
to O
the O
isolation O
of O
two O
novel O
coumarinolignoid B
alkaloids I
( O
indicumines B
A I
- I
B I
, O
1 O
- O
2 O
) O
and O
two O
new O
coumarinolignoids B
( O
indicumines B
C I
- I
D I
, O
3 O
- O
4 O
) O
, O
together O
with O
four O
known O
coumarins B
( O
5 O
- O
8 O
) O
. O

Swim O
training O
of O
monosodium B
L I
- I
glutamate I
- O
obese O
mice O
improves O
the O
impaired O
insulin O
receptor O
tyrosine B
phosphorylation O
in O
pancreatic O
islets O
. O

In O
addition O
, O
genes O
encoding O
tumor O
necrosis O
factor O
( O
TNF O
) O
, O
TNF O
receptor O
2 O
( O
TNFR2 O
) O
, O
and O
the O
signaling O
proteins O
stress O
- O
activated O
protein O
kinase O
( O
SAPK O
) O
/ O
Jun O
NH B
( I
2 I
) I
- O
terminal O
kinase O
( O
JNK O
) O
, O
were O
downregulated O
, O
and O
phosphorylated O
levels O
of O
SAPK O
/ O
JNK O
/ O
c O
- O
Jun O
were O
decreased O
in O
Retn O
( O
- O
/ O
- O
) O
mice O
. O

We O
examined O
in O
cats O
the O
1 O
) O
ulcerogenic O
effects O
of O
selective O
COX O
- O
1 O
( O
SC B
- I
560 I
, O
ketorolac B
) O
and O
COX O
- O
2 O
( O
celecoxib B
, O
meloxicam B
) O
inhibitors O
on O
the O
gastrointestinal O
mucosa O
, O
2 O
) O
effect O
of O
feeding O
and O
cimetidine B
on O
the O
expression O
of O
COX O
isoforms O
and O
prostaglandin B
E I
( I
2 I
) I
( O
PGE B
( I
2 I
) I
) O
level O
in O
the O
duodenum O
, O
and O
3 O
) O
localization O
of O
COX O
isoforms O
in O
the O
duodenum O
. O

Localization O
and O
expression O
of O
COX O
isoforms O
( O
by O
immunohistochemistry O
, O
Western O
blot O
) O
and O
PGE B
( I
2 I
) I
level O
( O
by O
enzyme O
immunoassay O
) O
were O
examined O
. O

Second O
, O
feeding O
increased O
both O
the O
expression O
of O
COX O
isoforms O
and O
PGE B
( I
2 I
) I
level O
in O
the O
duodenum O
, O
and O
the O
effects O
were O
markedly O
inhibited O
by O
pretreatment O
with O
cimetidine B
. O

Current O
knowledge O
of O
the O
coordination O
chemistry O
of O
d O
, O
f O
and O
p O
- O
block O
fluorides B
and O
oxide B
fluorides B
with O
neutral O
ligands O
( O
with O
donor O
atoms O
drawn O
from O
Groups O
15 O
and O
16 O
and O
including O
N B
- I
heterocyclic I
carbenes I
) O
is O
then O
presented O
and O
discussed O
, O
and O
the O
differences O
in O
properties O
compared O
to O
complexes O
containing O
the O
heavier O
halides B
are O
illustrated O
. O

Androstanol B
and O
androstenol B
, O
estrone B
, O
17 B
beta I
- I
estradiol I
, O
TCPOBOP B
, O
and O
CITCO B
showed O
compound O
- O
specific O
but O
similar O
affinities O
for O
both O
CARs O
. O

This O
study O
was O
conducted O
to O
investigate O
the O
potential O
of O
bambangan O
( O
Mangifera O
pajang O
) O
fruit O
extracts O
in O
the O
protection O
against O
oxidative O
damage O
caused O
by O
tert B
- I
butyl I
hydroperoxide I
in O
the O
human O
hepatocellular O
HepG2 O
cell O
line O
. O

C B
- I
dideoxyhexosyl I
flavones I
from O
the O
stems O
and O
leaves O
of O
Passiflora O
edulis O
Sims O
. O

HPLC O
analysis O
revealed O
gallic B
acid I
, O
trans B
- I
cinnamic I
acid I
, O
p B
- I
coumaric I
acid I
, O
and O
ferulic B
acid I
as O
the O
main O
compounds O
. O

HPLC O
analysis O
revealed O
gallic B
acid I
, O
trans B
- I
cinnamic I
acid I
, O
p B
- I
coumaric I
acid I
, O
and O
ferulic B
acid I
as O
the O
main O
compounds O
. O

The O
corresponding O
results O
emphasize O
why O
the O
use O
of O
[ O
( B
eta I
( I
7 I
) I
- I
C I
( I
7 I
) I
H I
( I
7 I
) I
) I
ZrCl I
( I
tmeda I
) I
] O
is O
clearly O
an O
advancement O
in O
the O
chemistry O
of O
the O
still O
fairly O
unexplored O
area O
of O
cycloheptatrienyl B
transition I
metal I
complexes I
. O

1 O
. O
In O
this O
study O
, O
hydrophilic O
interaction O
liquid O
chromatography O
( O
HILIC O
) O
, O
radiochemical O
activity O
monitoring O
and O
linear O
trap O
quadrupole O
orbitrap O
mass O
spectrometry O
( O
MS O
) O
and O
tandem O
mass O
spectrometry O
( O
MS O
/ O
MS O
) O
were O
used O
to O
identify O
the O
metabolites O
of O
a O
highly O
polar O
novel O
gamma B
- I
aminobutyric I
acid I
type O
- O
B O
receptor O
agonist O
, O
lesogaberan B
, O
in O
rats O
. O

The O
severe O
toxicity O
of O
antitumor O
organotin B
( I
IV I
) I
compounds O
limits O
their O
application O
in O
clinic O
, O
however O
, O
the O
toxic O
mechanism O
is O
still O
unclear O
. O

Di B
- I
n I
- I
butyl I
- I
di I
- I
( I
4 I
- I
chlorobenzohydroxama I
) I
Tin I
( I
IV I
) I
( O
DBDCT B
) O
, O
an O
antitumor O
agent O
with O
high O
activity O
and O
obvious O
neurotoxicity O
was O
chosen O
as O
a O
typical O
diorganotin B
( I
IV I
) I
compound O
to O
investigate O
its O
neurotoxic O
mechanism O
using O
PC12 O
cells O
and O
comprehensive O
methods O
. O

When O
these O
inhibition O
studies O
were O
performed O
with O
the O
artificial O
oxidant O
tert B
- I
butyl I
hydroperoxide I
, O
CYP2E1 O
did O
not O
significantly O
inhibit O
CYP2B4 O
activity O
. O

Songaricalarins B
A I
- I
E I
, O
cytotoxic O
oplopane B
sesquiterpenes I
from O
Ligularia O
songarica O
. O

Five O
new O
highly O
oxygenated B
oplopane I
sesquiterpenes I
, O
songaricalarins B
A I
- I
E I
( O
1 O
- O
5 O
) O
, O
and O
two O
known O
analogues O
( O
6 O
and O
7 O
) O
were O
isolated O
from O
the O
roots O
and O
rhizomes O
of O
Ligularia O
songarica O
. O

Since O
we O
wanted O
to O
focus O
on O
sub O
lethal O
ion O
- O
osmoregulatory O
and O
respiratory O
disturbances O
, O
arterial O
blood O
samples O
were O
analysed O
for O
pH O
( O
a O
) O
, O
PaO O
( O
2 O
) O
, O
haematocrit O
and O
total O
CO B
( I
2 I
) I
values O
at O
several O
time O
points O
. O

To O
further O
investigate O
ion O
and O
osmoregulation O
, O
Na B
( I
+ I
) I
/ O
K B
( I
+ I
) I
- O
ATPase O
activities O
in O
gill O
and O
rectal O
gland O
were O
analysed O
as O
well O
as O
rates O
of O
ammonia B
and O
urea B
excretion O
. O

To O
further O
investigate O
ion O
and O
osmoregulation O
, O
Na B
( I
+ I
) I
/ O
K B
( I
+ I
) I
- O
ATPase O
activities O
in O
gill O
and O
rectal O
gland O
were O
analysed O
as O
well O
as O
rates O
of O
ammonia B
and O
urea B
excretion O
. O

Pb B
caused O
impaired O
Na B
( I
+ I
) I
/ O
K B
( I
+ I
) I
- O
ATPase O
activity O
in O
gills O
, O
but O
not O
in O
rectal O
gland O
. O

Pb B
caused O
impaired O
Na B
( I
+ I
) I
/ O
K B
( I
+ I
) I
- O
ATPase O
activity O
in O
gills O
, O
but O
not O
in O
rectal O
gland O
. O

The O
association O
of O
serum O
25 B
- I
hydroxyvitamin I
D I
and O
vertebral O
fractures O
in O
patients O
with O
type O
2 O
diabetes O
. O

The O
objective O
of O
this O
study O
was O
to O
examine O
whether O
low O
serum O
25 B
- I
hydroxyvitamin I
D I
[ O
25 B
( I
OH I
) I
D I
] O
levels O
were O
associated O
with O
vertebral O
fractures O
in O
patients O
with O
type O
2 O
diabetes O
. O

In O
EPD O
, O
TiO B
( I
2 I
) I
nanoparticles O
were O
used O
to O
enhance O
the O
surface O
energy O
and O
create O
nanoporous O
structures O
, O
while O
BDA O
was O
employed O
to O
produce O
microporous O
structures O
. O

Filament O
formation O
and O
dissolution O
in O
the O
system O
Ag B
( I
Cu I
) I
/ O
ZrO B
( I
2 I
) I
/ O
Pt B
were O
observed O
by O
Liu O
et O
al O
. O

Filament O
formation O
and O
dissolution O
in O
the O
system O
Ag B
( I
Cu I
) I
/ O
ZrO B
( I
2 I
) I
/ O
Pt B
were O
observed O
by O
Liu O
et O
al O
. O

Unlike O
the O
majority O
of O
G O
protein O
- O
coupled O
receptors O
, O
the O
prostaglandin B
E I
( I
2 I
) I
( O
PGE B
( I
2 I
) I
) O
E B
- I
prostanoid I
3 O
( O
EP3 O
) O
receptor O
binds O
agonist O
with O
high O
affinity O
that O
is O
insensitive O
to O
the O
presence O
of O
guanosine B
5 I
[ I
prime I
] I
- I
O I
- I
( I
3 I
- I
thio I
) I
triphosphate I
( O
GTP B
gamma I
S I
) O
. O

We O
examined O
the O
effects O
of O
carbaryl B
( O
1 B
- I
naphthyl I
methylcarbamate I
; O
sevin B
) O
, O
a O
carbamate B
pesticide O
, O
on O
interrenal O
and O
thyroid O
activities O
and O
mitochondrial O
rich O
( O
MR O
) O
cell O
function O
in O
climbing O
perch O
to O
understand O
the O
physiological O
basis O
of O
toxicity O
acclimation O
in O
this O
fish O
to O
the O
chemical O
stressor O
. O

The O
ouabain B
- O
sensitive O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
- O
ATPase O
activity O
showed O
an O
increase O
in O
the O
gills O
but O
the O
intestinal O
and O
renal O
tissues O
showed O
little O
response O
to O
carbaryl B
treatment O
. O

The O
ouabain B
- O
sensitive O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
- O
ATPase O
activity O
showed O
an O
increase O
in O
the O
gills O
but O
the O
intestinal O
and O
renal O
tissues O
showed O
little O
response O
to O
carbaryl B
treatment O
. O

However O
, O
substantial O
increases O
in O
the O
intestinal O
and O
renal O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
- O
ATPase O
activities O
occurred O
in O
the O
recovery O
fish O
. O

However O
, O
substantial O
increases O
in O
the O
intestinal O
and O
renal O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
- O
ATPase O
activities O
occurred O
in O
the O
recovery O
fish O
. O

The O
MR O
cells O
in O
the O
branchial O
epithelia O
showed O
a O
strong O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
- O
ATPase O
immunoreactivity O
to O
carbaryl B
treatment O
indicating O
an O
activated O
MR O
cell O
function O
. O

The O
MR O
cells O
in O
the O
branchial O
epithelia O
showed O
a O
strong O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
- O
ATPase O
immunoreactivity O
to O
carbaryl B
treatment O
indicating O
an O
activated O
MR O
cell O
function O
. O

Lanthanum B
( I
III I
) I
regulates O
the O
nitrogen B
assimilation O
in O
soybean O
seedlings O
under O
ultraviolet O
- O
B O
radiation O
. O

Here O
, O
the O
regulation O
effects O
of O
lanthanum B
( O
La B
( I
III I
) I
) O
on O
nitrogen B
assimilation O
in O
soybean O
seedlings O
( O
Glycine O
max O
L O
. O
) O
under O
ultraviolet O
- O
B O
radiation O
were O
investigated O
to O
elucidate O
the O
regulation O
mechanism O
of O
REEs O
on O
plants O
under O
UV O
- O
B O
radiation O
. O

The O
pretreatment O
with O
20 O
mg O
L O
( O
- O
1 O
) O
La B
( I
III I
) I
could O
alleviate O
the O
effects O
of O
UV O
- O
B O
radiation O
on O
the O
activities O
of O
nitrate B
reductase O
, O
glutamine B
synthetase O
, O
glutamate B
synthase O
, O
and O
glutamate B
dehydrogenase O
, O
promoting O
amino B
acid I
conversion O
and O
protein O
synthesis O
in O
soybean O
seedlings O
. O

The O
regulation O
effect O
of O
La B
( I
III I
) I
under O
UV O
- O
B O
radiation O
at O
the O
low O
level O
was O
better O
than O
that O
of O
UV O
- O
B O
radiation O
at O
the O
high O
level O
. O

The O
results O
indicated O
that O
the O
pretreatment O
with O
20 O
mg O
L O
( O
- O
1 O
) O
La B
( I
III I
) I
could O
alleviate O
the O
inhibition O
of O
UV O
- O
B O
radiation O
on O
nitrogen B
assimilation O
in O
soybean O
seedlings O
. O

The O
design O
of O
pyridyl B
- O
based O
ligands O
for O
the O
separation O
of O
Am B
( I
III I
) I
from O
lanthanide B
( I
III I
) I
ions O
is O
considered O
, O
as O
well O
as O
ligands O
for O
the O
removal O
of O
metal O
ions O
such O
as O
Cu B
( I
II I
) I
or O
Zn B
( I
II I
) I
in O
neurological O
diseases O
such O
as O
Alzheimer O
' O
s O
. O

The O
design O
of O
pyridyl B
- O
based O
ligands O
for O
the O
separation O
of O
Am B
( I
III I
) I
from O
lanthanide B
( I
III I
) I
ions O
is O
considered O
, O
as O
well O
as O
ligands O
for O
the O
removal O
of O
metal O
ions O
such O
as O
Cu B
( I
II I
) I
or O
Zn B
( I
II I
) I
in O
neurological O
diseases O
such O
as O
Alzheimer O
' O
s O
. O

The O
design O
of O
pyridyl B
- O
based O
ligands O
for O
the O
separation O
of O
Am B
( I
III I
) I
from O
lanthanide B
( I
III I
) I
ions O
is O
considered O
, O
as O
well O
as O
ligands O
for O
the O
removal O
of O
metal O
ions O
such O
as O
Cu B
( I
II I
) I
or O
Zn B
( I
II I
) I
in O
neurological O
diseases O
such O
as O
Alzheimer O
' O
s O
. O

The O
design O
of O
pyridyl B
- O
based O
ligands O
for O
the O
separation O
of O
Am B
( I
III I
) I
from O
lanthanide B
( I
III I
) I
ions O
is O
considered O
, O
as O
well O
as O
ligands O
for O
the O
removal O
of O
metal O
ions O
such O
as O
Cu B
( I
II I
) I
or O
Zn B
( I
II I
) I
in O
neurological O
diseases O
such O
as O
Alzheimer O
' O
s O
. O

It O
is O
concluded O
that O
for O
lighter O
metal O
ions O
with O
smaller O
zeta O
values O
such O
as O
Zn B
( I
II I
) I
and O
Ca B
( I
II I
) I
, O
and O
to O
a O
lesser O
extent O
Cd B
( I
II I
) I
, O
that O
the O
CHEF O
effect O
can O
be O
achieved O
with O
pyridyl B
- O
containing O
fluorophores O
that O
coordinate O
directly O
to O
the O
metal O
ion O
. O

It O
is O
concluded O
that O
for O
lighter O
metal O
ions O
with O
smaller O
zeta O
values O
such O
as O
Zn B
( I
II I
) I
and O
Ca B
( I
II I
) I
, O
and O
to O
a O
lesser O
extent O
Cd B
( I
II I
) I
, O
that O
the O
CHEF O
effect O
can O
be O
achieved O
with O
pyridyl B
- O
containing O
fluorophores O
that O
coordinate O
directly O
to O
the O
metal O
ion O
. O

It O
is O
concluded O
that O
for O
lighter O
metal O
ions O
with O
smaller O
zeta O
values O
such O
as O
Zn B
( I
II I
) I
and O
Ca B
( I
II I
) I
, O
and O
to O
a O
lesser O
extent O
Cd B
( I
II I
) I
, O
that O
the O
CHEF O
effect O
can O
be O
achieved O
with O
pyridyl B
- O
containing O
fluorophores O
that O
coordinate O
directly O
to O
the O
metal O
ion O
. O

The O
way O
in O
which O
steric O
effects O
can O
be O
used O
to O
decrease O
the O
CHEF O
effect O
in O
Zn B
( I
II I
) I
relative O
to O
Cd B
( I
II I
) I
to O
enable O
selective O
sensing O
of O
the O
latter O
is O
analyzed O
. O

The O
way O
in O
which O
steric O
effects O
can O
be O
used O
to O
decrease O
the O
CHEF O
effect O
in O
Zn B
( I
II I
) I
relative O
to O
Cd B
( I
II I
) I
to O
enable O
selective O
sensing O
of O
the O
latter O
is O
analyzed O
. O

For O
heavier O
metal O
ions O
such O
as O
Hg B
( I
II I
) I
and O
Pb B
( I
II I
) I
, O
because O
of O
their O
large O
zeta O
values O
which O
quench O
fluorescence O
, O
it O
is O
concluded O
that O
the O
fluorophore O
should O
be O
tethered O
to O
the O
metal O
- O
binding O
part O
of O
the O
sensor O
, O
and O
prevented O
from O
binding O
to O
the O
metal O
ion O
by O
steric O
and O
electronic O
factors O
. O

For O
heavier O
metal O
ions O
such O
as O
Hg B
( I
II I
) I
and O
Pb B
( I
II I
) I
, O
because O
of O
their O
large O
zeta O
values O
which O
quench O
fluorescence O
, O
it O
is O
concluded O
that O
the O
fluorophore O
should O
be O
tethered O
to O
the O
metal O
- O
binding O
part O
of O
the O
sensor O
, O
and O
prevented O
from O
binding O
to O
the O
metal O
ion O
by O
steric O
and O
electronic O
factors O
. O

How O
Hg B
( I
II I
) I
can O
quench O
the O
CHEF O
effect O
by O
pi O
- O
contact O
with O
fluorophores O
such O
as O
the O
anthracenyl B
group O
, O
which O
at O
first O
sight O
might O
not O
seem O
able O
to O
bond O
with O
metal O
ions O
, O
is O
examined O
. O

However O
, O
other O
BAs O
, O
like O
beta B
- I
boswellic I
acid I
( O
beta B
BA I
) O
, O
might O
also O
contribute O
to O
the O
anti O
- O
inflammatory O
actions O
of O
BSE O
. O

Here O
, O
we O
determined O
the O
metabolic O
stability O
, O
permeability O
and O
brain O
availability O
of O
six O
major O
BAs O
, O
that O
is O
, O
KBA B
, O
AKBA B
, O
beta B
BA I
, O
3 B
- I
acetyl I
- I
beta I
- I
boswellic I
acid I
( O
A B
beta I
BA I
) O
, O
alpha B
- I
boswellic I
acid I
( O
alpha B
BA I
) O
, O
and O
3 B
- I
acetyl I
- I
alpha I
- I
boswellic I
acid I
( O
A B
alpha I
BA I
) O
. O

Arsenic B
trioxide I
- O
induced O
hERG O
K B
( I
+ I
) I
channel O
deficiency O
can O
be O
rescued O
by O
matrine B
and O
oxymatrine B
through O
up O
- O
regulating O
transcription O
factor O
Sp1 O
expression O
. O

[ B
2 I
, I
5 I
- I
( I
15 I
) I
N I
] I
Ornithine I
or O
( B
15 I
) I
NH I
( I
4 I
) I
( I
+ I
) I
were O
administered O
intravenously O
and O
the O
incorporation O
of O
( B
15 I
) I
N I
in O
amino B
acids I
as O
well O
as O
the O
content O
of O
the O
amino B
acids I
were O
subsequently O
determined O
in O
plasma O
, O
skeletal O
muscle O
, O
liver O
and O
kidney O
. O

OP O
treatment O
did O
not O
increase O
( B
15 I
) I
N I
labeling O
in O
glutamine B
from O
[ B
2 I
, I
5 I
- I
( I
15 I
) I
N I
] I
ornithine I
and O
( B
15 I
) I
NH I
( I
4 I
) I
( I
+ I
) I
in O
skeletal O
muscle O
or O
liver O
. O

Seven O
constituents O
were O
isolated O
from O
the O
stems O
of O
Lawsonia O
alba O
Lam O
. O
, O
following O
an O
activity O
- O
guided O
isolation O
, O
which O
include O
two O
new O
constituents O
, O
namely O
lawsorosemarinol B
( O
1 O
) O
and O
lawsofructose B
( O
2 O
) O
, O
one O
known O
compound O
2 B
- I
( I
beta I
- I
d I
- I
glucopyranosyloxy I
) I
- I
1 I
, I
4 I
- I
naphthoquinone I
( O
3 O
) O
and O
four O
compounds O
, O
4 B
- I
hydroxy I
coumarine I
( O
4 O
) O
, O
3 B
- I
( I
4 I
- I
hyroxyphenyl I
) I
- I
triacontyl I
- I
( I
Z I
) I
- I
propenoate I
( O
5 O
) O
, O

N B
- I
Arachidonyl I
glycine I
does O
not O
activate O
G O
protein O
- O
coupled O
receptor O
18 O
signaling O
via O
canonical O
pathways O
. O

Recent O
studies O
propose O
that O
N B
- I
arachidonyl I
glycine I
( O
NAGly B
) O
, O
a O
carboxylic B
analogue O
of O
anandamide B
, O
is O
an O
endogenous O
ligand O
of O
the O
G O
alpha O
( O
i O
/ O
o O
) O
protein O
- O
coupled O
receptor O
18 O
( O
GPR18 O
) O
. O

Rat O
aortic O
VSMC O
were O
treated O
with O
1 O
- O
100 O
micro O
M O
of O
either O
sodium B
arsenate I
( O
As B
( I
V I
) I
) O
, O
sodium B
arsenite I
( O
As B
( I
III I
) I
) O
, O
monomethylarsonic B
acid I
, O
or O
dimethylarsinic B
acid I
. O

Rat O
aortic O
VSMC O
were O
treated O
with O
1 O
- O
100 O
micro O
M O
of O
either O
sodium B
arsenate I
( O
As B
( I
V I
) I
) O
, O
sodium B
arsenite I
( O
As B
( I
III I
) I
) O
, O
monomethylarsonic B
acid I
, O
or O
dimethylarsinic B
acid I
. O

None O
of O
the O
treatments O
induced O
VSMC O
calcification O
in O
the O
presence O
of O
1mM O
inorganic O
phosphate B
( O
Pi O
) O
, O
but O
1 O
micro O
M O
As B
( I
III I
) I
did O
increase O
calcification O
when O
induced O
with O
2 O
. O
5mM O
Pi O
. O

A O
lactate B
dehydrogenase O
assay O
revealed O
that O
this O
increase O
was O
explained O
by O
a O
rise O
in O
cytotoxicity O
due O
to O
simultaneous O
incubation O
with O
1 O
micro O
M O
As B
( I
III I
) I
and O
2 O
. O
5mM O
Pi O
. O

Nevertheless O
, O
both O
senescence O
- O
associated O
beta O
- O
galactosidase O
activity O
and O
p21 O
expression O
were O
increased O
by O
As B
( I
III I
) I
, O
which O
reveals O
the O
induction O
of O
SIPS O
. O

As B
( I
III I
) I
also O
caused O
dedifferentiation O
of O
VSMC O
, O
as O
shown O
by O
the O
reduced O
expression O
of O
the O
VSMC O
markers O
SM22 O
alpha O
and O
calponin O
. O

Senescence O
and O
gene O
expression O
were O
also O
observed O
in O
the O
aortas O
of O
healthy O
rats O
treated O
with O
50 O
ppm O
As B
( I
V I
) I
in O
drinking O
water O
for O
1 O
month O
. O

Methotrexate B
- O
conjugated O
and O
hyperbranched O
polyglycerol B
- O
grafted O
Fe B
3 I
O I
4 I
magnetic O
nanoparticles O
for O
targeted O
anticancer O
effects O
. O

Significant O
effects O
could O
be O
observed O
after O
incubation O
with O
griseofulvin B
as O
measured O
by O
Wst B
- I
1 I
- O
, O
BrdUrd B
- O
, O
and O
[ B
3H I
] I
dT I
- O
uptake O
assays O
. O

The O
increased O
inhaled O
application O
of O
titanium B
dioxide I
nanoparticles O
( O
TiO B
( I
2 I
) I
NPs O
) O
increases O
the O
potential O
pulmonary O
health O
risks O
. O

The O
present O
investigations O
were O
carried O
out O
to O
study O
the O
TiO B
( I
2 I
) I
NPs O
- O
induced O
apoptosis O
, O
oxidative O
stress O
and O
genotoxicity O
in O
the O
human O
lung O
cancer O
cell O
line O
, O
A549 O
, O
a O
widely O
used O
cell O
system O
for O
pulmonary O
toxicity O
studies O
. O

Cells O
exposed O
to O
TiO B
( I
2 I
) I
NPs O
( O
10 O
and O
50 O
mu O
g O
/ O
ml O
) O
for O
6 O
- O
24 O
h O
shows O
significant O
induction O
in O
oxidative O
stress O
, O
that O
is O
, O
the O
production O
of O
reactive O
oxygen B
species O
and O
malondialdehyde B
and O
decrease O
in O
the O
activity O
of O
catalase O
and O
glutathione B
. O

TiO B
( I
2 I
) I
NPs O
exposure O
also O
induces O
the O
formation O
of O
apoptotic O
bodies O
and O
micronucleus O
as O
marker O
of O
genotoxicity O
. O

TiO B
( I
2 I
) I
NPs O
exposure O
could O
not O
pose O
significant O
effects O
on O
Bax O
expression O
. O

Data O
indicate O
that O
nano O
- O
TiO B
( I
2 I
) I
induces O
oxidative O
stress O
, O
genotoxicity O
and O
apoptosis O
in O
human O
lung O
cancer O
cell O
line O
, O
A549 O
. O

Our O
result O
also O
identifies O
the O
mechanisms O
involved O
in O
TiO B
( I
2 I
) I
NP O
- O
induced O
changes O
in O
A549 O
cells O
. O

Perhaps O
, O
reporting O
for O
the O
first O
time O
, O
the O
association O
of O
TiO B
( I
2 I
) I
NPs O
- O
induced O
genotoxicity O
and O
apoptosis O
at O
transcriptional O
and O
translational O
level O
in O
the O
human O
lung O
cancer O
cell O
line O
, O
A549 O
cells O
. O

By O
using O
the O
whole O
- O
cell O
patch O
- O
clamp O
configurations O
, O
we O
found O
ECG B
enhanced O
the O
slowly O
inactivating O
component O
of O
voltage O
- O
gated O
Na B
( I
+ I
) I
currents O
( O
I O
( O
Na B
) O
) O
in O
a O
concentration O
- O
dependent O
manner O
( O
0 O
. O
1 O
- O
100 O
mu O
M O
) O
with O
an O
EC O
( O
50 O
) O
value O
of O
3 O
. O
8 O
mu O
M O
. O

Working O
at O
a O
concentration O
level O
of O
I O
( O
Na B
) O
enhancement O
, O
ECG B
has O
no O
notable O
effect O
on O
voltage O
- O
gated O
K B
( I
+ I
) I
currents O
and O
L O
- O
type O
Ca B
( I
2 I
+ I
) I
currents O
. O

Expression O
of O
Na B
( I
+ I
) I
/ O
I B
( I
- I
) I
symporter O
( O
NIS O
( O
SLC5A5 O
) O
) O
, O
the O
glycoprotein O
responsible O
for O
iodide B
transport O
, O
has O
been O
demonstrated O
in O
normal O
testicular O
tissue O
. O

Expression O
of O
Na B
( I
+ I
) I
/ O
I B
( I
- I
) I
symporter O
( O
NIS O
( O
SLC5A5 O
) O
) O
, O
the O
glycoprotein O
responsible O
for O
iodide B
transport O
, O
has O
been O
demonstrated O
in O
normal O
testicular O
tissue O
. O

The O
purity O
of O
sulforaphene B
was O
determined O
by O
HPLC O
analysis O
and O
its O
chemical O
structure O
was O
assessed O
by O
MS O
, O
( B
1 I
) I
H I
NMR O
, O
( B
13 I
) I
C I
NMR O
and O
DEPT O
- O
135 O
NMR O
. O

The O
purity O
of O
sulforaphene B
was O
determined O
by O
HPLC O
analysis O
and O
its O
chemical O
structure O
was O
assessed O
by O
MS O
, O
( B
1 I
) I
H I
NMR O
, O
( B
13 I
) I
C I
NMR O
and O
DEPT O
- O
135 O
NMR O
. O

The O
enzyme O
was O
extracted O
using O
a O
non O
- O
ionic O
detergent O
( O
Triton B
X I
- I
114 I
) O
, O
followed O
by O
temperature O
- O
induced O
phase O
partitioning O
technique O
which O
resulted O
in O
two O
separate O
layers O
( O
detergent O
- O
poor O
phase O
at O
the O
upper O
layer O
and O
detergent O
- O
rich O
phase O
at O
the O
lower O
layer O
) O
. O

High O
resolution O
( B
1 I
) I
H I
NMR O
spectroscopy O
was O
proposed O
for O
the O
determination O
of O
the O
fatty B
acid I
chain O
profile O
of O
lipids O
in O
pork O
meat O
products O
during O
ripening O
. O

The O
major O
compound O
found O
in O
all O
the O
preparations O
was O
luteolin B
O I
- I
acylhexoside I
. O

Many O
major O
components O
( O
> O
50 O
) O
of O
beeswax O
, O
odd O
and O
even O
hydrocarbons B
, O
oleofin B
, O
palmitate B
, O
oleate B
and O
hydroxypalmitate B
monoesters I
were O
detected O
, O
and O
for O
the O
first O
time O
palmitate B
and I
oleate I
monoesters I
esterified O
with O
1 B
- I
octadecanol I
and O
1 B
- I
eicosanol I
are O
reported O
to O
be O
present O
in O
beeswax O
. O

( B
23 I
) I
Na I
nuclear O
magnetic O
resonance O
( O
NMR O
) O
spectroscopy O
was O
used O
to O
study O
the O
molecular O
mobility O
of O
sodium B
ions O
in O
model O
cheeses O
through O
measurements O
of O
the O
relaxation O
and O
creation O
times O
. O

First O
- O
principles O
calculations O
of O
lithium B
- O
ion O
migration O
at O
a O
coherent O
grain O
boundary O
in O
a O
cathode O
material O
, O
LiCoO B
( I
2 I
) I
. O

Results O
of O
theoretical O
calculations O
are O
reported O
, O
examining O
the O
effect O
of O
a O
coherent O
twin O
boundary O
on O
the O
electrical O
properties O
of O
LiCoO B
( I
2 I
) I
. O

This O
study O
suggests O
that O
internal O
interfaces O
in O
LiCoO B
( I
2 I
) I
strongly O
affect O
the O
battery O
voltage O
, O
battery O
capacity O
, O
and O
power O
density O
of O
this O
material O
, O
which O
is O
of O
particular O
concern O
if O
it O
is O
used O
in O
all O
- O
solid O
- O
state O
Li B
- O
ion O
batteries O
. O

Chromatographic O
analysis O
revealed O
that O
ethion B
was O
degraded O
into O
ethion B
monooxon I
, O
ethion B
dioxon I
, O
O B
, I
O I
- I
diethyl I
phosphorothioate I
, O
O B
- I
ethyl I
phosphorothioate I
and O
one O
unknown O
compound O
. O

Precision O
- O
cut O
liver O
slices O
from O
humans O
and O
other O
species O
have O
been O
used O
to O
study O
pathways O
of O
phase O
I O
( O
e O
. O
g O
. O
cytochrome O
P450 O
- O
dependent O
biotransformations O
) O
and O
II O
( O
e O
. O
g O
. O
conjugation O
with O
D B
- I
glucuronic I
acid I
, O
sulphate B
and O
glutathione B
) O
metabolism O
of O
a O
wide O
range O
of O
xenobiotics O
. O

Annealing O
of O
MnO B
@ O
SiO B
( I
2 I
) I
nanospheres O
in O
a O
reducing O
gas O
environment O
resulted O
in O
the O
transformation O
of O
the O
core O
- O
shell O
structure O
into O
a O
hollow O
structure O
as O
a O
result O
of O
outward O
diffusion O
of O
MnO B
species O
into O
the O
thermodynamically O
more O
stable O
silicate B
phase O
. O

Therefore O
, O
when O
MnO B
@ O
SiO B
( I
2 I
) I
/ O
Pt B
( I
II I
) I
nanospheres O
were O
subjected O
to O
an O
oxidation O
/ O
reduction O
cycle O
by O
repeatedly O
switching O
the O
flowing O
gas O
between O
air O
and O
hydrogen B
, O
the O
nanospheres O
underwent O
a O
reversible O
change O
between O
solid O
and O
hollow O
structures O
, O
depending O
on O
the O
gas O
environment O
. O

Therefore O
, O
when O
MnO B
@ O
SiO B
( I
2 I
) I
/ O
Pt B
( I
II I
) I
nanospheres O
were O
subjected O
to O
an O
oxidation O
/ O
reduction O
cycle O
by O
repeatedly O
switching O
the O
flowing O
gas O
between O
air O
and O
hydrogen B
, O
the O
nanospheres O
underwent O
a O
reversible O
change O
between O
solid O
and O
hollow O
structures O
, O
depending O
on O
the O
gas O
environment O
. O

Copper B
toxicity O
and O
accumulation O
in O
plants O
are O
affected O
by O
physicochemical O
characteristics O
of O
soil O
solutions O
such O
as O
the O
concentrations O
of O
coexistent O
cations O
( O
e O
. O
g O
. O
, O
Ca B
( I
2 I
+ I
) I
, O
Mg B
( I
2 I
+ I
) I
, O
K B
( I
+ I
) I
, O
Na B
( I
+ I
) I
, O
and O
H B
( I
+ I
) I
) O
. O

Copper B
toxicity O
and O
accumulation O
in O
plants O
are O
affected O
by O
physicochemical O
characteristics O
of O
soil O
solutions O
such O
as O
the O
concentrations O
of O
coexistent O
cations O
( O
e O
. O
g O
. O
, O
Ca B
( I
2 I
+ I
) I
, O
Mg B
( I
2 I
+ I
) I
, O
K B
( I
+ I
) I
, O
Na B
( I
+ I
) I
, O
and O
H B
( I
+ I
) I
) O
. O

Copper B
toxicity O
and O
accumulation O
in O
plants O
are O
affected O
by O
physicochemical O
characteristics O
of O
soil O
solutions O
such O
as O
the O
concentrations O
of O
coexistent O
cations O
( O
e O
. O
g O
. O
, O
Ca B
( I
2 I
+ I
) I
, O
Mg B
( I
2 I
+ I
) I
, O
K B
( I
+ I
) I
, O
Na B
( I
+ I
) I
, O
and O
H B
( I
+ I
) I
) O
. O

This O
is O
the O
first O
study O
to O
demonstrate O
sonoelectrocatalytic O
disinfection O
using O
titanium B
dioxide I
( O
TiO B
( I
2 I
) I
) O
as O
an O
anode O
for O
effective O
inactivation O
of O
Escherichia O
coli O
. O

In O
brief O
, O
a O
non O
- O
woven O
TiO B
( I
2 I
) I
fabric O
used O
as O
an O
anode O
and O
a O
platinum B
cathode O
were O
immersed O
in O
an O
E O
. O
coli O
suspension O
in O
which O
a O
positive O
potential O
was O
applied O
to O
TiO B
( I
2 I
) I
concomitant O
with O
ultrasound O
( O
US O
) O
irradiation O
. O

In O
brief O
, O
a O
non O
- O
woven O
TiO B
( I
2 I
) I
fabric O
used O
as O
an O
anode O
and O
a O
platinum B
cathode O
were O
immersed O
in O
an O
E O
. O
coli O
suspension O
in O
which O
a O
positive O
potential O
was O
applied O
to O
TiO B
( I
2 I
) I
concomitant O
with O
ultrasound O
( O
US O
) O
irradiation O
. O

One O
was O
disinfection O
by O
applying O
a O
positive O
potential O
to O
a O
TiO B
( I
2 I
) I
electrode O
, O
but O
without O
US O
irradiation O
( O
electrochemical O
disinfection O
) O
. O

The O
other O
was O
disinfection O
without O
applying O
a O
potential O
, O
but O
with O
US O
irradiation O
in O
the O
presence O
of O
TiO B
( I
2 I
) I
( O
sonocatalytic O
disinfection O
) O
. O

This O
synergistically O
enhanced O
inactivation O
rate O
of O
E O
. O
coli O
cells O
was O
attributable O
to O
effective O
reaction O
of O
the O
sonocatalytically O
generated O
OH B
radicals O
with O
E O
. O
coli O
cells O
at O
the O
surface O
of O
the O
TiO B
( I
2 I
) I
anode O
, O
which O
resulted O
from O
the O
electroadsorption O
of O
E O
. O
coli O
cells O
toward O
the O
TiO B
( I
2 I
) I
anode O
. O

This O
synergistically O
enhanced O
inactivation O
rate O
of O
E O
. O
coli O
cells O
was O
attributable O
to O
effective O
reaction O
of O
the O
sonocatalytically O
generated O
OH B
radicals O
with O
E O
. O
coli O
cells O
at O
the O
surface O
of O
the O
TiO B
( I
2 I
) I
anode O
, O
which O
resulted O
from O
the O
electroadsorption O
of O
E O
. O
coli O
cells O
toward O
the O
TiO B
( I
2 I
) I
anode O
. O

Venom O
fractions O
were O
tested O
in O
electrophysiological O
assays O
on O
a O
panel O
of O
six O
K B
( I
+ I
) I
channels O
( O
K B
( O
v O
) O
1 O
. O
1 O
- O
1 O
. O
6 O
) O
by O
using O
the O
two O
- O
electrode O
voltage O
clamp O
technique O
. O

Three O
new O
alpha O
- O
KTx O
peptides O
were O
found O
and O
called O
MegKTx1 O
, O
MegKTx2 O
and O
MegKTx3 O
( O
M O
. O
gibbosus O
, O
K B
( I
+ I
) I
channel O
toxin O
number O
1 O
- O
3 O
) O
. O

Interestingly O
, O
diclofenac B
and O
flufenamic B
acid I
but O
not O
piroxicam B
significantly O
increased O
the O
extracellular O
superoxide B
anion O
production O
by O
neutrophils O
, O
and O
inhibition O
of O
nicotinamide B
adenine I
dinucleotide I
phosphate I
( O
NADPH B
) O
- O
oxidase O
activity O
with O
diphenyleneiodonium B
prevented O
the O
down O
- O
regulation O
of O
L O
- O
selectin O
by O
diclofenac B
. O

Comparative O
analysis O
of O
gene O
expression O
profiles O
revealed O
that O
some O
genes O
were O
commonly O
upregulated O
or O
downregulated O
in O
the O
renal O
papilla O
, O
reflecting O
papillary O
injuries O
induced O
by O
2 B
- I
bromoethylamine I
hydrobromide I
, O
phenylbutazone B
, O
or O
n B
- I
phenylanthranilic I
acid I
. O

Comparative O
analysis O
of O
gene O
expression O
profiles O
revealed O
that O
some O
genes O
were O
commonly O
upregulated O
or O
downregulated O
in O
the O
renal O
papilla O
, O
reflecting O
papillary O
injuries O
induced O
by O
2 B
- I
bromoethylamine I
hydrobromide I
, O
phenylbutazone B
, O
or O
n B
- I
phenylanthranilic I
acid I
. O

We O
examined O
the O
acute O
physiological O
responses O
to O
high O
environmental O
ammonia B
( O
HEA O
) O
, O
particularly O
the O
linkages O
between O
branchial O
ammonia B
fluxes O
and O
unidirectional O
Na B
( I
+ I
) I
fluxes O
, O
as O
well O
as O
urea B
excretion O
, O
cortisol B
, O
and O
indicators O
of O
gill O
permeability O
in O
three O
freshwater O
teleosts O
differing O
in O
their O
sensitivities O
to O
ammonia B
; O
the O
highly O
sensitive O
salmonid O
Oncorhynchus O
mykiss O
( O
rainbow O
trout O
) O
, O
the O
less O
sensitive O
cyprinid O
Cyprinus O
carpio O
( O
common O
carp O
) O
and O
the O
highly O
resistant O
cyprinid O

At O
1mM O
HEA O
, O
Na B
( I
+ I
) I
imbalance O
became O
progressively O
more O
severe O
in O
trout O
and O
carp O
due O
to O
a O
stimulation O
of O
unidirectional O
Na B
( I
+ I
) I
efflux O
( O
J O
( O
out O
) O
( O
Na B
) O
) O
without O
a O
concomitant O
increase O
in O
unidirectional O
Na B
( I
+ I
) I
influx O
( O
J O
( O
in O
) O
( O
Na B
) O
) O
. O

At O
1mM O
HEA O
, O
Na B
( I
+ I
) I
imbalance O
became O
progressively O
more O
severe O
in O
trout O
and O
carp O
due O
to O
a O
stimulation O
of O
unidirectional O
Na B
( I
+ I
) I
efflux O
( O
J O
( O
out O
) O
( O
Na B
) O
) O
without O
a O
concomitant O
increase O
in O
unidirectional O
Na B
( I
+ I
) I
influx O
( O
J O
( O
in O
) O
( O
Na B
) O
) O
. O

At O
1mM O
HEA O
, O
Na B
( I
+ I
) I
imbalance O
became O
progressively O
more O
severe O
in O
trout O
and O
carp O
due O
to O
a O
stimulation O
of O
unidirectional O
Na B
( I
+ I
) I
efflux O
( O
J O
( O
out O
) O
( O
Na B
) O
) O
without O
a O
concomitant O
increase O
in O
unidirectional O
Na B
( I
+ I
) I
influx O
( O
J O
( O
in O
) O
( O
Na B
) O
) O
. O

Goldfish O
showed O
an O
opposite O
trend O
for O
J O
( O
out O
) O
( O
Na B
) O
with O
reduced O
efflux O
rates O
and O
a O
positive O
Na B
( I
+ I
) I
balance O
during O
the O
first O
few O
hours O
of O
HEA O
. O

However O
, O
after O
12 O
h O
of O
exposure O
, O
both O
J O
( O
in O
) O
( O
Na B
) O
and O
J O
( O
out O
) O
( O
Na B
) O
were O
also O
increased O
in O
both O
carp O
and O
goldfish O
, O
whereas O
only O
J O
( O
out O
) O
( O
Na B
) O
was O
increased O
in O
trout O
, O
leading O
to O
a O
net O
Na B
( I
+ I
) I
loss O
. O

Na B
( I
+ I
) I
homeostasis O
was O
entirely O
disrupted O
in O
all O
three O
species O
when O
subjected O
to O
the O
5 O
or O
1 O
. O
4 O
mM O
ammonia B
for O
3 O
h O
: O
J O
( O
in O
) O
( O
Na B
) O
was O
significantly O
inhibited O
while O
considerable O
activation O
of O
J O
( O
out O
) O
( O
Na B
) O
was O
observed O
. O

Diffusive O
water O
efflux O
rates O
and O
net O
K B
( I
+ I
) I
loss O
rates O
across O
the O
gills O
were O
enhanced O
during O
HEA O
only O
in O
trout O
, O
indicating O
an O
increment O
in O
gill O
transcellular O
permeability O
. O

The O
novel O
metabolite O
21 B
- I
nortriamcinolone I
acetonide I
was O
also O
identified O
by O
liquid O
chromatography O
- O
mass O
spectrometry O
and O
NMR O
analysis O
. O

Recently O
, O
it O
has O
been O
proven O
that O
directional O
flow O
of O
photogenerated O
charge O
carriers O
occurs O
on O
specific O
facets O
of O
TiO B
( I
2 I
) I
nanocrystals O
. O

Herein O
, O
we O
demonstrate O
that O
the O
photocatalytic O
activity O
of O
anatase O
TiO B
( I
2 I
) I
nanocrystals O
in O
both O
photoreduction O
and O
photooxidation O
processes O
can O
be O
enhanced O
by O
selectively O
depositing O
Pt B
nanoparticles O
on O
the O
{ O
101 O
} O
facets O
, O
which O
strengthens O
spontaneously O
surface O
- O
induced O
separation O
between O
photogenerated O
electrons O
and O
holes O
in O
the O
photocatalysis O
process O
. O

An O
optimal O
ratio O
of O
the O
oxidative O
{ O
001 O
} O
facets O
to O
the O
reductive O
{ O
101 O
} O
facets O
exists O
with O
regard O
to O
the O
photocatalysis O
of O
the O
faceted O
TiO B
( I
2 I
) I
nanocrystals O
, O
and O
this O
is O
crucial O
for O
balancing O
the O
recombination O
and O
redox O
reaction O
rates O
of O
photogenerated O
electrons O
and O
holes O
. O

Structural O
optimization O
of O
2 B
, I
5 I
- I
thiophene I
amides I
as O
highly O
potent O
and O
selective O
17 B
beta I
- I
hydroxysteroid I
dehydrogenase O
type O
2 O
inhibitors O
for O
the O
treatment O
of O
osteoporosis O
. O

Extracellular O
purine B
and I
pyrimidine I
nucleotides I
are O
involved O
in O
the O
physiology O
of O
virtually O
every O
body O
district O
, O
and O
their O
extracellular O
concentrations O
massively O
increase O
under O
pathological O
situations O
, O
suggesting O
that O
they O
might O
represent O
potential O
targets O
for O
the O
modulation O
of O
disease O
- O
associated O
symptoms O
, O
like O
pain O
. O

Toxicity O
of O
the O
synthetic O
polymeric O
3 B
- I
alkylpyridinium I
salt I
( O
APS3 B
) O
is O
due O
to O
specific O
block O
of O
nicotinic O
acetylcholine B
receptors O
. O

The O
in O
vivo O
and O
in O
vitro O
toxic O
effects O
of O
the O
synthetic O
polymeric O
3 B
- I
alkylpyridinium I
salt I
( O
APS3 B
) O
, O
from O
the O
Mediterranean O
marine O
sponge O
Reniera O
sarai O
, O
were O
evaluated O
on O
mammals O
, O
with O
emphasis O
to O
determine O
its O
mode O
of O
action O
. O

Data O
are O
presented O
showing O
the O
spontaneous O
formation O
of O
electric O
fields O
within O
solid O
films O
of O
the O
chlorofluorocarbons B
( O
CFCs B
) O
CF B
( I
3 I
) I
Cl I
, O
CF B
( I
2 I
) I
Cl I
( I
2 I
) I
and O
CFCl B
( I
3 I
) I
as O
a O
function O
of O
film O
deposition O
temperature O
from O
40 O
K O
and O
above O
. O

Maximum O
deposition O
temperatures O
for O
display O
of O
an O
electric O
field O
lie O
at O
~ O
50 O
K O
, O
~ O
65 O
K O
and O
~ O
52 O
K O
for O
CF B
( I
3 I
) I
Cl I
, O
CF B
( I
2 I
) I
Cl I
( I
2 I
) I
and O
CFCl B
( I
3 I
) I
respectively O
. O

CFCl B
( I
3 I
) I
films O
possess O
electric O
fields O
which O
show O
an O
onset O
of O
temporal O
metastability O
between O
deposition O
temperatures O
of O
46 O
K O
and O
50 O
K O
. O

CFCl B
( I
3 I
) I
displays O
a O
comparatively O
sharp O
Curie O
point O
at O
55 O
K O
. O

The O
title O
compounds O
were O
characterized O
by O
FT O
- O
IR O
, O
NMR O
( O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
) O
and O
elemental O
analysis O
. O

The O
title O
compounds O
were O
characterized O
by O
FT O
- O
IR O
, O
NMR O
( O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
) O
and O
elemental O
analysis O
. O

In O
order O
to O
differentiate O
between O
exogenous O
and O
endogenous O
FA O
the O
rats O
were O
exposed O
to O
stable O
isotope O
( O
( B
13 I
) I
C I
) O
labeled O
FA O
by O
inhalation O
. O

Density O
functional O
theory O
calculations O
were O
performed O
to O
examine O
the O
effect O
of O
a O
C B
vacancy O
on O
the O
physisorption O
of O
H B
( I
2 I
) I
onto O
Ti B
- O
functionalized O
C B
( I
60 I
) I
fullerene I
when O
H B
( I
2 I
) I
is O
oriented O
along O
the O
x O
- O
, O
y O
- O
, O
and O
z O
- O
axes O
of O
the O
fullerene B
. O

Density O
functional O
theory O
calculations O
were O
performed O
to O
examine O
the O
effect O
of O
a O
C B
vacancy O
on O
the O
physisorption O
of O
H B
( I
2 I
) I
onto O
Ti B
- O
functionalized O
C B
( I
60 I
) I
fullerene I
when O
H B
( I
2 I
) I
is O
oriented O
along O
the O
x O
- O
, O
y O
- O
, O
and O
z O
- O
axes O
of O
the O
fullerene B
. O

The O
effect O
of O
the O
C B
vacancy O
on O
the O
physisorption O
modes O
of O
H B
( I
2 I
) I
was O
investigated O
as O
a O
function O
of O
H B
( I
2 I
) I
binding O
energy O
within O
the O
energy O
window O
( O
- O
0 O
. O
2 O
to O
- O
0 O
. O
6 O
eV O
) O
targeted O
by O
the O
Department O
of O
Energy O
( O
DOE O
) O
, O
and O
as O
functions O
of O
a O
variety O
of O
other O
physicochemical O
properties O
. O

The O
effect O
of O
the O
C B
vacancy O
on O
the O
physisorption O
modes O
of O
H B
( I
2 I
) I
was O
investigated O
as O
a O
function O
of O
H B
( I
2 I
) I
binding O
energy O
within O
the O
energy O
window O
( O
- O
0 O
. O
2 O
to O
- O
0 O
. O
6 O
eV O
) O
targeted O
by O
the O
Department O
of O
Energy O
( O
DOE O
) O
, O
and O
as O
functions O
of O
a O
variety O
of O
other O
physicochemical O
properties O
. O

The O
results O
indicate O
that O
the O
preferential O
orientations O
of O
H B
( I
2 I
) I
in O
the O
defect O
- O
free O
( O
i O
. O
e O
. O
, O
no O
C B
vacancy O
) O
C B
( I
60 I
) I
TiH I
( I
2 I
) I
complex O
are O
along O
the O
x O
- O
and O
y O
- O
axes O
of O
C B
( I
60 I
) I
( O
with O
adsorption O
energies O
of O
- O
0 O
. O
23 O
and O
- O
0 O
. O
21 O
eV O
, O
respectively O
) O
, O
making O
these O
orientations O
the O
most O
suitable O
ones O
for O
hydrogen B
storage O
, O
in O
contrast O
to O
the O
results O
obtained O
for O
defect O
- O
containing O
fullerenes O
. O

The O
results O
indicate O
that O
the O
preferential O
orientations O
of O
H B
( I
2 I
) I
in O
the O
defect O
- O
free O
( O
i O
. O
e O
. O
, O
no O
C B
vacancy O
) O
C B
( I
60 I
) I
TiH I
( I
2 I
) I
complex O
are O
along O
the O
x O
- O
and O
y O
- O
axes O
of O
C B
( I
60 I
) I
( O
with O
adsorption O
energies O
of O
- O
0 O
. O
23 O
and O
- O
0 O
. O
21 O
eV O
, O
respectively O
) O
, O
making O
these O
orientations O
the O
most O
suitable O
ones O
for O
hydrogen B
storage O
, O
in O
contrast O
to O
the O
results O
obtained O
for O
defect O
- O
containing O
fullerenes O
. O

The O
binding O
of O
H B
( I
2 I
) I
is O
dominated O
by O
the O
pairwise O
support O
- O
metal O
interaction O
energy O
E O
( O
i O
) O
( O
Cn O
. O
. O
. O
Ti B
) O
, O
and O
the O
role O
of O
the O
fullerene B
is O
not O
restricted O
to O
supporting O
the O
metal O
. O

The O
C B
vacancy O
enhances O
the O
adsorption O
energy O
of O
Ti B
, O
in O
contrast O
to O
that O
of O
H B
( I
2 I
) I
. O

A O
significant O
reduction O
in O
the O
energy O
gap O
of O
the O
pristine O
C B
( I
60 I
) I
fullerene I
is O
observed O
when O
TiH B
( I
2 I
) I
is O
adsorbed O
by O
it O
. O

While O
the O
C B
( I
n I
) I
fullerene I
readily O
participates O
in O
nucleophilic O
processes O
, O
the O
adjacent O
TiH B
( I
2 I
) I
fragment O
is O
available O
for O
electrophilic O
processes O
. O

Ilexpublesnins B
C I
- I
M I
, O
eleven O
new O
triterpene B
saponins I
from O
the O
roots O
of O
Ilex O
pubescens O
. O

Eleven O
new O
triterpene B
saponins I
, O
ilexpublesnins B
C I
- I
M I
( O
1 O
- O
11 O
) O
, O
along O
with O
ten O
known O
analogues O
were O
isolated O
from O
the O
roots O
of O
Ilex O
pubescens O
. O

The O
carrier O
mobility O
can O
reach O
about O
1500 O
cm O
( O
2 O
) O
V O
( O
- O
1 O
) O
s O
( O
- O
1 O
) O
, O
which O
is O
about O
three O
times O
the O
value O
of O
those O
grown O
on O
SiO B
( I
2 I
) I
/ O
Si B
substrates O
, O
and O
also O
is O
better O
than O
some O
examples O
of O
metal O
- O
catalyzed O
graphene B
, O
reflecting O
the O
good O
quality O
of O
the O
graphene B
lattice O
. O

In O
most O
catchments O
, O
HCO B
3 I
( I
- I
) I
and O
SO B
4 I
( I
2 I
- I
) I
concentrations O
were O
greater O
than O
Cl B
( I
- I
) I
concentration O
. O

The O
molecular O
structure O
of O
the O
blue O
mussel O
Mytilus O
edulis O
whole O
anchoring O
threads O
was O
studied O
by O
two O
- O
dimensional O
( B
13 I
) I
C I
solid O
- O
state O
NMR O
on O
fully O
labeled O
fibers O
. O

Our O
data O
suggest O
that O
the O
atomic O
hydrogen B
( O
H B
) O
, O
methyl B
( O
CH B
( I
3 I
) I
) O
, O
and O
vinyl B
( O
C B
( I
2 I
) I
H I
( I
3 I
) I
) O
losses O
are O
open O
with O
estimated O
branching O
ratios O
of O
about O
86 O
+ O
/ O
- O
4 O
% O
, O
8 O
+ O
/ O
- O
2 O
% O
, O
and O
6 O
+ O
/ O
- O
2 O
% O
, O
respectively O
. O

The O
8 B
- I
hydroxy I
EFV I
metabolite O
was O
detected O
in O
blood O
plasma O
, O
seminal O
plasma O
, O
and O
cerebrospinal O
fluid O
, O
with O
median O
concentrations O
of O
314 O
. O
5 O
ng O
/ O
ml O
, O
358 O
. O
5 O
ng O
/ O
ml O
, O
and O
3 O
. O
37 O
ng O
/ O
ml O
, O
respectively O
. O

Discovery O
of O
Schaeffer B
' I
s I
acid I
analogues O
as O
lead O
structures O
of O
mycobacterium O
tuberculosis O
type O
II O
dehydroquinase O
using O
a O
rational O
drug O
design O
approach O
. O

Rational O
ligand O
design O
: O
Schaeffer B
' I
s I
acid I
analogues O
were O
identified O
as O
novel O
inhibitors O
of O
M O
. O
tuberculosis O
type O
II O
dehydroquinase O
, O
a O
key O
enzyme O
of O
the O
shikimate O
pathway O
. O

Some O
novel O
alpha B
and I
beta I
ionone I
based O
chalcones B
and O
their O
dihydropyrazolidines B
/ O
pyrazolidines B
have O
been O
synthesized O
and O
evaluated O
for O
their O
in O
vitro O
and O
in O
vivo O
antileishmanial O
activities O
against O
Leishmania O
donovani O
. O

Two O
new O
C B
- I
benzylated I
dihydrochalcone I
derivatives O
from O
the O
leaves O
of O
Melodorum O
siamensis O
. O

Two O
new O
C B
- I
benzylated I
dihydrochalcone I
derivatives O
, O
4 B
, I
2 I
' I
, I
4 I
' I
- I
trihydroxy I
- I
6 I
' I
- I
methoxy I
- I
3 I
' I
( I
2 I
' I
' I
- I
hydroxybenzyl I
) I
dihydrochalcone I
( O
1 O
) O
and O
2 B
' I
, I
4 I
' I
- I
dihydroxy I
- I
4 I
, I
6 I
' I
- I
dimethoxy I
- I
3 I
' I
( I
2 I
' I
' I
- I
hydroxybenzyl I
) I
dihydrochalcone I
( O
2 O
) O
, O
along O
with O
six O
known O
flavonoid B
derivatives O
( O
3 O
- O
8 O
) O
, O
a O

The O
high O
- O
frequency O
reorientation O
dynamics O
of O
O B
- I
( I
2 I
) I
H I
bonds O
is O
investigated O
in O
various O
amorphous O
ices O
including O
eHDA O
( O
expanded O
high O
density O
amorphous O
ice O
) O
, O
LDA O
- O
II O
( O
low O
density O
amorphous O
ice O
II O
) O
and O
HGW O
( O
hyperquenched O
glassy O
water O
) O
using O
( B
2 I
) I
H I
- O
NMR O
spin O
- O
lattice O
relaxation O
as O
a O
local O
probe O
. O

Decolourization O
of O
direct B
blue I
15 I
by O
Fenton O
/ O
ultrasonic O
process O
using O
a O
zero B
- I
valent I
iron I
aggregate O
catalyst O
. O

Zero B
- I
valent I
iron I
( O
ZVI B
) O
aggregates O
were O
used O
as O
the O
catalyst O
. O

A O
positive O
synergistic O
effect O
occurred O
when O
Fenton B
' I
s I
reagent I
was O
combined O
with O
ultrasonic O
irradiation O
. O

Experimental O
results O
showed O
that O
the O
optimum O
conditions O
for O
decolourization O
were O
pH O
3 O
. O
0 O
, O
Fe B
( I
0 I
) I
1g O
/ O
L O
, O
H B
( I
2 I
) I
O I
( I
2 I
) I
5 O
. O
15 O
x O
10 O
( O
- O
3 O
) O
mol O
/ O
L O
with O
ultrasound O
density O
of O
120W O
/ O
L O
at O
60kHz O
. O

Although O
the O
solutions O
containing O
H B
( I
2 I
) I
CO I
( I
3 I
) I
, O
Cl B
( I
- I
) I
, O
ClO B
( I
4 I
) I
( I
- I
) I
, O
NO B
( I
3 I
) I
( I
- I
) I
and O
SO B
( I
4 I
) I
( I
2 I
- I
) I
ions O
did O
not O
have O
a O
significant O
effect O
on O
the O
decolouration O
, O
the O
H B
( I
2 I
) I
PO I
( I
4 I
) I
( I
- I
) I
ion O
did O
decrease O
the O
decolouration O
rate O
. O

The O
precursor O
- O
product O
ion O
pairs O
used O
for O
LC O
- O
MS O
/ O
MS O
analysis O
were O
: O
m O
/ O
z O
945 O
- O
- O
> O
475 O
for O
ginsenoside B
Re I
, O
799 O
- O
- O
> O
637 O
for O
ginsenoside B
Rg1 I
, O
783 O
- O
- O
> O
475 O
for O
ginsenoside B
Rg2 I
, O
637 O
- O
- O
> O
475 O
for O
ginsenosides B
Rh1 I
and I
F1 I
, O
475 O
- O
- O
> O
391 O
for O
protopanaxatriol B
, O
and O
779 O
- O
- O
> O
641 O
for O
digoxin B
( O
internal O
standard O
) O
. O

The O
major O
ginsenosides B
excreted O
in O
urine O
were O
ginsenosides B
Re I
and I
Rg1 I
, O
and O
only O
minimal O
amounts O
of O
ginsenosides B
Rg2 I
and I
Rh1 I
were O
found O
. O

The O
major O
ginsenosides B
excreted O
in O
urine O
were O
ginsenosides B
Re I
and I
Rg1 I
, O
and O
only O
minimal O
amounts O
of O
ginsenosides B
Rg2 I
and I
Rh1 I
were O
found O
. O

The O
main O
anthocyanins B
were O
3 B
- I
sophoroside I
- I
5 I
- I
glucoside I
derivatives O
from O
cyanidin B
and O
peonidin B
, O
acylated O
with O
p B
- I
hydroxybenzoic I
acid I
, O
ferulic B
acid I
, O
or O
caffeic B
acid I
. O

Oestrogenic O
, O
androgenic O
, O
progestagenic O
and O
glucocorticoid O
activity O
was O
found O
in O
38 O
% O
, O
38 O
% O
, O
36 O
% O
and O
55 O
% O
of O
the O
samples O
, O
respectively O
at O
an O
average O
concentration O
of O
10 O
ng O
/ O
l O
17 B
beta I
- I
estradiol I
equivalent O
( O
EEQ O
) O
, O
26 O
ng O
/ O
l O
testosterone B
equivalent O
( O
TEQ O
) O
, O
123 O
ng O
/ O
l O
progesterone B
equivalent O
( O
PEQ O
) O
and O
13 O
. O
5 O
ng O
/ O
l O
hydrocortisone B
equivalent O
( O
HEQ O
) O
. O

TNF O
- O
alpha O
) O
, O
and O
prostaglandin B
E I
( I
2 I
) I
( O
PGE B
( I
2 I
) I
) O
. O

Cucurbitacins B
I I
and I
D I
showed O
a O
very O
strong O
cytotoxicity O
, O
which O
was O
higher O
than O
that O
of O
cytochalasin B
D I
, O
used O
as O
a O
drug O
reference O
. O

Almost O
100 O
% O
of O
the O
cells O
were O
apoptotic O
as O
observed O
by O
DNA O
fragmentation O
( O
TUNEL O
assay O
) O
after O
12 O
h O
with O
cucurbitacins B
I I
and I
D I
( O
1 O
mu O
M O
) O
and O
cucurbitacin B
E I
( O
10 O
mu O
M O
) O
. O

In O
terms O
of O
IC O
( O
50 O
) O
values O
, O
cucurbitacins B
I I
and I
E I
presented O
a O
higher O
toxicity O
compared O
to O
that O
of O
cucurbitacin B
D I
( O
MTT B
assay O
) O
. O

These O
yeast O
may O
grow O
more O
slowly O
due O
to O
slower O
reduction O
of O
acetaldehyde B
and O
a O
higher O
NADH B
/ O
NAD B
( I
+ I
) I
ratio O
, O
which O
should O
decrease O
the O
oxidation O
of O
allyl B
alcohol I
. O

Well O
- O
designed O
hierarchical O
nanostructures O
with O
one O
dimensional O
( O
1D O
) O
TiO B
( I
2 I
) I
nanofibers O
( O
120 O
- O
350 O
nm O
in O
diameter O
and O
several O
micrometers O
in O
length O
) O
and O
ultrathin O
hexagonal O
SnS B
( I
2 I
) I
nanosheets O
( O
40 O
- O
70 O
nm O
in O
lateral O
size O
and O
4 O
- O
8 O
nm O
in O
thickness O
) O
were O
successfully O
synthesized O
by O
combining O
the O
electrospinning O
technique O
( O
for O
TiO B
( I
2 I
) I
nanofibers O
) O
and O
a O
hydrothermal O
growth O
method O
( O
for O
SnS B
( I
2 I
) I
nanosheets O
) O
. O

Well O
- O
designed O
hierarchical O
nanostructures O
with O
one O
dimensional O
( O
1D O
) O
TiO B
( I
2 I
) I
nanofibers O
( O
120 O
- O
350 O
nm O
in O
diameter O
and O
several O
micrometers O
in O
length O
) O
and O
ultrathin O
hexagonal O
SnS B
( I
2 I
) I
nanosheets O
( O
40 O
- O
70 O
nm O
in O
lateral O
size O
and O
4 O
- O
8 O
nm O
in O
thickness O
) O
were O
successfully O
synthesized O
by O
combining O
the O
electrospinning O
technique O
( O
for O
TiO B
( I
2 I
) I
nanofibers O
) O
and O
a O
hydrothermal O
growth O
method O
( O
for O
SnS B
( I
2 I
) I
nanosheets O
) O
. O

Well O
- O
designed O
hierarchical O
nanostructures O
with O
one O
dimensional O
( O
1D O
) O
TiO B
( I
2 I
) I
nanofibers O
( O
120 O
- O
350 O
nm O
in O
diameter O
and O
several O
micrometers O
in O
length O
) O
and O
ultrathin O
hexagonal O
SnS B
( I
2 I
) I
nanosheets O
( O
40 O
- O
70 O
nm O
in O
lateral O
size O
and O
4 O
- O
8 O
nm O
in O
thickness O
) O
were O
successfully O
synthesized O
by O
combining O
the O
electrospinning O
technique O
( O
for O
TiO B
( I
2 I
) I
nanofibers O
) O
and O
a O
hydrothermal O
growth O
method O
( O
for O
SnS B
( I
2 I
) I
nanosheets O
) O
. O

Well O
- O
designed O
hierarchical O
nanostructures O
with O
one O
dimensional O
( O
1D O
) O
TiO B
( I
2 I
) I
nanofibers O
( O
120 O
- O
350 O
nm O
in O
diameter O
and O
several O
micrometers O
in O
length O
) O
and O
ultrathin O
hexagonal O
SnS B
( I
2 I
) I
nanosheets O
( O
40 O
- O
70 O
nm O
in O
lateral O
size O
and O
4 O
- O
8 O
nm O
in O
thickness O
) O
were O
successfully O
synthesized O
by O
combining O
the O
electrospinning O
technique O
( O
for O
TiO B
( I
2 I
) I
nanofibers O
) O
and O
a O
hydrothermal O
growth O
method O
( O
for O
SnS B
( I
2 I
) I
nanosheets O
) O
. O

The O
single O
- O
crystalline O
SnS B
( I
2 I
) I
nanosheets O
with O
a O
2D O
layered O
structure O
were O
uniformly O
grown O
onto O
the O
electrospun O
TiO B
( I
2 I
) I
nanofibers O
consisted O
of O
either O
anatase B
( O
A O
) O
phase O
or O
anatase B
- O
rutile B
( O
AR O
) O
mixed O
phase O
TiO B
( I
2 I
) I
nanoparticles O
. O

The O
single O
- O
crystalline O
SnS B
( I
2 I
) I
nanosheets O
with O
a O
2D O
layered O
structure O
were O
uniformly O
grown O
onto O
the O
electrospun O
TiO B
( I
2 I
) I
nanofibers O
consisted O
of O
either O
anatase B
( O
A O
) O
phase O
or O
anatase B
- O
rutile B
( O
AR O
) O
mixed O
phase O
TiO B
( I
2 I
) I
nanoparticles O
. O

The O
single O
- O
crystalline O
SnS B
( I
2 I
) I
nanosheets O
with O
a O
2D O
layered O
structure O
were O
uniformly O
grown O
onto O
the O
electrospun O
TiO B
( I
2 I
) I
nanofibers O
consisted O
of O
either O
anatase B
( O
A O
) O
phase O
or O
anatase B
- O
rutile B
( O
AR O
) O
mixed O
phase O
TiO B
( I
2 I
) I
nanoparticles O
. O

The O
definite O
heterojunction O
interface O
between O
SnS B
( I
2 I
) I
nanosheets O
and O
TiO B
( I
2 I
) I
( I
A I
or I
R I
) I
nanoparticles O
were O
investigated O
by O
high O
resolution O
transmission O
electron O
microscopy O
( O
HRTEM O
) O
and O
X O
- O
ray O
photoelectron O
spectroscopy O
( O
XPS O
) O
. O

Moreover O
, O
the O
as O
- O
prepared O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
hierarchical O
nanostructures O
as O
nanoheterojunction O
photocatalysts O
exhibited O
excellent O
UV O
and O
visible O
light O
photocatalytic O
activities O
for O
the O
degradation O
of O
organic O
dyes O
( O
rhodamine B
B I
and O
methyl B
orange I
) O
and O
phenols B
( O
4 B
- I
nitrophenol I
) O
, O
remarkably O
superior O
to O
the O
TiO B
( I
2 I
) I
nanofibers O
and O
the O
SnS B
( I
2 I
) I
nanosheets O
, O
mainly O
owing O
to O
the O
photoinduced O
interfacial O
charge O
transfer O
based O
on O
the O

Moreover O
, O
the O
as O
- O
prepared O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
hierarchical O
nanostructures O
as O
nanoheterojunction O
photocatalysts O
exhibited O
excellent O
UV O
and O
visible O
light O
photocatalytic O
activities O
for O
the O
degradation O
of O
organic O
dyes O
( O
rhodamine B
B I
and O
methyl B
orange I
) O
and O
phenols B
( O
4 B
- I
nitrophenol I
) O
, O
remarkably O
superior O
to O
the O
TiO B
( I
2 I
) I
nanofibers O
and O
the O
SnS B
( I
2 I
) I
nanosheets O
, O
mainly O
owing O
to O
the O
photoinduced O
interfacial O
charge O
transfer O
based O
on O
the O

Moreover O
, O
the O
as O
- O
prepared O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
hierarchical O
nanostructures O
as O
nanoheterojunction O
photocatalysts O
exhibited O
excellent O
UV O
and O
visible O
light O
photocatalytic O
activities O
for O
the O
degradation O
of O
organic O
dyes O
( O
rhodamine B
B I
and O
methyl B
orange I
) O
and O
phenols B
( O
4 B
- I
nitrophenol I
) O
, O
remarkably O
superior O
to O
the O
TiO B
( I
2 I
) I
nanofibers O
and O
the O
SnS B
( I
2 I
) I
nanosheets O
, O
mainly O
owing O
to O
the O
photoinduced O
interfacial O
charge O
transfer O
based O
on O
the O

Moreover O
, O
the O
as O
- O
prepared O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
hierarchical O
nanostructures O
as O
nanoheterojunction O
photocatalysts O
exhibited O
excellent O
UV O
and O
visible O
light O
photocatalytic O
activities O
for O
the O
degradation O
of O
organic O
dyes O
( O
rhodamine B
B I
and O
methyl B
orange I
) O
and O
phenols B
( O
4 B
- I
nitrophenol I
) O
, O
remarkably O
superior O
to O
the O
TiO B
( I
2 I
) I
nanofibers O
and O
the O
SnS B
( I
2 I
) I
nanosheets O
, O
mainly O
owing O
to O
the O
photoinduced O
interfacial O
charge O
transfer O
based O
on O
the O

photosynergistic O
effect O
of O
the O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
heterojunction O
. O

photosynergistic O
effect O
of O
the O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
heterojunction O
. O

Significantly O
, O
the O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
( I
AR I
) I
hierarchical O
nanostructures O
as O
the O
tricomponent O
heterojunction O
system O
possessed O
stronger O
photocatalytic O
activity O
than O
the O
bicomponent O
heterojunction O
system O
of O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
( I
A I
) I
hierarchical O
nanostructures O
or O
TiO B
( I
2 I
) I
( I
AR I
) I
nanofibers O
, O
which O
was O
discussed O
in O
terms O
of O
the O
three O
- O
way O
photosynergistic O
effect O
between O
SnS B
( I
2 I
) I
, O
TiO B
( I
2 I

Significantly O
, O
the O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
( I
AR I
) I
hierarchical O
nanostructures O
as O
the O
tricomponent O
heterojunction O
system O
possessed O
stronger O
photocatalytic O
activity O
than O
the O
bicomponent O
heterojunction O
system O
of O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
( I
A I
) I
hierarchical O
nanostructures O
or O
TiO B
( I
2 I
) I
( I
AR I
) I
nanofibers O
, O
which O
was O
discussed O
in O
terms O
of O
the O
three O
- O
way O
photosynergistic O
effect O
between O
SnS B
( I
2 I
) I
, O
TiO B
( I
2 I

Significantly O
, O
the O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
( I
AR I
) I
hierarchical O
nanostructures O
as O
the O
tricomponent O
heterojunction O
system O
possessed O
stronger O
photocatalytic O
activity O
than O
the O
bicomponent O
heterojunction O
system O
of O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
( I
A I
) I
hierarchical O
nanostructures O
or O
TiO B
( I
2 I
) I
( I
AR I
) I
nanofibers O
, O
which O
was O
discussed O
in O
terms O
of O
the O
three O
- O
way O
photosynergistic O
effect O
between O
SnS B
( I
2 I
) I
, O
TiO B
( I
2 I

) I
( I
A I
) I
and O
TiO B
( I
2 I
) I
( I
R I
) I
component O
in O
the O
SnS B
( I
2 I
) I
/ O
TiO B
( I
2 I
) I
( I
AR I
) I
heterojunction O
resulting O
in O
the O
high O
separation O
efficiency O
of O
photoinduced O
electron O
- O
hole O
pairs O
, O
as O
evidenced O
by O
photoluminescence O
( O
PL O
) O
and O
surface O
photovoltage O
spectra O
( O
SPS O
) O
. O

Metabolites O
M3 O
, O
M4 O
and O
M5 O
were O
identified O
as O
the O
mono B
- I
glucuronic I
acid I
conjugates O
of O
parent O
compound O
( O
M0 O
) O
, O
M1 O
and O
M2 O
, O
respectively O
. O

Eugenol B
, O
ferulic B
and I
caffeic I
acids I
interacted O
synergistically O
with O
the O
drug O
, O
in O
bringing O
about O
a O
reduction O
in O
the O
amount O
of O
the O
latter O
. O

First O
we O
visualized O
and O
evaluated O
the O
dynamics O
of O
our O
method O
by O
monitoring O
the O
formation O
of O
a O
fluorescent O
metal O
- O
organic O
complex O
( O
Zn B
( I
bix I
) I
) O
. O

Pharmacological O
characterization O
of O
1 B
- I
nitrosocyclohexyl I
acetate I
, O
a O
long O
- O
acting O
nitroxyl B
donor O
that O
shows O
vasorelaxant O
and O
antiaggregatory O
effects O
. O

1 B
- I
Nitrosocyclohexyl I
acetate I
( O
NCA B
) O
, O
a O
new O
HNO B
donor O
, O
in O
contrast O
to O
the O
classic O
HNO B
donors O
Angeli B
' I
s I
salt I
and O
isopropylamine B
NONOate I
, O
predominantly O
releases O
HNO B
and O
has O
a O
longer O
half O
- O
life O
. O

1 B
- I
Nitrosocyclohexyl I
acetate I
( O
NCA B
) O
, O
a O
new O
HNO B
donor O
, O
in O
contrast O
to O
the O
classic O
HNO B
donors O
Angeli B
' I
s I
salt I
and O
isopropylamine B
NONOate I
, O
predominantly O
releases O
HNO B
and O
has O
a O
longer O
half O
- O
life O
. O

The O
mechanism O
of O
action O
of O
HNO B
was O
examined O
by O
applying O
NCA B
in O
the O
absence O
and O
presence O
of O
the O
HNO B
scavenger O
glutathione B
( O
GSH B
) O
and O
inhibitors O
of O
soluble O
guanylyl B
cyclase O
( O
sGC O
) O
, O
adenylyl B
cyclase O
( O
AC O
) O
, O
calcitonin O
gene O
- O
related O
peptide O
receptor O
( O
CGRP O
) O
, O
and O
K B
( I
+ I
) I
channels O
. O

Inhibitors O
of O
sGC O
, O
CGRP O
, O
and O
voltage O
- O
dependent O
K B
( I
+ I
) I
channels O
each O
significantly O
impaired O
the O
vasodilator O
response O
to O
NCA B
. O

In O
contrast O
, O
inhibitors O
of O
AC O
, O
ATP B
- O
sensitive O
K B
( I
+ I
) I
channels O
, O
or O
high O
- O
conductance O
Ca B
( I
2 I
+ I
) I
- O
activated O
K B
( I
+ I
) I
channels O
did O
not O
change O
the O
effects O
of O
NCA B
. O

In O
contrast O
, O
inhibitors O
of O
AC O
, O
ATP B
- O
sensitive O
K B
( I
+ I
) I
channels O
, O
or O
high O
- O
conductance O
Ca B
( I
2 I
+ I
) I
- O
activated O
K B
( I
+ I
) I
channels O
did O
not O
change O
the O
effects O
of O
NCA B
. O

Enhancement O
of O
hepatic O
4 O
- O
hydroxylation O
of O
25 B
- I
hydroxyvitamin I
D3 I
through O
CYP3A4 O
induction O
in O
vitro O
and O
in O
vivo O
: O
Implications O
for O
drug O
- O
induced O
osteomalacia O
. O

In O
this O
study O
, O
the O
inducibility O
of O
these O
enzymes O
and O
monohydroxylation O
of O
25 B
- I
hydroxyvitamin I
D3 I
( O
25OHD3 B
) O
were O
evaluated O
after O
exposure O
to O
P450 O
- O
inducing O
drugs O
. O

Upon O
heating O
of O
the O
solutions O
the O
lamellar O
spacing O
increases O
, O
with O
significant O
differences O
in O
the O
presence O
of O
NaCl B
or O
CaCl B
( I
2 I
) I
as O
compared O
to O
the O
standard O
solution O
. O

These O
probes O
produce O
the O
corresponding O
fluorescent O
products O
via O
multiple O
interfacial O
electron O
transfer O
processes O
, O
allowing O
us O
to O
investigate O
the O
photoinduced O
redox O
reactions O
over O
individual O
pristine O
and O
Au B
- O
nanoparticle O
- O
deposited O
TiO B
( I
2 I
) I
nanoparticles O
at O
the O
single O
- O
particle O
, O
single O
- O
molecule O
levels O
. O

The O
minimum O
probe O
concentration O
to O
detect O
single O
- O
product O
molecules O
on O
a O
single O
TiO B
( I
2 I
) I
nanoparticle O
was O
found O
to O
be O
in O
the O
nanomolar O
range O
( O
< O
10 O
nM O
) O
in O
acidic O
solution O
. O

Furthermore O
, O
super O
- O
resolution O
mapping O
of O
the O
reaction O
sites O
revealed O
that O
visible O
- O
light O
- O
induced O
reduction O
reactions O
preferentially O
occurred O
on O
the O
TiO B
( I
2 I
) I
surface O
within O
a O
distance O
of O
a O
few O
tens O
of O
nanometers O
around O
the O
deposited O
Au B
nanoparticles O
. O

The O
5 B
, I
7 I
- I
OH I
group O
of O
A O
ring O
and O
one O
4 B
' I
- I
OH I
group O
of O
the O
B O
ring O
in O
apigenin B
and O
naringenin B
are O
important O
for O
synergistic O
activity O
. O

Microsomal O
prostaglandin B
E I
synthase O
- O
1 O
( O
mPGES O
- O
1 O
) O
is O
an O
inducible O
prostaglandin B
E I
synthase O
that O
catalyzes O
the O
conversion O
of O
prostaglandin B
PGH B
( I
2 I
) I
to O
PGE B
( I
2 I
) I
and O
represents O
a O
novel O
target O
for O
therapeutic O
treatment O
of O
inflammatory O
disorders O
. O

Microsomal O
prostaglandin B
E I
synthase O
- O
1 O
( O
mPGES O
- O
1 O
) O
is O
an O
inducible O
prostaglandin B
E I
synthase O
that O
catalyzes O
the O
conversion O
of O
prostaglandin B
PGH B
( I
2 I
) I
to O
PGE B
( I
2 I
) I
and O
represents O
a O
novel O
target O
for O
therapeutic O
treatment O
of O
inflammatory O
disorders O
. O

In O
addition O
, O
the O
activity O
of O
compound O
6f O
was O
again O
tested O
at O
10 O
mu O
M O
concentration O
in O
presence O
of O
0 O
. O
1 O
% O
Triton B
X I
- I
100 I
and O
found O
to O
be O
reduced O
to O
1 O
/ O
4 O
of O
its O
original O
activity O
without O
this O
detergent O
. O

ATP B
- O
sensitive O
K B
( I
+ I
) I
( O
K B
( O
ATP B
) O
) O
channels O
, O
comprised O
of O
pore O
- O
forming O
Kir6 O
. O
x O
and O
regulatory O
SURx O
subunits O
, O
play O
important O
roles O
in O
many O
cellular O
functions O
; O
because O
of O
their O
sensitivity O
to O
inhibition O
by O
intracellular O
ATP B
, O
K B
( O
ATP B
) O
channels O
provide O
a O
link O
between O
cell O
metabolism O
and O
membrane O
electrical O
activity O
. O

beta B
- I
phenylethyl I
isothiocyanate I
reverses O
platinum B
resistance O
by O
a O
GSH B
- O
dependent O
mechanism O
in O
cancer O
cells O
with O
epithelial O
- O
mesenchymal O
transition O
phenotype O
. O

Importantly O
, O
we O
found O
that O
the O
natural O
compound O
beta B
- I
phenylethyl I
isothiocyanate I
( O
PEITC B
) O
was O
able O
to O
effectively O
abolish O
this O
drug O
resistant O
mechanism O
by O
effective O
depletion O
of O
cellular O
GSH B
, O
leading O
to O
a O
significant O
increase O
in O
cellular O
Pt B
as O
well O
as O
DNA O
- O
bound O
Pt B
. O

We O
have O
discovered O
that O
2 B
- I
arylvinylboronic I
acids I
and O
some O
of O
their O
esters B
possess O
a O
set O
of O
properties O
which O
makes O
them O
highly O
useful O
as O
neuroprotective O
agents O
affecting O
multiple O
biological O
targets O
involved O
in O
AD O
. O

These O
properties O
are O
not O
paralleled O
by O
the O
related O
2 B
- I
arylboronic I
acids I
. O

The O
organochlorine B
contamination O
at O
FU20 O
and O
FU50 O
was O
associated O
with O
variable O
changes O
in O
the O
MRCs O
and O
inhibition O
of O
Na B
( I
+ I
) I
/ O
K B
( I
+ I
) I
- O
ATPase O
( O
NKA O
) O
activity O
, O
especially O
in O
P O
. O
maculatus O
. O

The O
organochlorine B
contamination O
at O
FU20 O
and O
FU50 O
was O
associated O
with O
variable O
changes O
in O
the O
MRCs O
and O
inhibition O
of O
Na B
( I
+ I
) I
/ O
K B
( I
+ I
) I
- O
ATPase O
( O
NKA O
) O
activity O
, O
especially O
in O
P O
. O
maculatus O
. O

We O
investigated O
the O
inhibition O
by O
cimetidine B
of O
alcohol B
oxidation O
by O
recombinant O
human O
ADH1A O
, O
ADH1B1 O
, O
ADH1B2 O
, O
ADH1B3 O
, O
ADH1C1 O
, O
ADH1C2 O
, O
ADH2 O
, O
and O
ADH4 O
, O
and O
aldehyde B
oxidation O
by O
ALDH1A1 O
and O
ALDH2 O
at O
pH O
7 O
. O
5 O
and O
a O
cytosolic O
NAD B
( I
+ I
) I
concentration O
. O

Nine O
mycotoxins O
including O
six O
aspergillic B
acid I
group O
toxins O
, O
aluminiumneoaspergil B
( O
1 O
) O
, O
zirconiumneoaspergil B
( O
2 O
) O
, O
aspergilliamide B
( O
3 O
) O
, O
ferrineoaspergillin B
( O
5 O
) O
, O
flavacol B
( O
6 O
) O
, O
neoaspergillic B
acid I
( O
7 O
) O
, O
and O
three O
ochratoxins B
, O
ochratoxin B
A I
n I
- I
butyl I
ester I
( O
4 O
) O
, O
ochratoxin B
A I
( O
8 O
) O
, O
ochratoxin B
A I
methyl I
ester I
( O
9 O
) O
, O
were O
isolated O
from O

The O
formation O
of O
Co B
( I
3 I
) I
O I
( I
4 I
) I
nano O
- O
scale O
colloid O
particles O
by O
gamma O
irradiation O
of O
CoSO B
( I
4 I
) I
solutions O
was O
investigated O
. O

Solutions O
of O
0 O
. O
2 O
- O
0 O
. O
3 O
mM O
CoSO B
( I
4 I
) I
at O
pH O
6 O
. O
0 O
and O
10 O
. O
6 O
( O
air O
- O
saturated O
and O
Ar O
- O
purged O
) O
were O
irradiated O
at O
an O
absorbed O
dose O
rate O
of O
5 O
. O
5 O
kGy O
h O
( O
- O
1 O
) O
. O

The O
resulting O
concentrations O
of O
H B
( I
2 I
) I
, O
H B
( I
2 I
) I
O I
( I
2 I
) I
, O
Co B
( I
II I
) I
and O
Co B
( I
III I
) I
species O
in O
solution O
and O
the O
chemical O
composition O
and O
sizes O
of O
particles O
that O
were O
formed O
were O
measured O
as O
a O
function O
of O
irradiation O
time O
. O

The O
resulting O
concentrations O
of O
H B
( I
2 I
) I
, O
H B
( I
2 I
) I
O I
( I
2 I
) I
, O
Co B
( I
II I
) I
and O
Co B
( I
III I
) I
species O
in O
solution O
and O
the O
chemical O
composition O
and O
sizes O
of O
particles O
that O
were O
formed O
were O
measured O
as O
a O
function O
of O
irradiation O
time O
. O

The O
resulting O
concentrations O
of O
H B
( I
2 I
) I
, O
H B
( I
2 I
) I
O I
( I
2 I
) I
, O
Co B
( I
II I
) I
and O
Co B
( I
III I
) I
species O
in O
solution O
and O
the O
chemical O
composition O
and O
sizes O
of O
particles O
that O
were O
formed O
were O
measured O
as O
a O
function O
of O
irradiation O
time O
. O

Particle O
formation O
was O
observed O
only O
for O
initially O
air O
- O
saturated O
CoSO B
( I
4 I
) I
solutions O
at O
pH O
10 O
. O
6 O
. O

The O
radiolytic O
oxidation O
of O
Co B
( I
II I
) I
to O
Co B
( I
III I
) I
was O
completed O
in O
100 O
min O
and O
the O
chemical O
composition O
of O
the O
final O
particles O
was O
identified O
as O
Co B
( I
3 I
) I
O I
( I
4 I
) I
by O
XPS O
, O
Raman O
and O
UV O
- O
Vis O
spectroscopy O
. O

The O
radiolytic O
oxidation O
of O
Co B
( I
II I
) I
to O
Co B
( I
III I
) I
was O
completed O
in O
100 O
min O
and O
the O
chemical O
composition O
of O
the O
final O
particles O
was O
identified O
as O
Co B
( I
3 I
) I
O I
( I
4 I
) I
by O
XPS O
, O
Raman O
and O
UV O
- O
Vis O
spectroscopy O
. O

We O
perform O
ab O
initio O
molecular O
dynamics O
simulations O
of O
aminophenyl B
acid I
dyes O
NK1 B
and O
NK7 B
, O
differing O
by O
the O
electron O
donating O
group O
, O
in O
a O
vacuum O
and O
adsorbed O
in O
mono O
- O
and O
bi O
- O
dentate O
modes O
on O
a O
dry O
and O
a O
water O
- O
covered O
anatase B
( I
101 I
) I
surface O
of O
TiO B
( I
2 I
) I
, O
at O
300 O
and O
350 O
K O
. O

We O
perform O
ab O
initio O
molecular O
dynamics O
simulations O
of O
aminophenyl B
acid I
dyes O
NK1 B
and O
NK7 B
, O
differing O
by O
the O
electron O
donating O
group O
, O
in O
a O
vacuum O
and O
adsorbed O
in O
mono O
- O
and O
bi O
- O
dentate O
modes O
on O
a O
dry O
and O
a O
water O
- O
covered O
anatase B
( I
101 I
) I
surface O
of O
TiO B
( I
2 I
) I
, O
at O
300 O
and O
350 O
K O
. O

This O
effect O
is O
preserved O
in O
dyes O
on O
dry O
TiO B
( I
2 I
) I
but O
largely O
disappears O
in O
the O
presence O
of O
water O
. O

Recombination O
to O
the O
dye O
cation O
is O
expected O
to O
be O
much O
enhanced O
by O
the O
approach O
of O
the O
dye O
oxidation O
equivalent O
hole O
to O
the O
surface O
during O
dye O
wagging O
around O
TiO B
( I
2 I
) I
. O

Guided O
by O
the O
principles O
of O
dislocation O
theory O
, O
we O
use O
the O
first O
- O
principles O
calculations O
to O
determine O
the O
structure O
and O
properties O
of O
dislocations O
and O
grain O
boundaries O
( O
GB O
) O
in O
single O
- O
layer O
transition B
metal I
disulfides I
MS B
( I
2 I
) I
( O
M O
= O
Mo B
or O
W B
) O
. O

The O
analysis O
shows O
how O
the O
versatile O
GB O
in O
MS B
( I
2 I
) I
( O
if O
carefully O
engineered O
) O
should O
enable O
new O
developments O
for O
electronic O
and O
opto O
- O
electronic O
applications O
. O

The O
exogenous O
and O
exogenous O
estrogens B
were O
analyzed O
by O
gas O
chromatography O
combustion O
isotope O
ratio O
mass O
spectrometry O
( O
GC O
- O
C O
- O
IRMS O
) O
to O
determine O
the O
( B
13 I
) I
C I
/ O
( B
12 I
) I
C I
ratio O
( O
delta O
( B
13 I
) I
C I
/ O
1000 O
) O
. O

The O
exogenous O
and O
exogenous O
estrogens B
were O
analyzed O
by O
gas O
chromatography O
combustion O
isotope O
ratio O
mass O
spectrometry O
( O
GC O
- O
C O
- O
IRMS O
) O
to O
determine O
the O
( B
13 I
) I
C I
/ O
( B
12 I
) I
C I
ratio O
( O
delta O
( B
13 I
) I
C I
/ O
1000 O
) O
. O

The O
exogenous O
and O
exogenous O
estrogens B
were O
analyzed O
by O
gas O
chromatography O
combustion O
isotope O
ratio O
mass O
spectrometry O
( O
GC O
- O
C O
- O
IRMS O
) O
to O
determine O
the O
( B
13 I
) I
C I
/ O
( B
12 I
) I
C I
ratio O
( O
delta O
( B
13 I
) I
C I
/ O
1000 O
) O
. O

The O
delta O
( B
13 I
) I
C I
/ O
1000 O
values O
of O
reference O
standard O
of O
E1 O
, O
E2 O
, O
and O
E3 O
were O
- O
29 O
. O
36 O
+ O
/ O
- O
0 O
. O
72 O
, O
- O
27 O
. O
98 O
+ O
/ O
- O
0 O
. O
35 O
, O
- O
27 O
. O
62 O
+ O
/ O
- O
0 O
. O
51 O
, O
respectively O
. O

The O
delta O
( B
13 I
) I
C I
/ O
1000 O
values O
of O
the O
endogenous O
E1 O
, O
E2 O
, O
and O
E3 O
were O
- O
21 O
. O
62 O
+ O
/ O
- O
1 O
. O
07 O
, O
- O
22 O
. O
14 O
+ O
/ O
- O
0 O
. O
98 O
, O
and O
- O
21 O
. O
88 O
+ O
/ O
- O
1 O
. O
16 O
, O
with O
P O
< O
0 O
. O
01 O
( O
t O
- O
test O
) O
. O

Two O
DUB O
patients O
' O
urinary O
estradiol B
delta O
( B
13 I
) I
C I
/ O
1000 O
values O
was O
depleted O
to O
- O
28 O
. O
02 O
+ O
/ O
- O
0 O
. O
33 O
after O
the O
administration O
. O

The O
progesterone B
, O
17 B
alpha I
- I
hydroxyprogesterone I
, O
pregnanediol B
, O
as O
well O
as O
desogestrel B
and O
ethinylestradiol B
from O
contraceptives O
were O
also O
determined O
. O

The O
microcapsules O
were O
subsequently O
placed O
within O
a O
poly B
( I
ethylene I
glycol I
) I
( O
PEG B
) O
- O
coated O
poly B
( I
epsilon I
- I
caprolactone I
) I
( O
PCL B
) O
chamber O
covered O
with O
a O
PEG B
- I
grafted I
PCL I
nanoporous O
membrane O
formed O
by O
phase O
inversion O
. O

In O
order O
to O
quantify O
the O
relative O
oral O
bioavailability O
of O
3 B
- I
chloropropane I
- I
1 I
, I
2 I
- I
diol I
( O
3 B
- I
MCPD I
) O
from O
3 B
- I
MCPD I
fatty I
acid I
diesters I
in O
vivo O
, O
1 B
, I
2 I
- I
dipalmitoyl I
- I
3 I
- I
chloropropane I
- I
1 I
, I
2 I
- I
diol I
( O
3 B
- I
MCPD I
diester I
) O
and O
3 B
- I
MCPD I
were O
orally O
applied O
to O
rats O
in O
equimolar O
doses O
. O

The O
results O
show O
that O
3 B
- I
MCPD I
is O
released O
by O
enzymatic O
hydrolysis O
from O
the O
3 B
- I
MCPD I
diester I
in O
the O
gastrointestinal O
tract O
and O
distributed O
to O
blood O
, O
organs O
and O
tissues O
. O

By O
comparing O
both O
AUC O
, O
the O
relative O
amount O
of O
3 B
- I
MCPD I
bioavailable O
from O
the O
3 B
- I
MCPD I
diester I
was O
calculated O
to O
be O
86 O
% O
on O
average O
of O
the O
amount O
bioavailable O
following O
administration O
of O
3 B
- I
MCPD I
. O

In O
an O
effort O
to O
further O
understand O
this O
region O
of O
the O
molecule O
, O
analogues O
containing O
various O
N B
' I
- I
amino I
substituents O
were O
prepared O
and O
evaluated O
against O
two O
breast O
cancer O
cell O
lines O
for O
determination O
of O
their O
efficacy O
. O

Mode O
of O
action O
studies O
by O
molecular O
modeling O
indicate O
that O
the O
2 B
' I
- I
fluoro I
moiety O
by O
hydrogen B
bond O
as O
well O
as O
the O
Van O
der O
Waals O
interaction O
of O
the O
carbocyclic B
ring O
with O
the O
phenylalanine B
moiety O
of O
the O
polymerase O
promote O
the O
positive O
binding O
, O
even O
in O
the O
drug O
- O
resistant O
mutants O
. O

Complexes O
smaller O
than O
Mg B
( I
2 I
+ I
) I
( I
H2O I
) I
3 I
cannot O
be O
formed O
in O
this O
source O
because O
charge O
separation O
into O
MgOH B
( I
+ I
) I
( I
H2O I
) I
and O
H3O B
( I
+ I
) I
is O
a O
lower O
- O
energy O
pathway O
than O
simple O
water O
loss O
from O
Mg B
( I
2 I
+ I
) I
( I
H2O I
) I
3 I
. O

In O
this O
study O
, O
well O
- O
defined O
poly B
( I
glycidyl I
methacrylate I
) I
( O
P B
( I
GMA I
) I
) O
homopolymers O
were O
synthesized O
using O
reversible O
addition O
- O
fragmentation O
chain O
transfer O
( O
RAFT O
) O
polymerization O
followed O
by O
decoration O
using O
three O
different O
types O
of O
oligoamines B
, O
i O
. O
e O
. O
, O
tetraethylenepentami B
( O
TEPA B
) O
, O
pentaethylenehexamin B
( O
PEHA B
) O
, O
and O
tris B
( I
2 I
- I
aminoethyl I
) I
amine I
( O
TREN B
) O
, O
respectively O
, O
to O
generate O
various O
P B
( I
GMA I
- I
oligoamine I
) I

Polyplexes O
of O
block O
copolymers O
were O
stable O
against O
aggregation O
in O
physiological O
salt O
condition O
and O
in O
Opti O
- O
MEM O
due O
to O
the O
shielding O
effect O
of O
P B
( I
HPMA I
) I
and O
P B
( I
OEGMA I
) I
. O

Polyplexes O
of O
block O
copolymers O
were O
stable O
against O
aggregation O
in O
physiological O
salt O
condition O
and O
in O
Opti O
- O
MEM O
due O
to O
the O
shielding O
effect O
of O
P B
( I
HPMA I
) I
and O
P B
( I
OEGMA I
) I
. O

PKAA B
was O
designed O
to O
have O
acid O
- O
cleavable O
ketal O
linkages O
in O
the O
backbone O
of O
cationic O
biodegradable O
poly B
( I
amidoamine I
) I
. O

The O
obtained O
polymer O
( O
T24 O
) O
was O
then O
activated O
by O
reaction O
with O
4 B
- I
nitrophenyl I
chloroformate I
( O
NPC B
) O
in O
order O
to O
graft O
a O
cyclic O
peptide O
presenting O
an O
arginine B
- O
glycine B
- O
aspartic B
acid I
( O
RGD O
) O
motif O
. O

The O
association O
constants O
for O
the O
formation O
of O
anion O
- O
pi O
complexes O
in O
acetonitrile B
are O
in O
the O
range O
of O
239 O
to O
16950 O
M O
( O
- O
1 O
) O
, O
following O
the O
order O
of O
1 O
. O
NO B
( I
3 I
) I
( I
- I
) I
> O
1 O
. O
BF B
( I
4 I
) I
( I
- I
) I
> O
1 O
. O
PF B
( I
6 I
) I
( I
- I
) I
> O
1 O
. O
SCN B
( I
- I
) I
. O

The O
signaling O
pathway O
downstream O
from O
gp130 O
is O
based O
on O
at O
least O
, O
three O
distinct O
pathways O
: O
1 O
) O
the O
janus O
kinase O
/ O
signal O
transducer O
and O
activator O
of O
transcription O
( O
JAK O
/ O
STAT O
) O
pathway O
, O
2 O
) O
the O
p42 O
/ O
44 O
mitogen O
- O
activated O
protein O
kinase O
( O
p42 O
/ O
44 O
MAPK O
) O
pathway O
, O
also O
known O
as O
the O
extracellular O
receptor O
kinase O
- O
1 O
/ O
2 O
( O
ERK1 O
/ O
2 O
) O
pathway O
, O
and O
3 O
) O
the O
phosphatidylinositol B
3 I
- I
OH I
kinase O
( O
PI3K O
) O
/ O
Akt O
pathway O
. O

Using O
this O
concept O
, O
we O
have O
prepared O
a O
halogen B
bond O
donor O
bis B
( I
urea I
) I
gelator O
that O
forms O
co O
- O
gels O
with O
halogen B
bond O
acceptors O
. O

Zirconium B
- O
based O
metal O
organic O
framework O
( O
Zr B
- O
MOF O
) O
, O
UiO B
- I
66 I
and O
UiO B
- I
67 I
, O
were O
synthesized O
and O
used O
as O
adsorbents O
of O
NO B
( I
2 I
) I
at O
ambient O
temperatures O
in O
either O
dry O
or O
moist O
conditions O
. O

The O
samples O
were O
characterized O
before O
and O
after O
exposure O
to O
NO B
( I
2 I
) I
by O
X O
- O
ray O
diffraction O
, O
scanning O
electron O
microscopy O
, O
N B
( I
2 I
) I
- O
adsorption O
at O
77 O
K O
, O
thermal O
analysis O
, O
and O
infrared O
spectroscopy O
. O

The O
samples O
were O
characterized O
before O
and O
after O
exposure O
to O
NO B
( I
2 I
) I
by O
X O
- O
ray O
diffraction O
, O
scanning O
electron O
microscopy O
, O
N B
( I
2 I
) I
- O
adsorption O
at O
77 O
K O
, O
thermal O
analysis O
, O
and O
infrared O
spectroscopy O
. O

The O
results O
indicate O
the O
important O
effect O
of O
a O
ligand O
size O
on O
the O
adsorption O
of O
NO B
( I
2 I
) I
on O
Zr B
- O
MOF O
materials O
. O

While O
the O
large O
size O
of O
the O
4 B
, I
4 I
- I
benzenebiphenyldicar I
acid I
( O
BDPC B
) O
ligand O
has O
a O
positive O
impact O
on O
the O
adsorption O
of O
NO B
( I
2 I
) I
on O
UiO B
- I
67 I
in O
moist O
conditions O
, O
the O
opposite O
effect O
is O
found O
in O
dry O
conditions O
. O

The O
large O
pore O
volume O
of O
UiO B
- I
67 I
enhances O
the O
adsorption O
of O
moisture O
and O
formation O
of O
nitric B
and I
nitrous I
acids I
. O

The O
small O
pore O
sizes O
of O
UiO B
- I
66 I
favor O
the O
NO B
( I
2 I
) I
removal O
in O
dry O
conditions O
via O
dispersive O
forces O
. O

Upon O
interaction O
of O
NO B
( I
2 I
) I
molecules O
with O
the O
Zr B
- O
MOF O
in O
dry O
conditions O
, O
the O
bond O
between O
the O
organic O
linker O
and O
metallic O
oxide B
center O
is O
broken O
, O
leading O
to O
the O
formation O
of O
nitrate B
and O
nitrite B
species O
. O

Moreover O
, O
organic O
ligands O
also O
contribute O
to O
the O
NO B
( I
2 I
) I
reactive O
adsorption O
via O
nitration O
reaction O
. O

Substituent O
effect O
in O
2 B
- I
benzoylmethylenequin I
difluoroborates I
exhibiting O
through O
- O
space O
couplings O
. O

The O
series O
of O
nine O
2 B
- I
benzoylmethylenequin I
difluoroborates I
have O
been O
synthesized O
and O
characterized O
by O
multinuclear O
magnetic O
resonance O
, O
X O
- O
ray O
diffraction O
( O
XRD O
) O
, O
and O
computational O
methods O
. O

The O
through O
- O
space O
spin O
- O
spin O
couplings O
between O
( B
19 I
) I
F I
and O
( B
1 I
) I
H I
/ O
( B
13 I
) I
C I
nuclei O
have O
been O
observed O
in O
solution O
. O

The O
through O
- O
space O
spin O
- O
spin O
couplings O
between O
( B
19 I
) I
F I
and O
( B
1 I
) I
H I
/ O
( B
13 I
) I
C I
nuclei O
have O
been O
observed O
in O
solution O
. O

The O
through O
- O
space O
spin O
- O
spin O
couplings O
between O
( B
19 I
) I
F I
and O
( B
1 I
) I
H I
/ O
( B
13 I
) I
C I
nuclei O
have O
been O
observed O
in O
solution O
. O

Chemical O
Modification O
of O
Lysozyme O
, O
Glucose B
6 I
- I
Phosphate I
Dehydrogenase O
, O
and O
Bovine O
Eye O
Lens O
Proteins O
Induced O
by O
Peroxyl B
Radicals O
: O
Role O
of O
Oxidizable O
Amino B
Acid I
Residues O
. O

Chemical O
and O
structural O
alterations O
to O
lysozyme O
( O
LYSO O
) O
, O
glucose B
6 I
- I
phosphate I
dehydrogenase O
( O
G6PD O
) O
, O
and O
bovine O
eye O
lens O
proteins O
( O
BLP O
) O
promoted O
by O
peroxyl B
radicals O
generated O
by O
the O
thermal O
decomposition O
of O
2 B
, I
2 I
' I
- I
azobis I
( I
2 I
- I
amidinopropane I
) I
hydrochloride I
( O
AAPH B
) O
under O
aerobic O
conditions O
were O
investigated O
. O

In O
the O
male O
brain O
, O
the O
medial O
preoptic O
nucleus O
( O
POM O
) O
is O
known O
to O
be O
a O
critical O
relay O
for O
the O
activation O
of O
sexual O
behaviour O
, O
with O
the O
aromatisation O
of O
testosterone B
into O
17 B
beta I
- I
oestradiol I
( O
E2 O
) O
playing O
a O
key O
role O
. O

Formation O
and O
infrared O
absorption O
of O
protonated B
naphthalenes I
( O
1 B
- I
C10H9 I
+ I
and O
2 B
- I
C10H9 I
+ I
) O
and O
their O
neutral O
counterparts O
in O
solid O
para B
- I
hydrogen I
. O

Formation O
and O
infrared O
absorption O
of O
protonated B
naphthalenes I
( O
1 B
- I
C10H9 I
+ I
and O
2 B
- I
C10H9 I
+ I
) O
and O
their O
neutral O
counterparts O
in O
solid O
para B
- I
hydrogen I
. O

In O
this O
study O
, O
we O
investigated O
whether O
( B
129 I
) I
I I
- O
labeling O
of O
proteins O
with O
subsequent O
AMS O
measurements O
is O
a O
suitable O
method O
to O
perform O
microdose O
studies O
with O
therapeutic O
proteins O
. O

RESULTS O
: O
In O
an O
animal O
study O
with O
( B
129 I
) I
I I
- O
labeled O
EPO O
in O
Han O
- O
Wistar O
rats O
, O
an O
increase O
of O
( B
129 I
) I
I I
- O
EPO O
is O
observed O
after O
dose O
administration O
. O

RESULTS O
: O
In O
an O
animal O
study O
with O
( B
129 I
) I
I I
- O
labeled O
EPO O
in O
Han O
- O
Wistar O
rats O
, O
an O
increase O
of O
( B
129 I
) I
I I
- O
EPO O
is O
observed O
after O
dose O
administration O
. O

CoNCLUSION O
: O
Although O
further O
research O
is O
required O
, O
( B
129 I
) I
I I
- O
labeling O
of O
proteins O
seems O
a O
feasible O
method O
for O
AMS O
microdose O
studies O
with O
peptide O
and O
protein O
drugs O
, O
such O
as O
biosimilars O
. O

The O
measurement O
conditions O
for O
the O
radioactivity O
for O
low O
BG O
LSC O
were O
investigated O
and O
metabolite O
profiling O
in O
rat O
plasma O
after O
single O
oral O
administration O
of O
( B
14 I
) I
C I
- O
labeled O
compounds O
was O
performed O
. O

We O
find O
that O
: O
( O
i O
) O
Ti B
and O
Cu B
in O
( B
TiO I
( I
2 I
) I
) I
( I
x I
) I
( I
Cu I
( I
2 I
) I
O I
) I
( I
y I
) I
alloys O
have O
similar O
local O
environments O
as O
in O
bulk O
TiO B
( I
2 I
) I
and O
Cu B
( I
2 I
) I
O I
except O
for O
( O
TiO B
( I
2 I
) I
) O
( O
Cu B
( I
2 I
) I
O I
) O
which O
has O
some O
trigonal O
- O
planar O
Cu B
ions O
. O

We O
find O
that O
: O
( O
i O
) O
Ti B
and O
Cu B
in O
( B
TiO I
( I
2 I
) I
) I
( I
x I
) I
( I
Cu I
( I
2 I
) I
O I
) I
( I
y I
) I
alloys O
have O
similar O
local O
environments O
as O
in O
bulk O
TiO B
( I
2 I
) I
and O
Cu B
( I
2 I
) I
O I
except O
for O
( O
TiO B
( I
2 I
) I
) O
( O
Cu B
( I
2 I
) I
O I
) O
which O
has O
some O
trigonal O
- O
planar O
Cu B
ions O
. O

Functionalization O
of O
the O
branched O
PEG B
with O
HPA B
at O
varying O
degrees O
of O
substitution O
was O
confirmed O
via O
attenuated O
total O
reflectance O
Fourier O
transform O
infrared O
spectroscopy O
( O
ATR O
- O
FTIR O
) O
and O
( B
1 I
) I
H I
NMR O
. O

The O
uptake O
and O
distribution O
of O
selenium B
in O
three O
aquatic O
plants O
grown O
in O
Se B
( I
IV I
) I
solution O
. O

The O
uptake O
of O
Se B
( I
IV I
) I
by O
Myriophyllum O
spicatum O
, O
Ceratophyllum O
demersum O
and O
Potamogeton O
perfoliatus O
, O
and O
the O
effects O
of O
Se B
( I
IV I
) I
on O
their O
physiological O
and O
biochemical O
characteristics O
were O
studied O
. O

The O
uptake O
of O
Se B
( I
IV I
) I
by O
Myriophyllum O
spicatum O
, O
Ceratophyllum O
demersum O
and O
Potamogeton O
perfoliatus O
, O
and O
the O
effects O
of O
Se B
( I
IV I
) I
on O
their O
physiological O
and O
biochemical O
characteristics O
were O
studied O
. O

The O
response O
of O
M O
. O
spicatum O
and O
C O
. O
demersum O
to O
Se B
( I
IV I
) I
regarding O
chlorophylls B
was O
variable O
, O
however O
in O
the O
majority O
of O
cases O
, O
there O
was O
a O
trend O
of O
increasing O
the O
amount O
of O
chlorophylls B
, O
while O
in O
P O
. O
perfoliatus O
the O
amount O
of O
chlorophyll B
a I
decreased O
. O

The O
concentration O
of O
Se B
in O
plants O
cultured O
in O
10 O
mg O
Se B
( I
IV I
) I
L O
( O
- O
1 O
) O
ranged O
from O
436 O
to O
839 O
mu O
g O
Se B
g O
( O
- O
1 O
) O
DM O
in O
M O
. O
spicatum O
, O
319 O
to O
988 O
mu O
g O
Se B
g O
( O
- O
1 O
) O
DM O
in O
C O
. O
demersum O
and O
310 O
to O
661 O
mu O
g O
Se B
g O
( O
- O
1 O
) O
DM O
in O
P O
. O
perfoliatus O
. O

It O
was O
observed O
that O
the O
applied O
Se B
( I
IV I
) I
was O
mainly O
transformed O
to O
insoluble O
Se B
. O

We O
determined O
the O
kinetic O
parameters O
KM O
, O
kcat O
and O
kcat O
/ O
KM O
for O
oxidation O
of O
CBCP B
- I
ol I
and O
reduction O
of O
CBCP B
- I
one I
by O
AKR1C O
enzymes O
in O
the O
presence O
of O
NAD B
( I
+ I
) I
/ O
NADP B
( I
+ I
) I
and O
NADH B
/ O
NADPH B
, O
respectively O
. O

We O
determined O
the O
kinetic O
parameters O
KM O
, O
kcat O
and O
kcat O
/ O
KM O
for O
oxidation O
of O
CBCP B
- I
ol I
and O
reduction O
of O
CBCP B
- I
one I
by O
AKR1C O
enzymes O
in O
the O
presence O
of O
NAD B
( I
+ I
) I
/ O
NADP B
( I
+ I
) I
and O
NADH B
/ O
NADPH B
, O
respectively O
. O

The O
catalytic O
efficiencies O
for O
the O
oxidation O
of O
CBCP B
- I
ol I
in O
the O
presence O
of O
NAD B
( I
+ I
) I
or O
NADP B
( I
+ I
) I
were O
in O
general O
higher O
when O
compared O
to O
the O
catalytic O
efficiencies O
for O
reduction O
of O
CBCP B
- I
one I
in O
the O
presence O
of O
NADH B
or O
NADPH B
. O

The O
catalytic O
efficiencies O
for O
the O
oxidation O
of O
CBCP B
- I
ol I
in O
the O
presence O
of O
NAD B
( I
+ I
) I
or O
NADP B
( I
+ I
) I
were O
in O
general O
higher O
when O
compared O
to O
the O
catalytic O
efficiencies O
for O
reduction O
of O
CBCP B
- I
one I
in O
the O
presence O
of O
NADH B
or O
NADPH B
. O

When O
comparing O
to O
oxidations O
of O
the O
well O
- O
known O
artificial O
substrates O
, O
1 B
- I
acenaphthenol I
and O
S B
- I
tetralol I
, O
we O
observed O
similar O
catalytic O
efficiencies O
as O
for O
CBCP B
- I
ol I
oxidation O
with O
NAD B
( I
+ I
) I
and O
NADP B
( I
+ I
) I
. O

When O
comparing O
to O
oxidations O
of O
the O
well O
- O
known O
artificial O
substrates O
, O
1 B
- I
acenaphthenol I
and O
S B
- I
tetralol I
, O
we O
observed O
similar O
catalytic O
efficiencies O
as O
for O
CBCP B
- I
ol I
oxidation O
with O
NAD B
( I
+ I
) I
and O
NADP B
( I
+ I
) I
. O

The O
number O
of O
BrdU B
( I
+ I
) I
cells O
was O
significantly O
decreased O
6 O
h O
after O
9 O
- O
min O
OGD O
and O
this O
effect O
was O
antagonized O
by O
ZM241385 B
. O

After O
24 O
h O
from O
the O
end O
of O
9 O
- O
min O
OGD O
, O
the O
number O
of O
BrdU B
( I
+ I
) I
cells O
returned O
to O
that O
found O
before O
OGD O
and O
increased O
arborization O
of O
tertiary O
dendrites O
of O
DCX O
( O
+ O
) O
cells O
was O
observed O
. O

On O
the O
other O
hand O
, O
pretreatment O
with O
the O
selective O
cGMP B
- O
preferring O
phosphodiesterase O
PDE9 O
inhibitor O
BAY B
73 I
- I
6691 I
, O
increased O
locomotor O
activity O
induced O
by O
caffeine B
, O
but O
not O
paraxanthine B
. O

1 B
- I
Methylcyclopropene I
( O
1 B
- I
MCP I
) O
and O
gibberellic B
acid I
( O
GA B
( I
3 I
) I
) O
treatments O
delayed O
the O
softening O
and O
ethylene B
peak O
of O
persimmon O
fruit O
, O
as O
well O
as O
suppressed O
the O
expression O
of O
both O
XTH O
genes O
, O
especially O
DKXTH1 O
. O

Acrylamide B
formation O
was O
inhibited O
by O
30 O
. O
3 O
% O
, O
53 O
. O
3 O
% O
and O
89 O
. O
3 O
% O
when O
the O
sliced O
potato O
strips O
were O
soaked O
in O
0 O
. O
001 O
, O
0 O
. O
01 O
and O
0 O
. O
1 O
M O
vanadyl B
sulphate I
( O
VOSO B
( I
4 I
) I
) O
solutions O
, O
respectively O
, O
for O
60 O
min O
before O
frying O
. O

In O
a O
separate O
model O
reaction O
, O
a O
solution O
containing O
an O
equimolar O
concentration O
of O
L B
- I
asparagine I
and O
D B
- I
glucose I
showed O
a O
significant O
inhibition O
of O
acrylamide B
formation O
when O
heated O
at O
150 O
degrees O
C O
for O
30 O
min O
in O
the O
presence O
of O
vanadyl B
sulphate I
( O
VOSO B
( I
4 I
) I
) O
. O

The O
determination O
of O
fluorine B
in O
milk O
samples O
via O
the O
molecular O
absorption O
of O
calcium B
mono I
- I
fluoride I
( O
CaF B
) O
was O
performed O
using O
a O
HR O
- O
CS O
- O
ETAAS O
. O

In O
this O
paper O
a O
combination O
of O
NIR O
spectroscopy O
and O
FTIR O
and O
Raman O
microspectroscopy O
was O
used O
to O
elucidate O
the O
effects O
of O
different O
salts O
( O
NaCl B
, O
KCl B
and O
MgSO B
( I
4 I
) I
) O
on O
structural O
proteins O
and O
their O
hydration O
in O
muscle O
tissue O
. O

The O
modified O
monomers O
designed O
for O
these O
studies O
all O
share O
a O
common O
feature O
, O
they O
lack O
the O
naturally O
occurring O
3 B
' I
- I
hydroxyl I
group O
found O
in O
2 B
- I
deoxyribonucleosides I
. O

Modified O
H B
- I
phosphonates I
containing O
3 B
' I
- I
phenyl I
selenides I
as O
well O
as O
saturated B
and I
unsaturated I
sugars I
were O
obtained O
and O
incorporated O
in O
ODNs B
. O

These O
ODNs B
were O
used O
to O
investigate O
the O
fate O
of O
C3 B
' I
- I
dideoxyribonucleotid I
radicals O
in O
DNA O
. O

Protective O
effect O
of O
ganodermanondiol B
isolated O
from O
the O
Lingzhi O
mushroom O
against O
tert B
- I
butyl I
hydroperoxide I
- O
induced O
hepatotoxicity O
through O
Nrf2 O
- O
mediated O
antioxidant O
enzymes O
. O

The O
present O
study O
examined O
the O
protective O
effects O
of O
ganodermanondiol B
against O
tert B
- I
butyl I
hydroperoxide I
( O
t B
- I
BHP I
) O
- O
induced O
hepatotoxicity O
. O

DPEP B
induced O
dose O
- O
dependent O
reduction O
of O
the O
protein O
levels O
of O
inducible O
nitric B
oxide I
synthase O
( O
iNOS O
) O
and O
cyclooxygenase O
- O
2 O
( O
COX O
- O
2 O
) O
and O
concomitant O
reduction O
in O
the O
production O
of O
NO B
and O
prostaglandin B
E I
( I
2 I
) I
( O
PGE B
( I
2 I
) I
) O
. O

We O
investigated O
the O
mechanism O
by O
which O
DPEP B
inhibits O
NO B
and O
PGE B
( I
2 I
) I
by O
examining O
the O
level O
of O
nuclear O
factor O
- O
kappa O
B O
( O
NF O
- O
kappa O
B O
) O
activation O
within O
the O
mitogen O
- O
activated O
protein O
kinase O
( O
MAPK O
) O
pathway O
, O
which O
is O
an O
inflammation O
- O
induced O
signaling O
pathway O
in O
RAW O
264 O
. O
7 O
cells O
. O

Radioprotection O
by O
two O
phenolic B
compounds O
: O
chlorogenic B
and I
quinic I
acid I
, O
on O
X O
- O
ray O
induced O
DNA O
damage O
in O
human O
blood O
lymphocytes O
in O
vitro O
. O

Then O
, O
the O
effects O
of O
ethylene B
glycol I
tetraacetic I
acid I
( O
EGTA B
) O
( O
0 O
. O
5 O
mM O
) O
, O
calpeptin B
( O
2 O
. O
5 O
mu O
M O
) O
, O
and O
spironoclactone B
( O
10 O
mu O
M O
) O
were O
evaluated O
on O
cardiomyocytes O
activated O
by O
ALD B
. O

The O
synthetic O
sample O
showed O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
entirely O
different O
from O
those O
in O
the O
literature O
, O
revealing O
that O
the O
initially O
assigned O
structure O
was O
incorrect O
. O

The O
synthetic O
sample O
showed O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
entirely O
different O
from O
those O
in O
the O
literature O
, O
revealing O
that O
the O
initially O
assigned O
structure O
was O
incorrect O
. O

The O
hydroxy B
- I
carboxylic I
acid I
receptor O
( O
HCA1 O
) O
is O
a O
G O
protein O
- O
coupled O
receptor O
that O
is O
highly O
expressed O
on O
adipocytes O
and O
considered O
a O
potential O
target O
for O
the O
treatment O
of O
dyslipidemia O
. O

Twelve O
new O
dihydroagarofuran B
sesquiterpene I
polyol I
esters I
, O
triptersinines B
A I
- I
L I
( O
1 O
- O
12 O
) O
, O
and O
eight O
known O
sesquiterpene B
pyridine B
alkaloids I
were O
isolated O
from O
the O
leaves O
of O
Tripterygium O
wilfordii O
. O

Twelve O
new O
dihydroagarofuran B
sesquiterpene I
polyol I
esters I
, O
triptersinines B
A I
- I
L I
( O
1 O
- O
12 O
) O
, O
and O
eight O
known O
sesquiterpene B
pyridine B
alkaloids I
were O
isolated O
from O
the O
leaves O
of O
Tripterygium O
wilfordii O
. O

Their O
structures O
were O
elucidated O
on O
the O
basis O
of O
spectroscopic O
analyses O
, O
including O
UV O
, O
IR O
, O
and O
NMR O
experiments O
( O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
COSY O
, O
NOESY O
, O
HSQC O
, O
and O
HMBC O
) O
. O

Their O
structures O
were O
elucidated O
on O
the O
basis O
of O
spectroscopic O
analyses O
, O
including O
UV O
, O
IR O
, O
and O
NMR O
experiments O
( O
( B
1 I
) I
H I
- O
( B
1 I
) I
H I
COSY O
, O
NOESY O
, O
HSQC O
, O
and O
HMBC O
) O
. O

Our O
results O
indicate O
that O
nitrogen B
configuration O
and O
its O
location O
( O
armchair O
or O
zigzag O
edge O
) O
in O
nitrogen B
- I
doped I
graphene I
can O
be O
identified O
via O
the O
spectral O
analysis O
. O

Furthermore O
, O
some O
controversial O
spectral O
features O
observed O
in O
experiment O
for O
N B
- I
doped I
graphene I
- O
like O
materials O
are O
unambiguously O
assigned O
. O

We O
assessed O
OH B
production O
by O
quantifying O
the O
rate O
of O
formation O
of O
3 B
, I
4 I
- I
dihydroxybenzoic I
acid I
using O
a O
trapping O
agent O
, O
4 B
- I
hydroxybenzoic I
acid I
, O
infused O
via O
the O
microdialysis O
probe O
, O
into O
the O
prefrontal O
cortex O
of O
rats O
exposed O
intraperitoneally O
to O
the O
solvents O
. O

The O
pharmacological O
blockade O
of O
K B
( I
+ I
) I
channels O
with O
tetraethylammonium B
, O
glybenclamide B
, O
and O
4 B
- I
aminopyridine I
also O
blunted O
vasorelaxation O
induced O
by O
1 B
- I
nitro I
- I
2 I
- I
phenylethane I
. O

N B
- I
cinnamoylated I
chloroquine I
analogues O
as O
dual O
- O
stage O
antimalarial O
leads O
. O

Bistable O
magnetoresistance O
switching O
in O
exchange O
- O
coupled O
CoFe B
2 I
O I
4 I
- O
- O
Fe B
3 I
O I
4 I
binary O
nanocrystal O
superlattices O
by O
self O
- O
assembly O
and O
thermal O
annealing O
. O

Bistable O
magnetoresistance O
switching O
in O
exchange O
- O
coupled O
CoFe B
2 I
O I
4 I
- O
- O
Fe B
3 I
O I
4 I
binary O
nanocrystal O
superlattices O
by O
self O
- O
assembly O
and O
thermal O
annealing O
. O

In O
this O
work O
, O
we O
report O
the O
self O
- O
assembly O
of O
binary O
nanocrystal O
superlattices O
composed O
of O
magnetically O
hard O
CoFe B
2 I
O I
4 I
nanocrystals O
and O
magnetically O
soft O
Fe B
3 I
O I
4 I
nanocrystals O
. O

In O
this O
work O
, O
we O
report O
the O
self O
- O
assembly O
of O
binary O
nanocrystal O
superlattices O
composed O
of O
magnetically O
hard O
CoFe B
2 I
O I
4 I
nanocrystals O
and O
magnetically O
soft O
Fe B
3 I
O I
4 I
nanocrystals O
. O

Both O
NaZn B
1 I
3 I
- O
and O
MgZn B
2 I
- O
type O
CoFe B
2 I
O I
4 I
- O
- O
Fe B
3 I
O I
4 I
binary O
nanocrystal O
superlattices O
have O
been O
formed O
by O
the O
liquid O
- O
air O
interfacial O
assembly O
approach O
. O

Both O
NaZn B
1 I
3 I
- O
and O
MgZn B
2 I
- O
type O
CoFe B
2 I
O I
4 I
- O
- O
Fe B
3 I
O I
4 I
binary O
nanocrystal O
superlattices O
have O
been O
formed O
by O
the O
liquid O
- O
air O
interfacial O
assembly O
approach O
. O

The O
exchange O
- O
coupled O
CoFe B
2 I
O I
4 I
- O
- O
Fe B
3 I
O I
4 I
binary O
nanocrystal O
superlattices O
show O
single O
- O
phase O
magnetization O
switching O
behavior O
and O
magnetoresistance O
switching O
behavior O
below O
200 O
K O
. O

The O
exchange O
- O
coupled O
CoFe B
2 I
O I
4 I
- O
- O
Fe B
3 I
O I
4 I
binary O
nanocrystal O
superlattices O
show O
single O
- O
phase O
magnetization O
switching O
behavior O
and O
magnetoresistance O
switching O
behavior O
below O
200 O
K O
. O

The O
NaZn B
1 I
3 I
- O
type O
CoFe B
2 I
O I
4 I
- O
- O
Fe B
3 I
O I
4 I
binary O
nanocrystal O
superlattices O
annealed O
at O
500 O
degrees O
C O
even O
exhibit O
bistable O
magnetoresistance O
switching O
behavior O
at O
room O
temperature O
constituting O
a O
simple O
nonvolatile O
memory O
function O
. O

The O
NaZn B
1 I
3 I
- O
type O
CoFe B
2 I
O I
4 I
- O
- O
Fe B
3 I
O I
4 I
binary O
nanocrystal O
superlattices O
annealed O
at O
500 O
degrees O
C O
even O
exhibit O
bistable O
magnetoresistance O
switching O
behavior O
at O
room O
temperature O
constituting O
a O
simple O
nonvolatile O
memory O
function O
. O

In O
this O
study O
we O
report O
the O
isolation O
of O
three O
endophytic O
fungi O
from O
fruit O
and O
seed O
regions O
of O
Miquelia O
dentata O
( O
Icacinaceae O
) O
, O
that O
produce O
CPT B
, O
9 B
- I
methoxy I
CPT I
( O
9 B
- I
MeO I
- I
CPT I
) O
and O
10 B
- I
hydroxy I
CPT I
( O
10 B
- I
OH I
- I
CPT I
) O
. O

In O
this O
study O
we O
report O
the O
isolation O
of O
three O
endophytic O
fungi O
from O
fruit O
and O
seed O
regions O
of O
Miquelia O
dentata O
( O
Icacinaceae O
) O
, O
that O
produce O
CPT B
, O
9 B
- I
methoxy I
CPT I
( O
9 B
- I
MeO I
- I
CPT I
) O
and O
10 B
- I
hydroxy I
CPT I
( O
10 B
- I
OH I
- I
CPT I
) O
. O

Histone O
deacetylases O
are O
able O
to O
catalyze O
the O
hydrolysis O
of O
N B
- I
acetyl I
lysine I
residues O
of O
histones O
which O
package O
chromosomal O
DNA O
. O

Chondroitin O
sulfate B
( O
CS O
) O
is O
a O
natural O
glycosaminoglycan O
, O
formed O
by O
the O
1 O
- O
3 O
linkage O
of O
d B
- I
glucuronic I
acid I
to O
N B
- I
acetylgalactosamine I
, O
present O
in O
the O
extracellular O
matrix O
. O

The O
effect O
of O
the O
surface O
heterogeneity O
on O
the O
in O
vivo O
biodistribution O
was O
systematically O
investigated O
through O
in O
vivo O
tracking O
of O
the O
( B
125 I
) I
I I
- O
labeled O
MSMs O
determined O
by O
Gamma O
counter O
. O

The O
( O
6 O
' O
S O
) O
- O
configuration O
of O
brevipolides B
A I
- I
J I
( O
1 O
- O
10 O
) O
, O
isolated O
from O
Hyptis O
brevipes O
, O
was O
established O
by O
X O
- O
ray O
diffraction O
analysis O
of O
9 O
in O
conjunction O
with O
Mosher B
' I
s I
ester I
analysis O
of O
the O
tetrahydro O
derivative O
11 O
obtained O
from O
both O
geometric O
isomers O
8 O
and O
9 O
as O
well O
as O
by O
chemical O
correlations O
. O

The O
( O
6 O
' O
S O
) O
- O
configuration O
of O
brevipolides B
A I
- I
J I
( O
1 O
- O
10 O
) O
, O
isolated O
from O
Hyptis O
brevipes O
, O
was O
established O
by O
X O
- O
ray O
diffraction O
analysis O
of O
9 O
in O
conjunction O
with O
Mosher B
' I
s I
ester I
analysis O
of O
the O
tetrahydro O
derivative O
11 O
obtained O
from O
both O
geometric O
isomers O
8 O
and O
9 O
as O
well O
as O
by O
chemical O
correlations O
. O

Visualizing O
the O
perturbation O
of O
cellular O
cyclic B
di I
- I
GMP I
levels O
in O
bacterial O
cells O
. O

Cyclic B
di I
- I
GMP I
( O
c B
- I
di I
- I
GMP I
) O
has O
emerged O
as O
a O
prominent O
intracellular O
messenger O
that O
coordinates O
biofilm O
formation O
and O
pathogenicity O
in O
many O
bacterial O
species O
. O

A O
mild O
and O
highly O
stereoselective O
rhodium B
( I
II I
) I
- O
catalyzed O
cyclopropanation O
of O
alkenes B
, O
alkynes B
, O
and O
allenes B
with O
diacceptor O
diazo B
compounds O
is O
reported O
. O

Using O
the O
phosphonate B
moiety O
as O
an O
efficient O
trans O
- O
directing O
group O
, O
the O
first O
catalytic O
asymmetric O
route O
to O
diacceptor O
cycloprop B
( I
en I
) I
ylphosphonates I
was O
developed O
by O
employing O
an O
alpha B
- I
cyano I
diazophosphonate I
and O
Rh B
( I
2 I
) I
( I
S I
- I
IBAZ I
) I
( I
4 I
) I
as O
chiral O
catalyst O
. O

The O
isosteric O
character O
of O
phosphonic B
and I
carboxylic I
acid I
derivatives O
allowed O
the O
alternative O
use O
of O
an O
alpha B
- I
cyano I
diazo I
ester I
in O
the O
process O
, O
leading O
to O
alpha B
- I
cyano I
cycloprop I
( I
en I
) I
ylcarboxylates I
in O
high O
yields O
and O
stereoselectivities O
. O

A O
small O
series O
of O
thiazolidine B
- I
2 I
, I
4 I
- I
dione I
and O
barbituric B
acid I
derivatives O
1 O
- O
4 O
was O
prepared O
using O
a O
short O
synthetic O
route O
, O
and O
all O
compounds O
were O
characterized O
by O
elemental O
analysis O
, O
mass O
spectrometry O
, O
and O
NMR O
( O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
) O
spectroscopy O
. O

A O
small O
series O
of O
thiazolidine B
- I
2 I
, I
4 I
- I
dione I
and O
barbituric B
acid I
derivatives O
1 O
- O
4 O
was O
prepared O
using O
a O
short O
synthetic O
route O
, O
and O
all O
compounds O
were O
characterized O
by O
elemental O
analysis O
, O
mass O
spectrometry O
, O
and O
NMR O
( O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
) O
spectroscopy O
. O

The O
structures O
of O
thiosemicarbazones B
were O
confirmed O
by O
spectroscopic O
( O
IR O
, O
( B
1 I
) I
H I
NMR O
, O
( B
13 I
) I
C I
NMR O
and O
ESI O
- O
MS O
) O
method O
. O

The O
structures O
of O
thiosemicarbazones B
were O
confirmed O
by O
spectroscopic O
( O
IR O
, O
( B
1 I
) I
H I
NMR O
, O
( B
13 I
) I
C I
NMR O
and O
ESI O
- O
MS O
) O
method O
. O

The O
Pb B
- I
acetate I
( O
5mg O
/ O
kg O
body O
weight O
) O
treated O
rats O
exhibited O
a O
significant O
inhibition O
of O
co B
- I
enzymes I
Q I
, O
antioxidant O
enzymes O
and O
reduced O
glutathione B
levels O
in O
the O
tissues O
. O

KCNK1 O
, O
a O
member O
of O
the O
family O
of O
two O
- O
pore O
K B
( I
+ I
) I
ion O
channels O
, O
is O
specifically O
induced O
in O
the O
livers O
of O
male O
mice O
after O
phenobarbital B
treatment O
. O

The O
results O
of O
thermogravimetric O
analysis O
( O
TGA O
) O
, O
elemental O
analysis O
( O
EA O
) O
, O
and O
( B
1 I
) I
H I
/ O
( B
13 I
) I
C I
NMR O
spectroscopy O
confirmed O
the O
cluster O
composition O
. O

The O
results O
of O
thermogravimetric O
analysis O
( O
TGA O
) O
, O
elemental O
analysis O
( O
EA O
) O
, O
and O
( B
1 I
) I
H I
/ O
( B
13 I
) I
C I
NMR O
spectroscopy O
confirmed O
the O
cluster O
composition O
. O

To O
the O
best O
of O
our O
knowledge O
, O
this O
is O
the O
first O
report O
of O
selenolate B
- O
protected O
Au B
( I
18 I
) I
nanoclusters O
. O

AveC O
catalyzes O
the O
stereospecific O
spiroketalization O
of O
a O
dihydroxy B
- I
ketone I
polyketide I
intermediate O
and O
the O
optional O
dehydration O
to O
determine O
the O
regiospecific O
saturation O
characteristics O
of O
spiroketal O
diversity O
. O

A O
safety O
study O
on O
single O
intravenous O
dose O
of O
tetrachloro B
- I
diphenyl I
glycoluril I
[ O
iodogen B
] O
dissolved O
in O
dimethyl B
sulphoxide I
( O
DMSO B
) O
. O

Iodogen B
( O
tetrachloro B
- I
diphenyl I
glycoluril I
) O
dissolved O
in O
DMSO B
( O
dimethyl B
sulphoxide I
) O
appears O
indispensable O
in O
radioiodination O
of O
hypericin B
for O
a O
new O
anticancer O
strategy O
. O

This O
domain O
is O
capable O
of O
catalyzing O
the O
NADP B
( I
+ I
) I
- O
dependent O
oxidation O
of O
short O
chain O
aldehydes B
to O
their O
corresponding O
acids O
, O
and O
similar O
to O
most O
ALDHs O
it O
has O
two O
conserved O
catalytic O
residues O
, O
Cys707 B
and O
Glu673 B
. O

We O
suggested O
that O
this O
was O
due O
to O
the O
loss O
of O
a O
covalent O
bond O
between O
the O
cysteine B
and O
the O
C4N O
atom O
of O
nicotinamide B
ring O
of O
NADP B
( I
+ I
) I
formed O
during O
Ct O
- O
FDH O
catalysis O
. O

To O
obtain O
further O
insight O
into O
the O
functional O
significance O
of O
the O
covalent O
bond O
between O
Cys707 B
and O
the O
coenzyme O
, O
and O
the O
overall O
role O
of O
the O
two O
catalytic O
residues O
in O
the O
coenzyme O
binding O
and O
positioning O
, O
we O
have O
now O
solved O
crystal O
structures O
of O
Ct O
- O
FDH O
in O
the O
complex O
with O
thio B
- I
NADP I
( I
+ I
) I
and O
the O
complexes O
of O
the O
C707S O
mutant O
with O
NADP B
( I
+ I
) I
and O
NADPH B
. O

X O
- O
ray O
structure O
of O
the O
V301L O
aldo O
- O
keto O
reductase O
1B10 O
complexed O
with O
NADP B
( I
+ I
) I
and O
the O
potent O
aldose B
reductase O
inhibitor O
fidarestat B
: O
implications O
for O
inhibitor O
binding O
and O
selectivity O
. O

Only O
one O
crystal O
structure O
is O
currently O
available O
for O
tumor O
marker O
AKR1B10 O
, O
complexed O
with O
NADP B
( I
+ I
) I
and O
tolrestat B
, O
which O
is O
an O
aldose B
reductase O
inhibitor O
( O
ARI O
) O
of O
the O
carboxylic B
acid I
type O
. O

The O
aim O
of O
this O
study O
is O
to O
examine O
how O
different O
specific O
surface O
areas O
of O
similar O
- O
sized O
titanium B
dioxide I
( O
TiO B
( I
2 I
) I
) O
particles O
could O
influence O
both O
cytotoxicity O
and O
phototoxicity O
. O

TiO B
( I
2 I
) I
particles O
of O
different O
specific O
surface O
areas O
were O
compared O
for O
their O
toxic O
effects O
on O
RAW264 O
. O
7 O
cells O
in O
the O
absence O
and O
presence O
of O
UV O
light O
. O

From O
the O
results O
, O
TiO B
( I
2 I
) I
particles O
with O
larger O
specific O
surface O
area O
were O
found O
to O
induce O
higher O
cyto O
- O
( O
UV O
absent O
) O
and O
photo O
- O
toxicity O
( O
UV O
activated O
) O
to O
cells O
after O
24h O
incubation O
. O

The O
observed O
cytotoxicity O
from O
TiO B
( I
2 I
) I
particles O
with O
larger O
surface O
area O
could O
be O
explained O
from O
their O
interactions O
with O
biomolecules O
. O

Upon O
photoactivation O
, O
a O
larger O
number O
of O
hydroxyl B
radicals O
were O
detected O
from O
TiO B
( I
2 I
) I
particles O
with O
larger O
surface O
area O
, O
again O
suggesting O
a O
surface O
area O
dependent O
phototoxic O
effect O
. O

On O
the O
other O
hand O
, O
pre O
- O
adsorbing O
TiO B
( I
2 I
) I
particles O
with O
extracellular O
proteins O
were O
found O
to O
decrease O
toxicity O
effects O
. O

Polyethylenimine B
( O
PEI B
) O
is O
a O
highly O
positive O
charged O
polymer O
and O
is O
known O
to O
have O
varying O
degree O
of O
toxic O
effect O
to O
cells O
based O
on O
its O
chemical O
structure O
( O
i O
. O
e O
. O
, O
amount O
of O
primary B
and I
secondary I
amine I
) O
. O

The O
interaction O
of O
GO O
with O
actinides B
including O
Am B
( I
III I
) I
, O
Th B
( I
IV I
) I
, O
Pu B
( I
IV I
) I
, O
Np B
( I
V I
) I
, O
U B
( I
VI I
) I
and O
typical O
fission O
products O
Sr B
( I
II I
) I
, O
Eu B
( I
III I
) I
and O
Tc B
( I
VII I
) I
were O
studied O
, O
along O
with O
their O
sorption O
kinetics O
. O

The O
interaction O
of O
GO O
with O
actinides B
including O
Am B
( I
III I
) I
, O
Th B
( I
IV I
) I
, O
Pu B
( I
IV I
) I
, O
Np B
( I
V I
) I
, O
U B
( I
VI I
) I
and O
typical O
fission O
products O
Sr B
( I
II I
) I
, O
Eu B
( I
III I
) I
and O
Tc B
( I
VII I
) I
were O
studied O
, O
along O
with O
their O
sorption O
kinetics O
. O

The O
interaction O
of O
GO O
with O
actinides B
including O
Am B
( I
III I
) I
, O
Th B
( I
IV I
) I
, O
Pu B
( I
IV I
) I
, O
Np B
( I
V I
) I
, O
U B
( I
VI I
) I
and O
typical O
fission O
products O
Sr B
( I
II I
) I
, O
Eu B
( I
III I
) I
and O
Tc B
( I
VII I
) I
were O
studied O
, O
along O
with O
their O
sorption O
kinetics O
. O

The O
interaction O
of O
GO O
with O
actinides B
including O
Am B
( I
III I
) I
, O
Th B
( I
IV I
) I
, O
Pu B
( I
IV I
) I
, O
Np B
( I
V I
) I
, O
U B
( I
VI I
) I
and O
typical O
fission O
products O
Sr B
( I
II I
) I
, O
Eu B
( I
III I
) I
and O
Tc B
( I
VII I
) I
were O
studied O
, O
along O
with O
their O
sorption O
kinetics O
. O

The O
interaction O
of O
GO O
with O
actinides B
including O
Am B
( I
III I
) I
, O
Th B
( I
IV I
) I
, O
Pu B
( I
IV I
) I
, O
Np B
( I
V I
) I
, O
U B
( I
VI I
) I
and O
typical O
fission O
products O
Sr B
( I
II I
) I
, O
Eu B
( I
III I
) I
and O
Tc B
( I
VII I
) I
were O
studied O
, O
along O
with O
their O
sorption O
kinetics O
. O

The O
interaction O
of O
GO O
with O
actinides B
including O
Am B
( I
III I
) I
, O
Th B
( I
IV I
) I
, O
Pu B
( I
IV I
) I
, O
Np B
( I
V I
) I
, O
U B
( I
VI I
) I
and O
typical O
fission O
products O
Sr B
( I
II I
) I
, O
Eu B
( I
III I
) I
and O
Tc B
( I
VII I
) I
were O
studied O
, O
along O
with O
their O
sorption O
kinetics O
. O

The O
interaction O
of O
GO O
with O
actinides B
including O
Am B
( I
III I
) I
, O
Th B
( I
IV I
) I
, O
Pu B
( I
IV I
) I
, O
Np B
( I
V I
) I
, O
U B
( I
VI I
) I
and O
typical O
fission O
products O
Sr B
( I
II I
) I
, O
Eu B
( I
III I
) I
and O
Tc B
( I
VII I
) I
were O
studied O
, O
along O
with O
their O
sorption O
kinetics O
. O

The O
interaction O
of O
GO O
with O
actinides B
including O
Am B
( I
III I
) I
, O
Th B
( I
IV I
) I
, O
Pu B
( I
IV I
) I
, O
Np B
( I
V I
) I
, O
U B
( I
VI I
) I
and O
typical O
fission O
products O
Sr B
( I
II I
) I
, O
Eu B
( I
III I
) I
and O
Tc B
( I
VII I
) I
were O
studied O
, O
along O
with O
their O
sorption O
kinetics O
. O

Here O
, O
we O
show O
that O
oral O
administration O
of O
resveratrol B
, O
which O
leads O
to O
activation O
of O
an O
NAD B
( I
+ I
) I
- O
dependent O
protein O
deacetylase O
SIRT1 O
, O
suppresses O
cardiac O
hypertrophy O
and O
fibrosis O
and O
restores O
cardiac O
diastolic O
function O
in O
dystrophin O
- O
deficient O
mdx O
mice O
. O

Herein O
we O
report O
a O
NMR O
relaxation O
study O
[ O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
T O
( O
1 O
) O
, O
T O
( O
2 O
) O
; O
( B
13 I
) I
C I
{ O
( B
1 I
) I
H I
} O
NOE O
; O
various O
fields O
and O
temperatures O
] O
which O
reveals O
profound O
differences O
between O
the O
relaxation O
behavior O
of O
dendrimers O
and O
linear O
polymers O
. O

Herein O
we O
report O
a O
NMR O
relaxation O
study O
[ O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
T O
( O
1 O
) O
, O
T O
( O
2 O
) O
; O
( B
13 I
) I
C I
{ O
( B
1 I
) I
H I
} O
NOE O
; O
various O
fields O
and O
temperatures O
] O
which O
reveals O
profound O
differences O
between O
the O
relaxation O
behavior O
of O
dendrimers O
and O
linear O
polymers O
. O

Herein O
we O
report O
a O
NMR O
relaxation O
study O
[ O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
T O
( O
1 O
) O
, O
T O
( O
2 O
) O
; O
( B
13 I
) I
C I
{ O
( B
1 I
) I
H I
} O
NOE O
; O
various O
fields O
and O
temperatures O
] O
which O
reveals O
profound O
differences O
between O
the O
relaxation O
behavior O
of O
dendrimers O
and O
linear O
polymers O
. O

Herein O
we O
report O
a O
NMR O
relaxation O
study O
[ O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
T O
( O
1 O
) O
, O
T O
( O
2 O
) O
; O
( B
13 I
) I
C I
{ O
( B
1 I
) I
H I
} O
NOE O
; O
various O
fields O
and O
temperatures O
] O
which O
reveals O
profound O
differences O
between O
the O
relaxation O
behavior O
of O
dendrimers O
and O
linear O
polymers O
. O

The O
fluorescent O
dyes O
methylene B
blue I
, O
MB O
( O
+ O
) O
, O
and O
thionine B
, O
Th O
( O
+ O
) O
, O
can O
be O
trapped O
in O
the O
pores O
of O
mesoporous O
silica B
, O
MP O
- O
SiO B
( I
2 I
) I
, O
by O
means O
of O
functional O
nanostructures O
consisting O
of O
the O
Mg B
( I
2 I
+ I
) I
- O
or O
Zn B
( I
2 I
+ I
) I
- O
dependent O
DNAzyme O
sequences O
. O

The O
metal O
ion O
- O
driven O
DNAzyme O
release O
of O
substrates O
from O
the O
pores O
of O
MP O
- O
SiO B
( I
2 I
) I
, O
and O
particularly O
the O
allosteric O
activation O
of O
the O
DNAzymes O
through O
cooperative O
aptamer O
- O
substrate O
complexes O
or O
metal O
- O
ion O
bridges O
, O
has O
important O
future O
nanomedical O
implications O
for O
targeted O
release O
of O
drugs O
. O

Moreover O
, O
histopathological O
examination O
, O
mitotic O
index O
( O
MI O
) O
, O
proliferating O
cell O
nuclear O
antigen O
labeling O
, O
proliferation O
index O
( O
PI O
) O
, O
transferase O
- O
mediated O
2 B
' I
- I
deoxyuridine I
, O
5 B
' I
- I
triphosphate I
nick O
end O
- O
labeling O
assay O
, O
and O
apoptotic O
index O
( O
AI O
) O
were O
evaluated O
at O
7 O
days O
after O
hepatectomy O
. O

Moreover O
, O
histopathological O
examination O
, O
mitotic O
index O
( O
MI O
) O
, O
proliferating O
cell O
nuclear O
antigen O
labeling O
, O
proliferation O
index O
( O
PI O
) O
, O
transferase O
- O
mediated O
2 B
' I
- I
deoxyuridine I
, O
5 B
' I
- I
triphosphate I
nick O
end O
- O
labeling O
assay O
, O
and O
apoptotic O
index O
( O
AI O
) O
were O
evaluated O
at O
7 O
days O
after O
hepatectomy O
. O

Eight O
hydrolysable O
tannins B
( O
gallic B
acid I
, O
gallic B
acid I
methyl I
ester I
, O
corilagin B
, O
chebulagic B
acid I
, O
1 B
, I
2 I
, I
3 I
, I
6 I
- I
tetra I
- I
O I
- I
galloyl I
- I
beta I
- I
D I
- I
glucose I
, O
ellagic B
acid I
, O
chebulinic B
acid I
, O
and O
1 B
, I
2 I
, I
3 I
, I
4 I
, I
6 I
- I
penta I
- I
O I
- I
galloyl I
- I
beta I
- I
D I
- I
glucose I
) O
and O
six O
triterpene B
saponins I
( O
arjunglucoside B
- I
I I
, O
arjunglucoside B
- I
III I
, O

Propofol B
, O
a O
widely O
used O
intravenous O
general O
anesthetic O
, O
acts O
at O
anesthetic O
concentrations O
as O
a O
positive O
allosteric O
modulator O
of O
gamma B
- I
aminobutyric I
acid I
type O
A O
receptors O
and O
at O
higher O
concentration O
as O
an O
inhibitor O
of O
nicotinic O
acetylcholine B
receptors O
( O
nAChRs O
) O
. O

Results O
: O
N B
- I
methyl I
pyrrolidone I
( O
NMP B
) O
resulted O
as O
the O
best O
SPE O
: O
in O
addition O
, O
the O
critical O
factors O
influencing O
the O
PR O
diffusion O
through O
the O
human O
epidermis O
when O
loaded O
in O
the O
patch O
resulted O
in O
the O
matrix O
thickness O
( O
X O
( O
1 O
) O
, O
p O
= O
0 O
. O
0957 O
) O
and O
PR O
content O
( O
X O
( O
3 O
) O
, O
p O
= O
0 O
. O
0004 O
) O
which O
improved O
the O
flux O
; O
conversely O
, O
NMP B
lacked O
its O
enhancement O
effect O
when O
loaded O
in O
the O
patch O
and O
the O
increase O
in O
its O
concentration O
( O
X O
( O
4 O
) O
, O
p O
= O
0 O
. O
006 O
) O
affected O
the O
drug O

The O
simulations O
quantify O
the O
changes O
in O
film O
physisorption O
on O
graphene B
and O
the O
alkyl B
chain O
packing O
efficiency O
as O
the O
film O
surface O
is O
made O
more O
polar O
by O
changing O
the O
terminal O
groups O
from O
methyl B
( O
- O
CH B
( I
3 I
) I
) O
to O
amine B
( O
- O
NH B
( I
2 I
) I
) O
to O
hydroxyl B
( O
- O
OH B
) O
. O

The O
simulations O
quantify O
the O
changes O
in O
film O
physisorption O
on O
graphene B
and O
the O
alkyl B
chain O
packing O
efficiency O
as O
the O
film O
surface O
is O
made O
more O
polar O
by O
changing O
the O
terminal O
groups O
from O
methyl B
( O
- O
CH B
( I
3 I
) I
) O
to O
amine B
( O
- O
NH B
( I
2 I
) I
) O
to O
hydroxyl B
( O
- O
OH B
) O
. O

( B
99m I
) I
Tc I
labeling O
was O
performed O
by O
using O
different O
co O
- O
ligands O
: O
tricine B
and O
ethylenediamine B
diacetic I
acid I
( O
EDDA B
) O
. O

The O
Gd B
- I
DOTA I
monoamide I
cage O
( O
DOTA B
= O
1 B
, I
4 I
, I
7 I
, I
10 I
- I
tetraazacyclododecan I
- I
1 I
, I
4 I
, I
7 I
, I
10 I
- I
tetraacetic I
acid I
) O
represents O
the O
magnetic O
resonance O
imaging O
reporter O
, O
which O
is O
spaced O
from O
the O
phenylpyrazolo B
[ I
1 I
, I
5 I
- I
a I
] I
pyrimidineacetamide I
moiety O
( O
DPA B
- I
713 I
motif O
) O
by O
a O
six O
carbon B
- O
atom O
chain O
. O

Forty O
oopherectomized O
Wistar O
- O
Albino O
rats O
were O
used O
, O
and O
assigned O
to O
receive O
saline O
, O
17 B
beta I
Estradiol I
hemihydrate I
( O
4 O
mg O
/ O
kg O
) O
, O
17 B
beta I
Estradiol I
hemihydrate I
( O
4 O
mg O
/ O
kg O
) O
and O
metformin B
( O
50 O
mg O
/ O
kg O
) O
, O
17 B
beta I
Estradiol I
hemihydrate I
( O
4 O
mg O
/ O
kg O
) O
and O
MPA B
( O
1 O
mg O
/ O
day O
) O
for O
14 O
days O
. O

Forty O
oopherectomized O
Wistar O
- O
Albino O
rats O
were O
used O
, O
and O
assigned O
to O
receive O
saline O
, O
17 B
beta I
Estradiol I
hemihydrate I
( O
4 O
mg O
/ O
kg O
) O
, O
17 B
beta I
Estradiol I
hemihydrate I
( O
4 O
mg O
/ O
kg O
) O
and O
metformin B
( O
50 O
mg O
/ O
kg O
) O
, O
17 B
beta I
Estradiol I
hemihydrate I
( O
4 O
mg O
/ O
kg O
) O
and O
MPA B
( O
1 O
mg O
/ O
day O
) O
for O
14 O
days O
. O

Forty O
oopherectomized O
Wistar O
- O
Albino O
rats O
were O
used O
, O
and O
assigned O
to O
receive O
saline O
, O
17 B
beta I
Estradiol I
hemihydrate I
( O
4 O
mg O
/ O
kg O
) O
, O
17 B
beta I
Estradiol I
hemihydrate I
( O
4 O
mg O
/ O
kg O
) O
and O
metformin B
( O
50 O
mg O
/ O
kg O
) O
, O
17 B
beta I
Estradiol I
hemihydrate I
( O
4 O
mg O
/ O
kg O
) O
and O
MPA B
( O
1 O
mg O
/ O
day O
) O
for O
14 O
days O
. O

However O
, O
at O
high O
concentrations O
( O
= O
~ O
0 O
. O
2 O
mg O
/ O
mL O
) O
, O
( B
1 I
) I
H I
NMR O
and O
DOSY O
measurements O
confirmed O
that O
irradiating O
BBS B
at O
350 O
nm O
induced O
a O
conversion O
from O
the O
trans B
- I
BBS I
into O
its O
cis O
isomer O
by O
photoisomerization O
. O

In O
combination O
with O
dichloro B
- I
substituted I
phenylacetyl I
groups O
at O
the O
P4 O
position O
, O
three O
inhibitors O
with O
inhibition O
constants O
of O
< O
0 O
. O
2 O
mu O
M O
were O
obtained O
. O

The O
canthines B
represent O
a O
fairly O
large O
subclass O
of O
beta B
- I
carboline I
alkaloids I
, O
with O
the O
first O
members O
described O
75 O
years O
ago O
. O

Upon O
oxidation O
and O
reduction O
, O
these O
covalently O
interconnected O
layers O
do O
not O
disassemble O
, O
in O
contrast O
to O
poly B
( I
ferrocenylsilane I
) I
( O
PFS B
) O
layers O
featuring O
similar O
backbone O
structures O
that O
are O
held O
together O
by O
electrostatic O
forces O
. O

The O
design O
concept O
involved O
the O
replacement O
of O
the O
3 B
- I
carboxylic I
acid I
in O
ciprofloxacin B
with O
an O
oxaborole B
- O
fused O
ring O
as O
an O
acid O
- O
mimicking O
group O
. O

Toxic O
effects O
of O
dietary O
exposure O
to O
T B
- I
2 I
toxin I
on O
intestinal O
and O
hepatic O
biotransformation O
enzymes O
and O
drug O
transporter O
systems O
in O
broiler O
chickens O
. O

The O
effects O
of O
the O
mycotoxin B
T I
- I
2 I
on O
hepatic O
and O
intestinal O
drug O
- O
metabolizing O
enzymes O
( O
cytochrome O
P450 O
) O
and O
drug O
transporter O
systems O
( O
MDR1 O
and O
MRP2 O
) O
in O
poultry O
were O
investigated O
during O
this O
study O
. O

Broiler O
chickens O
received O
either O
uncontaminated O
feed O
, O
feed O
contaminated O
with O
68 O
mu O
g O
/ O
kg O
or O
752 O
mu O
g O
/ O
kg O
T B
- I
2 I
toxin I
. O

Purification O
of O
the O
extracts O
yielded O
four O
chiral O
polyphenols B
, O
suffruticosol B
A I
( O
1 O
) O
, O
suffruticosol B
B I
( O
2 O
) O
, O
trans B
- I
epsilon I
- I
viniferin I
( O
3 O
) O
, O
and O
trans B
- I
gnetin I
H I
( O
4 O
) O
. O

Monocyclic B
beta I
- I
lactams I
as O
antibacterial O
agents O
: O
facing O
antioxidant O
activity O
of O
N B
- I
methylthio I
- I
azetidinones I
. O

Tension O
studies O
demonstrated O
a O
rapid O
, O
concentration O
- O
dependent O
, O
vasodilatory O
response O
to O
TES B
that O
did O
not O
involve O
protein O
synthesis O
or O
aromatization O
to O
17 B
beta I
- I
estradiol I
. O

Ordered O
mesoporous O
boron B
- I
doped I
carbons I
as O
metal O
- O
free O
electrocatalysts O
for O
the O
oxygen B
reduction O
reaction O
in O
alkaline O
solution O
. O

Ordered O
mesoporous O
boron B
- I
doped I
carbons I
( O
BOMCs O
) O
were O
prepared O
by O
co O
- O
impregnation O
and O
carbonization O
of O
sucrose B
and O
4 B
- I
hydroxyphenylboronic I
acid I
into O
SBA B
- I
15 I
silica B
template O
. O

Ordered O
mesoporous O
boron B
- I
doped I
carbons I
( O
BOMCs O
) O
were O
prepared O
by O
co O
- O
impregnation O
and O
carbonization O
of O
sucrose B
and O
4 B
- I
hydroxyphenylboronic I
acid I
into O
SBA B
- I
15 I
silica B
template O
. O

Rapid O
and O
voltage O
- O
dependent O
inactivation O
greatly O
attenuates O
outward O
currents O
in O
ether B
- O
a O
- O
go O
- O
go O
- O
related O
gene O
( O
ERG O
) O
K B
( I
+ I
) I
channels O
. O

In O
contrast O
, O
inactivation O
of O
related O
ether B
- O
a O
- O
go O
- O
go O
( O
EAG O
) O
K B
( I
+ I
) I
channels O
is O
very O
slow O
and O
minimally O
reduces O
outward O
currents O
. O

Specifically O
, O
we O
review O
evidence O
gathered O
from O
postmortem O
and O
pharmacological O
studies O
, O
both O
preclinical O
and O
clinical O
, O
and O
discuss O
the O
involvement O
of O
dopaminergic O
and O
nondopaminergic O
systems O
, O
including O
glutamatergic O
, O
opioid O
, O
serotonergic O
, O
gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
- O
ergic O
, O
adenosine B
, O
cannabinoid O
, O
adrenergic O
, O
histaminergic O
, O
and O
cholinergic O
systems O
. O

A O
series O
of O
3 B
- I
[ I
( I
4 I
- I
substituted I
- I
benzylidene I
) I
- I
amino I
] I
- I
2 I
- I
phenyl I
- I
3H I
- I
quinazolin I
- I
4 I
- I
ones I
( O
5a O
- O
k O
) O
were O
synthesized O
by O
reacting O
3 B
- I
amino I
- I
2 I
- I
phenyl I
- I
1H I
- I
quinazolin I
- I
4 I
- I
one I
with O
p B
- I
hydroxybenzaldehyde I
, O
and O
then O
further O
with O
various O
alkyl B
/ I
benzyl I
halides I
or O
substituted O
phenacyl B
bromides I
. O

Seven O
new O
dibenzocyclooctadien B
lignans I
, O
marlignans B
M I
- I
S I
( O
1 O
- O
7 O
) O
, O
four O
new O
norlignans B
, O
marphenols B
C I
- I
F I
( O
8 O
- O
11 O
) O
, O
and O
21 O
known O
compounds O
( O
12 O
- O
32 O
) O
were O
isolated O
from O
the O
fruits O
of O
Schisandra O
wilsoniana O
. O

Seven O
new O
dibenzocyclooctadien B
lignans I
, O
marlignans B
M I
- I
S I
( O
1 O
- O
7 O
) O
, O
four O
new O
norlignans B
, O
marphenols B
C I
- I
F I
( O
8 O
- O
11 O
) O
, O
and O
21 O
known O
compounds O
( O
12 O
- O
32 O
) O
were O
isolated O
from O
the O
fruits O
of O
Schisandra O
wilsoniana O
. O

Uptake O
of O
the O
radiolabeled O
model O
substrates O
estradiol B
17 I
beta I
- I
glucuronide I
, O
estrone B
3 I
- I
sulfate I
, O
and O
dehydroepiandrostero B
sulfate I
( O
DHEAS B
) O
was O
determined O
in O
the O
absence O
and O
presence O
of O
compounds O
1 O
- O
6 O
using O
Chinese O
hamster O
ovary O
( O
CHO O
) O
cells O
stably O
expressing O
either O
OATP1B1 O
or O
OATP1B3 O
. O

Seven O
new O
labdane B
- O
type O
diterpenoids B
, O
vitextrifolins B
A I
- I
G I
( O
1 O
- O
7 O
) O
, O
along O
with O
eight O
previously O
reported O
analogues O
, O
were O
isolated O
from O
the O
fruits O
of O
Vitex O
trifolia O
. O

Extended B
- I
release I
ranolazine I
( O
ranolazine B
ER I
) O
[ O
Ranexa B
( O
( O
R O
) O
) O
] O
is O
an O
antianginal O
agent O
that O
achieves O
its O
effects O
via O
a O
novel O
mechanism O
of O
action O
( O
inhibition O
of O
the O
late O
phase O
of O
the O
inward O
sodium B
current O
) O
, O
without O
affecting O
heart O
rate O
or O
blood O
pressure O
( O
BP O
) O
. O

Interaction O
between O
group B
IIb I
divalent I
transition I
- I
metal I
cations O
and O
3 B
- I
mercaptopropionic I
acid I
: O
a O
computational O
and O
topological O
perspective O
. O

Density O
functional O
theory O
was O
applied O
to O
study O
the O
interaction O
of O
group B
IIb I
transition I
- I
metal I
cations O
( O
Zn B
( I
2 I
+ I
) I
, O
Cd B
( I
2 I
+ I
) I
, O
and O
Hg B
( I
2 I
+ I
) I
) O
with O
one O
and O
two O
fully O
or O
partially O
deprotonated O
3 B
- I
mercaptopropionic I
acid I
ligands O
. O

Planar O
to O
3D O
transition O
in O
the O
B6H B
( I
y I
) I
anions O
. O

Competing O
effects O
of O
hydrophilic O
( O
copper B
oxides I
and I
hydroxides I
) O
and O
hydrophobic O
( O
elemental O
sulfur B
) O
species O
on O
the O
mineral O
surface O
under O
oxidizing O
conditions O
at O
pH O
4 O
and O
the O
change O
in O
surface O
roughness O
at O
pH O
10 O
may O
contribute O
to O
the O
observed O
effects O
of O
electrochemically O
controlled O
oxidation O
on O
enargite B
hydrophobicity O
. O

In O
additional O
, O
the O
level O
of O
5 B
' I
- I
AMP I
- O
activated O
protein O
kinase O
( O
AMPK O
) O
expression O
showed O
a O
trend O
towards O
being O
restored O
in O
the O
ANP O
treated O
MLD O
- O
STZ B
- O
mice O
. O

Comparative O
pharmacokinetic O
profiles O
of O
picrosides B
I I
and I
II I
from O
kutkin O
, O
Picrorhiza O
kurroa O
extract O
and O
its O
formulation O
in O
rats O
. O

Picrosides B
I I
and I
II I
are O
the O
active O
chemical O
constituents O
, O
present O
in O
the O
roots O
and O
rhizomes O
of O
Picrorhiza O
kurroa O
Royle O
( O
family O
: O
Scrophulariaceae O
) O
. O

This O
study O
attempts O
to O
determine O
the O
in O
vivo O
pharmacokinetic O
profile O
of O
picrosides B
I I
and I
II I
in O
rats O
after O
oral O
administration O
of O
three O
different O
preparations O
namely O
, O
kutkin B
( O
a O
mixture O
of O
picrosides B
I I
and I
II I
) O
, O
P O
. O
kurroa O
extract O
and O
Picrolax O
( O
R O
) O
capsule O
( O
marketed O
formulation O
) O
. O

This O
study O
attempts O
to O
determine O
the O
in O
vivo O
pharmacokinetic O
profile O
of O
picrosides B
I I
and I
II I
in O
rats O
after O
oral O
administration O
of O
three O
different O
preparations O
namely O
, O
kutkin B
( O
a O
mixture O
of O
picrosides B
I I
and I
II I
) O
, O
P O
. O
kurroa O
extract O
and O
Picrolax O
( O
R O
) O
capsule O
( O
marketed O
formulation O
) O
. O

A O
simple O
, O
precise O
, O
specific O
and O
sensitive O
method O
was O
developed O
for O
simultaneous O
quantification O
of O
picrosides B
I I
and I
II I
in O
rat O
plasma O
and O
was O
applied O
for O
the O
pharmacokinetic O
study O
. O

Pharmacokinetic O
parameters O
were O
calculated O
from O
the O
observed O
plasma O
concentration O
of O
picrosides B
I I
and I
II I
. O

The O
results O
showed O
a O
significant O
difference O
( O
p O
< O
= O
0 O
. O
05 O
) O
in O
oral O
bioavailability O
of O
picrosides B
I I
and I
II I
from O
different O
preparations O
. O

We O
use O
molecular O
dynamics O
( O
MD O
) O
simulations O
to O
show O
that O
a O
DNA O
- O
like O
double O
helix O
of O
two O
poly B
( I
acetylene I
) I
( O
PA O
) O
chains O
can O
form O
inside O
single O
- O
walled O
carbon B
nanotubes O
( O
SWNTs O
) O
. O

AUC O
( O
0 O
- O
infinity O
) O
and O
C O
( O
max O
) O
of O
o B
- I
hydroxy I
atorvastatin I
decreased O
dose O
- O
independently O
[ O
AUC O
( O
0 O
- O
infinity O
) O
: O
0 O
. O
8 O
( O
0 O
. O
8 O
, O
0 O
. O
9 O
) O
( O
100 O
mg O
) O
, O
0 O
. O
6 O
( O
0 O
. O
5 O
, O
0 O
. O
6 O
) O
( O
200 O
mg O
) O
; O
C O
( O
max O
) O
: O
0 O
. O
3 O
( O
0 O
. O
3 O
, O
0 O
. O
4 O
) O
( O
100 O
mg O
) O
, O
0 O
. O
2 O
( O
0 O
. O
2 O
, O
0 O
. O
3 O
) O
( O
200 O
mg O
) O
] O
when O
atorvastatin B
was O
concomitantly O
administered O
. O

C O
( O
max O
) O
of O
o B
- I
hydroxy I
atorvastatin I
slightly O
decreased O
( O
0 O
. O
8 O
for O
both O
doses O
) O
following O
time O
- O
separated O
administration O
; O
AUC O
( O
0 O
- O
infinity O
) O
was O
unchanged O
. O

We O
reported O
previously O
that O
Ca B
( I
2 I
+ I
) I
influx O
through O
N B
- I
methly I
- I
d I
- I
aspartate I
- O
gated O
channels O
evokes O
ATP B
- O
sensitive O
K B
( I
+ I
) I
( O
K B
- O
ATP B
) O
currents O
in O
rat O
subthalamic O
nucleus O
( O
STN O
) O
neurons O
. O

Gobichelin B
A I
and I
B I
: O
Mixed O
- O
Ligand O
Siderophores O
Discovered O
Using O
Proteomics O
. O

Using O
the O
proteomics O
- O
based O
discovery O
platform O
called O
PrISM O
( O
Proteomic O
Investigation O
of O
Secondary O
Metabolism O
) O
, O
we O
discovered O
two O
new O
siderophores O
gobichelin B
A I
and I
B I
from O
Streptomyces O
sp O
. O

Abstract O
1 O
. O
We O
investigated O
the O
effects O
of O
the O
dose O
of O
and O
the O
number O
of O
times O
an O
inducer O
was O
administered O
and O
the O
duration O
of O
induction O
of O
hepatic O
and O
intestinal O
cytochrome O
P450 O
3A O
( O
CYP3A O
) O
in O
rats O
using O
dexamethasone B
21 I
- I
phosphate I
( O
DEX B
- I
P I
) O
and O
midazolam B
( O
MDZ B
) O
as O
an O
inducer O
and O
a O
substrate O
to O
CYP3A O
, O
respectively O
. O

Five O
phenolic B
acids I
( O
protocatechuic B
acid I
, O
p B
- I
hydroxybenzoic I
acid I
, O
vanillic B
acid I
, O
p B
- I
coumaric I
acid I
, O
and O
ferulic B
acid I
) O
proved O
to O
be O
stable O
, O
while O
two O
others O
( O
caffeic B
acid I
and O
sinapic B
acid I
) O
were O
degraded O
under O
ultrasound O
treatment O
. O

Five O
phenolic B
acids I
( O
protocatechuic B
acid I
, O
p B
- I
hydroxybenzoic I
acid I
, O
vanillic B
acid I
, O
p B
- I
coumaric I
acid I
, O
and O
ferulic B
acid I
) O
proved O
to O
be O
stable O
, O
while O
two O
others O
( O
caffeic B
acid I
and O
sinapic B
acid I
) O
were O
degraded O
under O
ultrasound O
treatment O
. O

Gentamicin B
which O
lacks O
3 B
' I
- I
hydroxyl I
group O
can O
avoid O
the O
attack O
from O
the O
modification O
enzymes O
of O
antibiotic O
- O
resistant O
bacteria O
in O
clinic O
. O

We O
suppose O
that O
there O
are O
some O
enzymes O
responsible O
for O
converting O
intermediate O
JI B
- I
20A I
to O
3 O
' O
, O
4 O
' O
- O
bisdehydroxylated O
final O
product O
gentamicin B
C I
( O
1a O
) O
, O
while O
phosphorylation O
of O
3 B
' I
- I
OH I
is O
possibly O
the O
first O
step O
for O
C O
- O
3 O
' O
dehydroxylation O
. O

Elucidation O
of O
NMR O
data O
of O
phosphorylated B
kanamycin I
B I
has O
unambiguously O
demonstrated O
a O
regiospecific O
phosphorylation O
of O
3 B
' I
- I
hydroxyl I
of O
the O
6 B
- I
aminohexose I
ring O
. O

O B
( I
2 I
) I
regulates O
various O
aspects O
of O
cellular O
biology O
and O
, O
in O
vivo O
, O
MSC O
are O
exposed O
to O
different O
O B
( I
2 I
) I
concentrations O
spanning O
from O
very O
low O
tension O
in O
the O
bone O
marrow O
niche O
, O
to O
higher O
amounts O
in O
wounds O
. O

O B
( I
2 I
) I
regulates O
various O
aspects O
of O
cellular O
biology O
and O
, O
in O
vivo O
, O
MSC O
are O
exposed O
to O
different O
O B
( I
2 I
) I
concentrations O
spanning O
from O
very O
low O
tension O
in O
the O
bone O
marrow O
niche O
, O
to O
higher O
amounts O
in O
wounds O
. O

In O
order O
to O
establish O
the O
effect O
of O
low O
O B
( I
2 I
) I
on O
cellular O
properties O
, O
we O
examined O
BSMC O
cultured O
under O
hypoxic O
( O
3 O
% O
O B
( I
2 I
) I
) O
conditions O
. O

In O
order O
to O
establish O
the O
effect O
of O
low O
O B
( I
2 I
) I
on O
cellular O
properties O
, O
we O
examined O
BSMC O
cultured O
under O
hypoxic O
( O
3 O
% O
O B
( I
2 I
) I
) O
conditions O
. O

Our O
results O
demonstrate O
that O
3 O
% O
O B
( I
2 I
) I
augmented O
proliferation O
of O
BMSC O
, O
as O
well O
as O
the O
formation O
of O
colonies O
in O
the O
colony O
- O
forming O
unit O
assay O
( O
CFU O
- O
A O
) O
, O
the O
percentage O
of O
quiescent O
cells O
, O
and O
the O
expression O
of O
stemness O
markers O
Rex O
- O
1 O
and O
Oct O
- O
4 O
, O
thereby O
suggesting O
an O
increase O
in O
the O
stemness O
of O
culture O
when O
exposed O
to O
hypoxia O
. O

In O
contrast O
, O
intrinsic O
differentiation O
processes O
were O
inhibited O
by O
3 O
% O
O B
( I
2 I
) I
. O

Overall O
yield O
of O
differentiation O
was O
dependent O
on O
the O
adjustment O
of O
O B
( I
2 I
) I
tension O
to O
the O
specific O
stage O
of O
BMSC O
culture O
. O

Thus O
, O
we O
established O
a O
strategy O
for O
efficient O
BMSC O
in O
vitro O
differentiation O
using O
an O
initial O
phase O
of O
cell O
propagation O
at O
3 O
% O
O B
( I
2 I
) I
, O
followed O
by O
differentiation O
stage O
at O
21 O
% O
O B
( I
2 I
) I
. O

Thus O
, O
we O
established O
a O
strategy O
for O
efficient O
BMSC O
in O
vitro O
differentiation O
using O
an O
initial O
phase O
of O
cell O
propagation O
at O
3 O
% O
O B
( I
2 I
) I
, O
followed O
by O
differentiation O
stage O
at O
21 O
% O
O B
( I
2 I
) I
. O

We O
also O
demonstrated O
that O
3 O
% O
O B
( I
2 I
) I
affected O
BMSC O
differentiation O
in O
p53 O
and O
reactive O
oxygen B
species O
( O
ROS O
) O
independent O
pathways O
. O

25 B
- I
Hydroxyvitamin I
D I
in O
Obese O
Youth O
Across O
the O
Spectrum O
of O
Glucose B
Tolerance O
From O
Normal O
to O
Prediabetes O
to O
Type O
2 O
Diabetes O
. O

OBJECTIVETo O
1 O
) O
determine O
if O
plasma O
25 B
- I
hydroxyvitamin I
D I
( O
25 B
[ I
OH I
] I
D I
) O
concentrations O
differ O
among O
obese O
youth O
with O
normal O
glucose B
tolerance O
( O
NGT O
) O
versus O
prediabetes O
versus O
type O
2 O
diabetes O
, O
and O
2 O
) O
assess O
the O
relationships O
between O
25 B
( I
OH I
) I
D I
and O
in O
vivo O
insulin O
sensitivity O
and O
beta O
- O
cell O
function O
in O
this O
cohort O
. O
RESEARCH O
DESIGN O
AND O
METHODSPlasma O
25 B
( I
OH I
) I
D I
concentrations O
were O
examined O
in O
banked O
specimens O
in O
9 O
- O
to O
20 O
- O
year O
- O
old O
obese O
youth O
( O

Serum O
25 B
- I
hydroxyvitamin I
D I
, O
parathyroid O
hormone O
, O
and O
their O
association O
with O
metabolic O
syndrome O
in O
Chinese O
. O

Increasing O
evidence O
suggests O
that O
25 B
- I
hydroxyvitamin I
D I
[ O
25 B
( I
OH I
) I
D I
] O
and O
parathyroid O
hormone O
( O
PTH O
) O
levels O
are O
associated O
with O
metabolic O
syndrome O
( O
MetS O
) O
. O

In O
the O
present O
work O
, O
we O
study O
a O
high O
concentrated O
collagen O
sample O
in O
its O
soluble O
, O
fibrillar O
, O
and O
denatured O
states O
using O
one O
and O
two O
dimensional O
{ O
( B
1 I
) I
H I
} O
- O
( B
13 I
) I
C I
solid O
- O
state O
NMR O
spectroscopy O
. O

In O
the O
present O
work O
, O
we O
study O
a O
high O
concentrated O
collagen O
sample O
in O
its O
soluble O
, O
fibrillar O
, O
and O
denatured O
states O
using O
one O
and O
two O
dimensional O
{ O
( B
1 I
) I
H I
} O
- O
( B
13 I
) I
C I
solid O
- O
state O
NMR O
spectroscopy O
. O

We O
interpret O
( B
13 I
) I
C I
chemical O
shift O
variations O
in O
terms O
of O
dihedral O
angle O
conformation O
changes O
. O

Moreover O
, O
based O
on O
a O
( B
13 I
) I
C I
quantitative O
spectrum O
, O
we O
estimate O
the O
percentage O
of O
residues O
implicated O
in O
each O
equilibrium O
. O

The O
structure O
, O
formation O
mechanism O
, O
and O
stability O
of O
the O
hybrid O
nanosheets O
were O
investigated O
in O
detail O
by O
taking O
the O
Co B
9 I
S I
8 I
- O
oleylamine B
( O
Co B
9 I
S I
8 I
- O
OA O
) O
hybrid O
nanosheets O
as O
an O
example O
. O

The O
structure O
, O
formation O
mechanism O
, O
and O
stability O
of O
the O
hybrid O
nanosheets O
were O
investigated O
in O
detail O
by O
taking O
the O
Co B
9 I
S I
8 I
- O
oleylamine B
( O
Co B
9 I
S I
8 I
- O
OA O
) O
hybrid O
nanosheets O
as O
an O
example O
. O

Both O
experimental O
data O
and O
theoretical O
simulations O
demonstrate O
that O
the O
hybrid O
nanosheets O
were O
formed O
by O
in O
- O
plane O
connection O
of O
small O
two O
- O
dimensional O
( O
2D O
) O
Co B
9 I
S I
8 I
nanoplates O
via O
oleylamine B
molecules O
adsorbed O
at O
the O
side O
surface O
and O
corner O
sites O
of O
the O
nanoplates O
. O

X O
- O
ray O
absorption O
fine O
structure O
spectroscopy O
study O
reveals O
the O
structure O
distortion O
of O
the O
small O
2D O
Co B
9 I
S I
8 I
nanoplates O
that O
endows O
structural O
stability O
of O
the O
atomically O
thick O
Co B
9 I
S I
8 I
- O
OA O
hybrid O
nanosheets O
. O

X O
- O
ray O
absorption O
fine O
structure O
spectroscopy O
study O
reveals O
the O
structure O
distortion O
of O
the O
small O
2D O
Co B
9 I
S I
8 I
nanoplates O
that O
endows O
structural O
stability O
of O
the O
atomically O
thick O
Co B
9 I
S I
8 I
- O
OA O
hybrid O
nanosheets O
. O

Although O
the O
excited O
state O
of O
the O
quinoidal B
thiophene I
dye O
is O
deactivated O
within O
several O
picoseconds O
even O
in O
solution O
, O
the O
DSSCs O
using O
the O
quinoidal B
thiophene I
dye O
showed O
incident O
photon O
to O
current O
conversion O
efficiency O
( O
IPCE O
) O
values O
of O
more O
than O
90 O
% O
, O
demonstrating O
the O
fast O
and O
efficient O
electron O
injection O
from O
the O
excited O
dye O
to O
TiO B
( I
2 I
) I
. O

After O
aging O
and O
digestion O
with O
pepsin O
at O
pH O
2 O
, O
peptide O
FGES198AGAAS O
from O
Sp B
- I
tabun I
thiocholine I
had O
a O
mass O
of O
902 O
. O
2 O
m O
/ O
z O
in O
negative O
mode O
, O
indicating O
that O
it O
had O
aged O
by O
deamination O
, O
whereas O
peptide O
FGES198AGAAS O
from O
Rp B
- I
tabun I
thiocholine I
had O
a O
mass O
of O
874 O
. O
2 O
m O
/ O
z O
in O
negative O
mode O
, O
indicating O
that O
it O
had O
aged O
by O
O B
- O
dealkylation O
. O

After O
aging O
and O
digestion O
with O
pepsin O
at O
pH O
2 O
, O
peptide O
FGES198AGAAS O
from O
Sp B
- I
tabun I
thiocholine I
had O
a O
mass O
of O
902 O
. O
2 O
m O
/ O
z O
in O
negative O
mode O
, O
indicating O
that O
it O
had O
aged O
by O
deamination O
, O
whereas O
peptide O
FGES198AGAAS O
from O
Rp B
- I
tabun I
thiocholine I
had O
a O
mass O
of O
874 O
. O
2 O
m O
/ O
z O
in O
negative O
mode O
, O
indicating O
that O
it O
had O
aged O
by O
O B
- O
dealkylation O
. O

The O
mannose B
6 I
- I
phosphate I
- O
binding O
sites O
of O
M6P B
/ O
IGF2R O
determine O
its O
capacity O
to O
suppress O
matrix O
invasion O
by O
squamous O
cell O
carcinoma O
cells O
. O

The O
M6P B
( O
mannose B
6 I
- I
phosphate I
) O
/ O
IGF2R O
( O
insulin O
- O
like O
growth O
factor O
II O
receptor O
) O
interacts O
with O
a O
variety O
of O
factors O
that O
impinge O
on O
tumour O
invasion O
and O
metastasis O
. O

Surface O
grafting O
and O
inclusion O
reactions O
were O
proved O
by O
solid O
( B
13 I
) I
C I
NMR O
and O
FTIR O
. O

The O
interfacial O
behavior O
of O
beta O
- O
casein O
( O
beta O
CS O
) O
has O
been O
investigated O
in O
presence O
of O
the O
cationic O
surfactant O
dodecyl B
trimethyl I
ammonium I
bromide I
( O
DoTAB B
) O
at O
the O
water O
/ O
hexane B
interface O
and O
compared O
to O
that O
obtained O
for O
the O
water O
/ O
air O
interface O
. O

Concomitantly O
, O
thromboxane B
B I
( B
TXB I
) I
2 I
and O
leukotriene B
B I
( B
LTB I
) I
4 I
in O
supernatants O
decreased O
, O
while O
levels O
of O
TXB3 B
and O
LTB5 B
increased O
. O

Concomitantly O
, O
thromboxane B
B I
( B
TXB I
) I
2 I
and O
leukotriene B
B I
( B
LTB I
) I
4 I
in O
supernatants O
decreased O
, O
while O
levels O
of O
TXB3 B
and O
LTB5 B
increased O
. O

Moreover O
, O
EPA B
and O
DHA B
gave O
rise O
to O
a O
variety O
of O
mono B
- I
and I
trihydroxy I
derivatives O
of O
highly O
anti O
- O
inflammatory O
potential O
, O
such O
as O
resolvins B
and O
their O
precursors O
. O

Copper B
( I
I I
) I
- O
catalyzed O
borylative O
exo O
- O
cyclization O
of O
alkenyl B
halides I
containing O
unactivated O
double O
bond O
. O

The O
reaction O
includes O
the O
regioselective O
addition O
of O
a O
borylcopper B
( I
I I
) I
intermediate O
to O
unactivated O
terminal O
alkenes B
, O
followed O
by O
the O
intramolecular O
substitution O
of O
the O
resulting O
alkylcopper B
( I
I I
) I
moiety O
for O
the O
halide B
leaving O
groups O
. O

The O
reaction O
includes O
the O
regioselective O
addition O
of O
a O
borylcopper B
( I
I I
) I
intermediate O
to O
unactivated O
terminal O
alkenes B
, O
followed O
by O
the O
intramolecular O
substitution O
of O
the O
resulting O
alkylcopper B
( I
I I
) I
moiety O
for O
the O
halide B
leaving O
groups O
. O

Pestaloficiols B
Q I
- I
S I
from O
the O
plant O
endophytic O
fungus O
Pestalotiopsis O
fici O
. O

Design O
, O
synthesis O
and O
SAR O
of O
piperidyl B
- I
oxadiazoles I
as O
11 B
beta I
- I
hydroxysteroid I
dehydrogenase O
1 O
inhibitors O
. O

( B
E I
) I
- I
4 I
- I
Aryl I
- I
4 I
- I
oxo I
- I
2 I
- I
butenoic I
acid I
amides I
, O
chalcone B
- I
aroylacrylic I
acid I
chimeras O
: O
Design O
, O
antiproliferative O
activity O
and O
inhibition O
of O
tubulin O
polymerization O
. O

Up O
to O
19 O
simple O
polyphenols B
were O
determined O
in O
mushrooms O
extracts O
, O
the O
more O
abundant O
being O
p B
- I
OH I
- I
benzoic I
acid I
, O
p B
- I
OH I
- I
phenylacetic I
acid I
, O
o B
- I
coumaric I
acid I
, O
ferulic B
acid I
and O
chrysin B
. O

Elevated O
urinary O
excretion O
of O
3 B
- I
methylglutaconic I
acid I
is O
considered O
rare O
in O
patients O
suspected O
of O
a O
metabolic O
disorder O
. O

Identification O
of O
alpha B
- I
tocopherol I
and O
alpha B
- I
tocopheryl I
acetate I
from O
the O
cuticle O
of O
soybean O
pods O
armyworm O
( O
Spodoptera O
cosmioides O
) O
. O

Among O
the O
usual O
lipids O
found O
in O
the O
insect O
cuticle O
, O
alpha B
- I
tocopherol I
and O
alpha B
- I
tocopheryl I
acetate I
were O
also O
isolated O
from O
S O
. O
cosmioides O
. O

In O
the O
present O
research O
, O
nanomaterial O
interaction O
with O
DCFH B
- I
DA I
was O
studied O
in O
relation O
to O
its O
nature O
and O
/ O
or O
assay O
conditions O
( O
cell O
- O
based O
and O
time O
exposure O
) O
by O
incubating O
Rhodamine B
( O
Rhd B
) O
- O
labeled O
25nm O
and O
50nm O
silica B
( O
SiO2 B
) O
, O
naked O
and O
oleic B
acid I
coated I
magnetite I
, O
( O
Fe3O4 B
) O
and O
maghemite B
( O
Fe2O3 B
) O
iron B
oxide I
, O
titanium B
dioxide I
( O
TiO2 B
) O
and O
poly B
( I
ethylene I
oxide I
) I
- I
poly I
( I
lactide I
/ I

Chemical O
investigation O
of O
a O
Korean O
marine O
sponge O
, O
Monanchora O
sp O
. O
, O
yielded O
nine O
new O
sesterterpenoids B
( O
1 O
- O
9 O
) O
along O
with O
phorbaketals B
A I
- I
C I
( O
10 O
- O
12 O
) O
. O

Compounds O
1 O
- O
8 O
, O
designated O
as O
phorbaketals B
D I
- I
K I
, O
possess O
a O
spiroketal B
- O
modified O
benzopyran B
moiety O
such O
as O
phorbaketal B
A I
, O
and O
their O
structural O
variations O
are O
due O
to O
oxidation O
and O
/ O
or O
reduction O
of O
the O
tricyclic O
core O
or O
the O
side O
chain O
. O

A O
nonribosomal O
peptide O
synthetase O
- O
derived O
iron B
( I
III I
) I
complex O
from O
the O
pathogenic O
fungus O
Aspergillus O
fumigatus O
. O

Based O
on O
microarray O
analysis O
followed O
by O
comparative O
metabolomics O
of O
overexpression O
/ O
knockout O
mutants O
, O
we O
identified O
a O
tryptophan B
- O
derived O
iron B
( I
III I
) I
- O
complex O
, O
hexadehydro B
- I
astechrome I
( O
HAS B
) O
, O
as O
the O
major O
product O
of O
the O
cryptic O
has O
nonribosomal O
peptide O
synthetase O
( O
NRPS O
) O
gene O
cluster O
in O
the O
human O
pathogen O
Aspergillus O
fumigatus O
. O

Evidence O
for O
metal O
- O
surface O
interactions O
and O
their O
role O
in O
stabilizing O
well O
- O
defined O
immobilized O
Ru B
- I
NHC I
alkene I
metathesis O
catalysts O
. O

Specifically O
, O
they O
can O
be O
described O
as O
interactions O
between O
the O
metal O
center O
( O
active O
site O
) O
and O
the O
surface O
functionality O
of O
the O
support O
, O
and O
they O
have O
been O
detected O
by O
surface O
- O
enhanced O
( B
1 I
) I
H I
- O
( B
29 I
) I
Si I
NMR O
spectroscopy O
of O
the O
ligand O
and O
( B
31 I
) I
P I
solid O
- O
state O
NMR O
of O
the O
catalyst O
precursor O
. O

Specifically O
, O
they O
can O
be O
described O
as O
interactions O
between O
the O
metal O
center O
( O
active O
site O
) O
and O
the O
surface O
functionality O
of O
the O
support O
, O
and O
they O
have O
been O
detected O
by O
surface O
- O
enhanced O
( B
1 I
) I
H I
- O
( B
29 I
) I
Si I
NMR O
spectroscopy O
of O
the O
ligand O
and O
( B
31 I
) I
P I
solid O
- O
state O
NMR O
of O
the O
catalyst O
precursor O
. O

Specifically O
, O
they O
can O
be O
described O
as O
interactions O
between O
the O
metal O
center O
( O
active O
site O
) O
and O
the O
surface O
functionality O
of O
the O
support O
, O
and O
they O
have O
been O
detected O
by O
surface O
- O
enhanced O
( B
1 I
) I
H I
- O
( B
29 I
) I
Si I
NMR O
spectroscopy O
of O
the O
ligand O
and O
( B
31 I
) I
P I
solid O
- O
state O
NMR O
of O
the O
catalyst O
precursor O
. O

Assignment O
of O
the O
absolute O
configuration O
of O
cyclic O
peptides O
frequently O
yields O
challenges O
, O
leaving O
one O
or O
more O
stereogenic O
centers O
unassigned O
due O
to O
small O
quantities O
of O
sample O
and O
the O
limited O
utility O
of O
Marfey O
' O
s O
or O
other O
methods O
for O
assigning O
amino B
or I
hydroxy I
acids I
. O

Surface O
excess O
quantities O
were O
estimated O
for O
hydrate O
- O
oil O
and O
water O
- O
oil O
interfaces O
using O
four O
carboxylic B
and I
sulfonic I
acids I
. O

Neurotoxic O
potential O
and O
cellular O
uptake O
of O
T B
- I
2 I
toxin I
in O
human O
astrocytes O
in O
primary O
culture O
. O

The O
trichothecene B
mycotoxin O
T B
- I
2 I
toxin I
, O
which O
is O
produced O
by O
fungi O
of O
the O
Fusarium O
species O
, O
is O
a O
worldwide O
occurring O
contaminant O
of O
cereal O
based O
food O
and O
feed O
. O

The O
cytotoxic O
properties O
of O
T B
- I
2 I
toxin I
are O
already O
well O
described O
with O
apoptosis O
being O
a O
major O
mechanism O
of O
action O
in O
various O
cell O
lines O
as O
well O
as O
in O
primary O
cells O
of O
different O
origin O
. O

However O
, O
only O
few O
data O
on O
neurotoxic O
properties O
of O
T B
- I
2 I
toxin I
are O
reported O
so O
far O
, O
but O
in O
vivo O
studies O
showed O
different O
effects O
of O
T B
- I
2 I
toxin I
on O
behavior O
as O
well O
as O
on O
levels O
of O
brain O
amines B
in O
animals O
. O

However O
, O
only O
few O
data O
on O
neurotoxic O
properties O
of O
T B
- I
2 I
toxin I
are O
reported O
so O
far O
, O
but O
in O
vivo O
studies O
showed O
different O
effects O
of O
T B
- I
2 I
toxin I
on O
behavior O
as O
well O
as O
on O
levels O
of O
brain O
amines B
in O
animals O
. O

To O
further O
investigate O
the O
cytotoxic O
properties O
of O
T B
- I
2 I
toxin I
on O
cells O
derived O
from O
brain O
tissue O
, O
normal O
human O
astrocytes O
in O
primary O
culture O
( O
NHA O
) O
were O
used O
in O
this O
study O
. O

Besides O
studies O
of O
cytotoxicity O
, O
apoptosis O
( O
caspase O
- O
3 O
- O
activation O
, O
Annexin O
V O
) O
and O
necrosis O
( O
LDH O
- O
release O
) O
, O
the O
cellular O
uptake O
and O
metabolism O
of O
T B
- I
2 I
toxin I
in O
NHA O
was O
analyzed O
and O
compared O
to O
the O
uptake O
in O
an O
established O
human O
cell O
line O
( O
HT O
- O
29 O
) O
. O

The O
results O
show O
that O
human O
astrocytes O
were O
highly O
sensitive O
to O
the O
cytotoxic O
properties O
of O
T B
- I
2 I
toxin I
, O
and O
apoptosis O
, O
induced O
at O
low O
concentrations O
, O
was O
identified O
for O
the O
first O
time O
as O
the O
mechanism O
of O
toxic O
action O
in O
NHA O
. O

Furthermore O
, O
a O
strong O
accumulation O
of O
T B
- I
2 I
toxin I
in O
NHA O
and O
HT O
- O
29 O
cells O
was O
detected O
, O
and O
T B
- I
2 I
toxin I
was O
subjected O
to O
metabolism O
leading O
to O
HT B
- I
2 I
toxin I
, O
a O
commonly O
found O
metabolite O
after O
T B
- I
2 I
toxin I
incubation O
in O
both O
cell O
types O
. O

Furthermore O
, O
a O
strong O
accumulation O
of O
T B
- I
2 I
toxin I
in O
NHA O
and O
HT O
- O
29 O
cells O
was O
detected O
, O
and O
T B
- I
2 I
toxin I
was O
subjected O
to O
metabolism O
leading O
to O
HT B
- I
2 I
toxin I
, O
a O
commonly O
found O
metabolite O
after O
T B
- I
2 I
toxin I
incubation O
in O
both O
cell O
types O
. O

Furthermore O
, O
a O
strong O
accumulation O
of O
T B
- I
2 I
toxin I
in O
NHA O
and O
HT O
- O
29 O
cells O
was O
detected O
, O
and O
T B
- I
2 I
toxin I
was O
subjected O
to O
metabolism O
leading O
to O
HT B
- I
2 I
toxin I
, O
a O
commonly O
found O
metabolite O
after O
T B
- I
2 I
toxin I
incubation O
in O
both O
cell O
types O
. O

Furthermore O
, O
a O
strong O
accumulation O
of O
T B
- I
2 I
toxin I
in O
NHA O
and O
HT O
- O
29 O
cells O
was O
detected O
, O
and O
T B
- I
2 I
toxin I
was O
subjected O
to O
metabolism O
leading O
to O
HT B
- I
2 I
toxin I
, O
a O
commonly O
found O
metabolite O
after O
T B
- I
2 I
toxin I
incubation O
in O
both O
cell O
types O
. O

This O
formation O
seems O
to O
occur O
within O
the O
cells O
since O
incubations O
of O
T B
- I
2 I
toxin I
with O
cell O
depleted O
culture O
medium O
did O
not O
lead O
to O
any O
degradation O
of O
the O
parent O
toxin O
. O

The O
results O
of O
this O
study O
emphasize O
the O
neurotoxic O
potential O
of O
T B
- I
2 I
toxin I
in O
human O
astrocytes O
at O
low O
concentrations O
after O
short O
incubation O
times O
. O

Inspired O
by O
our O
results O
that O
the O
electrochemical O
activity O
and O
electrical O
conductivity O
of O
ZnO B
nanowires O
were O
greatly O
improved O
after O
hydrogenation O
, O
we O
designed O
and O
fabricated O
hydrogenated O
single O
- O
crystal O
ZnO B
@ O
amorphous O
ZnO B
- I
doped I
MnO2 I
core O
- O
shell O
nanocables O
( O
HZM O
) O
on O
carbon B
cloth O
as O
SC O
electrodes O
, O
showing O
excellent O
performance O
such O
as O
areal O
capacitance O
of O
138 O
. O
7 O
mF O
/ O
cm O
( O
2 O
) O
and O
specific O
capacitance O
of O
1260 O
. O
9 O
F O
/ O
g O
. O

In O
preceding O
studies O
, O
we O
demonstrated O
that O
choline B
carboxylates I
ChC B
( I
m I
) I
with O
alkyl B
chain O
lengths O
of O
m O
= O
12 O
- O
18 O
are O
highly O
water O
- O
soluble O
( O
for O
m O
= O
12 O
, O
soluble O
up O
to O
93 O
wt O
% O
soap O
and O
0 O
degrees O
C O
) O
. O

We O
have O
investigated O
the O
aqueous O
phase O
behavior O
of O
choline B
soaps O
with O
C B
( I
8 I
) I
and O
C B
( I
10 I
) I
chain O
- O
lengths O
( O
choline B
octanoate I
and O
choline B
decanoate I
) O
and O
with O
a O
C B
( I
18 I
) I
chain O
- O
length O
with O
a O
cis O
- O
double O
bond O
( O
choline B
oleate I
) O
. O

We O
have O
investigated O
the O
aqueous O
phase O
behavior O
of O
choline B
soaps O
with O
C B
( I
8 I
) I
and O
C B
( I
10 I
) I
chain O
- O
lengths O
( O
choline B
octanoate I
and O
choline B
decanoate I
) O
and O
with O
a O
C B
( I
18 I
) I
chain O
- O
length O
with O
a O
cis O
- O
double O
bond O
( O
choline B
oleate I
) O
. O

We O
have O
investigated O
the O
aqueous O
phase O
behavior O
of O
choline B
soaps O
with O
C B
( I
8 I
) I
and O
C B
( I
10 I
) I
chain O
- O
lengths O
( O
choline B
octanoate I
and O
choline B
decanoate I
) O
and O
with O
a O
C B
( I
18 I
) I
chain O
- O
length O
with O
a O
cis O
- O
double O
bond O
( O
choline B
oleate I
) O
. O

In O
previous O
studies O
we O
have O
demonstrated O
that O
the O
gamma B
- I
aminobutryic I
acid I
- O
A O
( O
GABA B
- O
A O
) O
receptor O
antagonist O
oroxylin B
A I
has O
an O
awakening O
effect O
and O
it O
also O
represses O
ADHD O
- O
like O
behaviors O
( O
hyperactivity O
, O
impulsivity O
and O
inattention O
) O
in O
the O
spontaneously O
hypertensive O
rat O
( O
SHR O
) O
model O
of O
attention O
- O
deficit O
hyperactivity O
disorder O
( O
ADHD O
) O
. O

The O
gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
A O
receptor O
is O
composed O
of O
a O
variety O
of O
subunits O
and O
combinations O
and O
shows O
a O
characteristic O
distribution O
in O
the O
CNS O
. O

The O
influence O
of O
these O
effects O
on O
a O
binuclear O
, O
strongly O
luminescent O
copper B
( I
I I
) I
complex O
was O
investigated O
. O

For O
this O
purpose O
, O
markers O
of O
bone O
formation O
( O
osteocalcin O
, O
procollagen O
I O
, O
osteoprotegerin O
, O
alkaline O
phosphatase O
) O
and O
resorption O
( O
telopeptides O
of O
collagen O
I O
, O
soluble O
receptor O
activator O
of O
nuclear O
factor O
- O
kappa O
B O
ligand O
) O
, O
calciotropic O
hormones O
( O
parathormone O
, O
calcitonin O
, O
25 B
- I
hydroxyvitamin I
D I
and O
1 B
, I
25 I
- I
dihydroxyvitamin I
D I
) O
in O
the O
serum O
, O
and O
the O
femur O
content O
of O
mineral O
( O
including O
calcium B
- O

The O
method O
involves O
wet O
- O
spinning O
of O
poly B
( I
3 I
, I
4 I
- I
ethylenedioxythiophe I
) I
poly B
( I
styrenesulfonate I
) I
( O
PEDOT B
: O
PSS B
) O
fibre O
, O
which O
served O
as O
the O
inner O
core O
to O
the O
electropolymerised O
outer O
shell O
layer O
of O
polypyrrole B
( O
Ppy B
) O
. O

Results O
revealed O
that O
the O
electronic O
transitions O
of O
La B
@ O
C O
( O
2v O
) O
- O
C B
( I
82 I
) I
, O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
and O
Sc B
( I
3 I
) I
N I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
can O
be O
assigned O
using O
these O
techniques O
. O

Results O
revealed O
that O
the O
electronic O
transitions O
of O
La B
@ O
C O
( O
2v O
) O
- O
C B
( I
82 I
) I
, O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
and O
Sc B
( I
3 I
) I
N I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
can O
be O
assigned O
using O
these O
techniques O
. O

Results O
revealed O
that O
the O
electronic O
transitions O
of O
La B
@ O
C O
( O
2v O
) O
- O
C B
( I
82 I
) I
, O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
and O
Sc B
( I
3 I
) I
N I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
can O
be O
assigned O
using O
these O
techniques O
. O

Results O
revealed O
that O
the O
electronic O
transitions O
of O
La B
@ O
C O
( O
2v O
) O
- O
C B
( I
82 I
) I
, O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
and O
Sc B
( I
3 I
) I
N I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
can O
be O
assigned O
using O
these O
techniques O
. O

Particularly O
, O
a O
difference O
in O
the O
electronic O
transitions O
between O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
and O
Sc B
( I
3 I
) I
N I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
which O
is O
invisible O
in O
absorption O
spectra O
, O
was O
observed O
clearly O
in O
MCD O
spectra O
. O

Particularly O
, O
a O
difference O
in O
the O
electronic O
transitions O
between O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
and O
Sc B
( I
3 I
) I
N I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
which O
is O
invisible O
in O
absorption O
spectra O
, O
was O
observed O
clearly O
in O
MCD O
spectra O
. O

Particularly O
, O
a O
difference O
in O
the O
electronic O
transitions O
between O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
and O
Sc B
( I
3 I
) I
N I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
which O
is O
invisible O
in O
absorption O
spectra O
, O
was O
observed O
clearly O
in O
MCD O
spectra O
. O

In O
addition O
, O
the O
MCD O
bands O
of O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
were O
altered O
upon O
[ O
5 O
, O
6 O
] O
- O
addition O
, O
demonstrating O
that O
the O
MCD O
spectroscopy O
is O
sensitive O
to O
chemical O
functionalization O
of O
EMFs O
, O
and O
that O
it O
is O
therefore O
powerful O
to O
distinguish O
[ O
5 O
, O
6 O
] O
- O
adducts O
from O
pristine O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
although O
no O
marked O
difference O
exists O
in O
their O
absorption O
spectra O
. O

In O
addition O
, O
the O
MCD O
bands O
of O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
were O
altered O
upon O
[ O
5 O
, O
6 O
] O
- O
addition O
, O
demonstrating O
that O
the O
MCD O
spectroscopy O
is O
sensitive O
to O
chemical O
functionalization O
of O
EMFs O
, O
and O
that O
it O
is O
therefore O
powerful O
to O
distinguish O
[ O
5 O
, O
6 O
] O
- O
adducts O
from O
pristine O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
although O
no O
marked O
difference O
exists O
in O
their O
absorption O
spectra O
. O

In O
addition O
, O
the O
MCD O
bands O
of O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
were O
altered O
upon O
[ O
5 O
, O
6 O
] O
- O
addition O
, O
demonstrating O
that O
the O
MCD O
spectroscopy O
is O
sensitive O
to O
chemical O
functionalization O
of O
EMFs O
, O
and O
that O
it O
is O
therefore O
powerful O
to O
distinguish O
[ O
5 O
, O
6 O
] O
- O
adducts O
from O
pristine O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
although O
no O
marked O
difference O
exists O
in O
their O
absorption O
spectra O
. O

In O
addition O
, O
the O
MCD O
bands O
of O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
were O
altered O
upon O
[ O
5 O
, O
6 O
] O
- O
addition O
, O
demonstrating O
that O
the O
MCD O
spectroscopy O
is O
sensitive O
to O
chemical O
functionalization O
of O
EMFs O
, O
and O
that O
it O
is O
therefore O
powerful O
to O
distinguish O
[ O
5 O
, O
6 O
] O
- O
adducts O
from O
pristine O
La B
( I
2 I
) I
@ O
I O
( O
h O
) O
- O
C B
( I
80 I
) I
, O
although O
no O
marked O
difference O
exists O
in O
their O
absorption O
spectra O
. O

The O
unsymmetrical O
( O
unsym O
) O
arrangement O
of O
the O
dppv B
ligands O
is O
reflected O
in O
the O
values O
of O
A O
( O
( B
31 I
) I
P I
) O
, O
which O
range O
from O
31 O
MHz O
for O
the O
basal O
phosphines B
to O
284 O
MHz O
for O
the O
apical O
phosphine B
. O

Density O
functional O
theory O
calculations O
were O
employed O
to O
rationalize O
the O
electronic O
structure O
of O
[ O
H1 B
] O
( O
0 O
) O
and O
to O
facilitate O
spectral O
simulation O
and O
assignment O
of O
EPR O
parameters O
including O
( B
1 I
) I
H I
and O
( B
31 I
) I
P I
hyperfine O
couplings O
. O

Density O
functional O
theory O
calculations O
were O
employed O
to O
rationalize O
the O
electronic O
structure O
of O
[ O
H1 B
] O
( O
0 O
) O
and O
to O
facilitate O
spectral O
simulation O
and O
assignment O
of O
EPR O
parameters O
including O
( B
1 I
) I
H I
and O
( B
31 I
) I
P I
hyperfine O
couplings O
. O

The O
EPR O
spectra O
of O
[ O
H1 B
] O
( O
0 O
) O
and O
[ O
D1 O
] O
( O
0 O
) O
demonstrate O
that O
the O
singly O
occupied O
molecular O
orbital O
is O
primarily O
localized O
on O
the O
Fe B
center O
with O
the O
longer O
bond O
to O
H B
, O
that O
is O
, O
Fe B
( I
II I
) I
- I
H I
. O
. O
. O
Fe B
( I
I I
) I
. O

The O
coupling O
to O
the O
hydride B
is O
A O
( O
( B
1 I
) I
H I
) O
= O
55 O
and O
74 O
MHz O
for O
unsym O
- O
amd O
sym O
- O
[ O
H1 B
] O
( O
0 O
) O
, O
respectively O
. O

Treatment O
of O
[ O
H1 B
] O
( O
0 O
) O
with O
H B
( I
+ I
) I
gives O
0 O
. O
5 O
equiv O
of O
H2 B
and O
[ B
H1 I
] I
( I
+ I
) I
. O

Reduction O
of O
D B
( I
+ I
) I
affords O
D2 B
, O
leaving O
the O
hydride B
ligand O
intact O
. O

Based O
on O
multivariate O
pattern O
recognition O
methods O
( O
PLS O
- O
DA O
or O
soft O
independent O
modelling O
of O
class O
analogy O
[ O
SIMCA O
] O
) O
, O
these O
models O
allowed O
prediction O
of O
N B
- O
acetylation O
and O
subsequent O
N B
- I
oxanilic I
acid I
formation O
. O

Inclusion O
of O
parameters O
describing O
the O
N B
- I
acetyl I
moiety O
had O
little O
effect O
on O
the O
predictive O
ability O
of O
a O
stepwise O
parent O
to O
N B
- I
acetyl I
to O
N B
- I
oxanilic I
acid I
PLS O
- O
DA O
model O
, O
and O
had O
a O
negative O
impact O
on O
that O
of O
SIMCA O
models O
. O

Thus O
, O
salicylate B
coordinated O
in O
the O
G106A O
variant O
with O
the O
catalytically O
active O
Fe B
( I
II I
) I
ion O
in O
an O
unusual O
and O
unproductive O
manner O
because O
of O
the O
inability O
of O
salicylate B
to O
displace O
a O
hydrogen B
bond O
that O
was O
formed O
between O
Trp104 B
and O
Asp174 B
in O
the O
G106A O
variant O
. O

Selenite B
and O
tellurite B
form O
mixed O
seleno B
- I
and I
tellurotrisulfides I
with O
CstR O
from O
Staphylococcus O
aureus O
. O

Unlike O
CsoR O
, O
CstR O
does O
not O
form O
a O
stable O
complex O
with O
transition B
metals I
but O
instead O
reacts O
with O
sulfite B
to O
form O
a O
mixture O
of O
di B
- I
and I
trisulfide I
species O
, O
CstR2 O
( O
RS B
- I
SR I
' I
) O
and O
CstR2 O
( O
RS B
- I
S I
- I
SR I
' I
) O
n O
) O
n O
= O
1 O
or O
2 O
, O
respectively O
. O

Unlike O
CsoR O
, O
CstR O
does O
not O
form O
a O
stable O
complex O
with O
transition B
metals I
but O
instead O
reacts O
with O
sulfite B
to O
form O
a O
mixture O
of O
di B
- I
and I
trisulfide I
species O
, O
CstR2 O
( O
RS B
- I
SR I
' I
) O
and O
CstR2 O
( O
RS B
- I
S I
- I
SR I
' I
) O
n O
) O
n O
= O
1 O
or O
2 O
, O
respectively O
. O

We O
show O
that O
Cys31 B
initiates O
the O
reaction O
with O
sulfite B
through O
the O
formation O
of O
S B
- I
sulfocysteine I
( O
RS B
- I
SO3 I
( I
2 I
- I
) I
) O
and O
Cys60 B
is O
required O
to O
fully O
derivatize O
CstR O
to O
CstR2 O
( O
RS B
- I
SR I
' I
) O
and O
CstR2 O
( O
RS B
- I
S I
- I
SR I
' I
) O
. O

Its O
role O
for O
this O
indication O
requires O
further O
study O
, O
but O
it O
may O
be O
considered O
as O
adjunctive O
therapy O
when O
clinicians O
are O
concerned O
about O
respiratory O
suppression O
associated O
with O
escalating O
doses O
of O
gamma B
- I
aminobutyric I
acid I
agonists O
. O

Organothiols B
and O
other O
AuNP O
surface O
adsorbates O
such O
as O
thiophene B
, O
adenine B
, O
rhodamine B
, O
small O
anions O
( O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
) O
, O
and O
a O
polymer O
( O
PVP B
, O
poly B
( I
N I
- I
vinylpyrrolidone I
) I
) O
can O
all O
be O
rapidly O
and O
completely O
removed O
from O
the O
AuNP O
surfaces O
. O

Organothiols B
and O
other O
AuNP O
surface O
adsorbates O
such O
as O
thiophene B
, O
adenine B
, O
rhodamine B
, O
small O
anions O
( O
Br B
( I
- I
) I
and O
I B
( I
- I
) I
) O
, O
and O
a O
polymer O
( O
PVP B
, O
poly B
( I
N I
- I
vinylpyrrolidone I
) I
) O
can O
all O
be O
rapidly O
and O
completely O
removed O
from O
the O
AuNP O
surfaces O
. O

We O
characterized O
the O
oxidative O
stress O
( O
OS O
) O
status O
by O
the O
levels O
of O
reduced B
/ I
oxidized I
glutathione I
( O
GSH B
/ O
GSSG B
) O
, O
malondialdehyde B
( O
MDA B
) O
and O
the O
mutagenic O
base O
8 B
- I
oxo I
- I
7 I
' I
8 I
- I
dihydro I
- I
2 I
' I
- I
deoxyguanosine I
( O
8 B
- I
oxo I
- I
dG I
) O
in O
human O
gastric O
carcinoma O
( O
HGC O
) O
samples O
and O
compared O
the O
results O
with O
normal O
tissue O
from O
the O
same O
patients O
. O

Antimicrobial O
N B
- I
halamine I
polymers I
and O
coatings O
: O
a O
review O
of O
their O
synthesis O
, O
characterization O
, O
and O
applications O
. O

Antimicrobial O
N B
- I
halamine I
polymers I
and O
coatings O
have O
been O
studied O
extensively O
over O
the O
past O
decade O
thanks O
to O
their O
numerous O
qualities O
such O
as O
effectiveness O
toward O
a O
broad O
spectrum O
of O
microorganisms O
, O
long O
- O
term O
stability O
, O
regenerability O
, O
safety O
to O
humans O
and O
environment O
and O
low O
cost O
. O

Poly B
( I
dimethylsiloxane I
) I
( O
PDMS B
) O
materials O
have O
been O
extensively O
shown O
to O
function O
as O
excellent O
fouling O
- O
release O
( O
FR O
) O
coatings O
in O
the O
marine O
environment O
. O

Then O
, O
HX0969 B
disodium I
phosphate I
monoester I
( O
HX0969W B
) O
and O
glycine B
ester I
trifluoroacetic I
acid I
salt I
( O
HX101230 B
) O
were O
synthesized O
, O
and O
their O
pharmacological O
features O
were O
compared O
with O
those O
of O
Lusedra B
( O
R O
) O
, O
which O
has O
been O
recognized O
and O
marketed O
as O
a O
water O
- O
soluble O
prodrug O
of O
propofol B
since O
2008 O
. O

In O
the O
early O
stages O
, O
the O
efficiency O
of O
DSCs O
with O
arylamine B
organic O
dyes O
with O
D O
- O
pi O
- O
A O
character O
was O
far O
behind O
that O
of O
DSCs O
with O
ruthenium B
( I
II I
) I
complexes O
partly O
due O
to O
the O
lack O
of O
information O
about O
the O
relationship O
between O
the O
chemical O
structures O
and O
the O
photovoltaic O
performance O
. O

, O
methimazole B
, O
3 B
- I
methylcholanthrene I
, O
aminotriazole B
, O
amiodarone B
, O
cadmium B
chloride I
, O
dimethoate B
, O
fenvalerate B
, O
octylmethoxycinnamat B
, O
iopanoic B
acid I
, O
methoxychlor B
, O
and O
4 B
- I
methylbenzylidene I
- I
camphor I
) O
. O

In O
current O
work O
, O
MD O
simulation O
was O
carried O
out O
to O
study O
the O
dynamical O
structure O
of O
a O
special O
G O
- O
DNA O
( O
with O
sequence O
d O
( O
G O
( O
4 O
) O
T O
( O
4 O
) O
G O
( O
4 O
) O
) O
) O
complexed O
with O
five O
K B
( I
+ I
) I
ions O
. O

Our O
study O
showed O
that O
polarization O
of O
the O
nucleobases B
by O
K B
( I
+ I
) I
enhanced O
electrostatic O
attraction O
between O
the O
base O
and O
ions O
. O

The O
position O
of O
the O
Au B
4f O
( O
7 O
/ O
2 O
) O
peak O
indicates O
that O
the O
size O
of O
the O
agglomerated O
clusters O
is O
still O
smaller O
than O
that O
of O
Au B
( I
101 I
) I
. O

The O
authors O
conducted O
an O
aquatic O
mesocosm O
experiment O
to O
assess O
the O
behavior O
of O
three O
NBFRs O
: O
bis B
( I
tribromophenoxy I
) I
ethane I
( O
BTBPE B
) O
, O
tetrabromobisphenol B
A I
bis I
( I
2 I
, I
3 I
- I
dibromopropyl I
ether I
; O
TBBPA B
- O
DBPE B
) O
, O
and O
Firemaster B
BZ I
- I
54 I
, O
a O
commercial O
mixture O
containing O
bis B
( I
2 I
- I
ethylhexyl I
) I
tetrabromophthalate I
( O
BEHTBP B
) O
and O
2 B
- I
ethylhexyl I
- I
2 I
, I
3 I
, I
4 I

Here O
, O
a O
K B
- I
O I
( I
2 I
) I
battery O
is O
report O
that O
uses O
K B
( I
+ I
) I
ions O
to O
capture O
O B
( I
2 I
) I
( I
- I
) I
to O
form O
the O
thermodynamically O
stable O
KO B
( I
2 I
) I
product O
. O

Here O
, O
a O
K B
- I
O I
( I
2 I
) I
battery O
is O
report O
that O
uses O
K B
( I
+ I
) I
ions O
to O
capture O
O B
( I
2 I
) I
( I
- I
) I
to O
form O
the O
thermodynamically O
stable O
KO B
( I
2 I
) I
product O
. O

This O
allows O
for O
the O
battery O
to O
operate O
through O
the O
one O
- O
electron O
redox O
process O
of O
O B
( I
2 I
) I
/ O
O B
( I
2 I
) I
( I
- I
) I
. O

Our O
studies O
confirm O
the O
formation O
and O
removal O
of O
KO B
( I
2 I
) I
in O
the O
battery O
cycle O
test O
. O

Selective O
oxidation O
of O
omega B
- I
tertiary I
amine I
self O
- O
assembled O
thiol B
monolayers O
to O
tertiary B
amine I
N I
- I
oxides I
is O
shown O
to O
transform O
the O
adhesion O
of O
model O
proteins O
lysozyme O
and O
fibrinogen O
upon O
them O
. O

The O
surface O
containing O
a O
dimethylamine B
N I
- I
oxide I
headgroup O
and O
ethyl B
secondary I
amide I
linker O
showed O
the O
largest O
difference O
in O
adsorption O
of O
both O
proteins O
. O

The O
solution O
structure O
of O
this O
cyclic O
peptide O
was O
solved O
using O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
and O
( B
15 I
) I
N I
NMR O
spectroscopy O
and O
molecular O
dynamics O
( O
MD O
) O
simulations O
with O
NMR O
- O
derived O
distance O
and O
torsion O
angle O
restraints O
. O

The O
solution O
structure O
of O
this O
cyclic O
peptide O
was O
solved O
using O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
and O
( B
15 I
) I
N I
NMR O
spectroscopy O
and O
molecular O
dynamics O
( O
MD O
) O
simulations O
with O
NMR O
- O
derived O
distance O
and O
torsion O
angle O
restraints O
. O

The O
solution O
structure O
of O
this O
cyclic O
peptide O
was O
solved O
using O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
and O
( B
15 I
) I
N I
NMR O
spectroscopy O
and O
molecular O
dynamics O
( O
MD O
) O
simulations O
with O
NMR O
- O
derived O
distance O
and O
torsion O
angle O
restraints O
. O

PEM O
revealed O
that O
the O
DO O
was O
rapidly O
depleted O
, O
leading O
to O
the O
release O
of O
a O
huge O
amount O
of O
Fe B
( I
II I
) I
ions O
and O
hydrogen B
peroxide I
( O
HPO B
) O
in O
a O
two O
- O
phase O
kinetic O
pattern O
. O

The O
kinetic O
coefficients O
for O
Fe B
( I
II I
) I
ion O
release O
ranged O
from O
0 O
. O
347 O
h O
( O
- O
1 O
) O
to O
0 O
. O
774 O
h O
( O
- O
1 O
) O
; O
and O
those O
for O
Fe B
( I
III I
) I
ion O
production O
were O
from O
6 O
. O
66 O
x O
10 O
( O
- O
3 O
) O
h O
( O
- O
1 O
) O
to O
8 O
. O
93 O
x O
10 O
( O
- O
3 O
) O
h O
( O
- O
1 O
) O
. O

The O
kinetic O
coefficients O
for O
Fe B
( I
II I
) I
ion O
release O
ranged O
from O
0 O
. O
347 O
h O
( O
- O
1 O
) O
to O
0 O
. O
774 O
h O
( O
- O
1 O
) O
; O
and O
those O
for O
Fe B
( I
III I
) I
ion O
production O
were O
from O
6 O
. O
66 O
x O
10 O
( O
- O
3 O
) O
h O
( O
- O
1 O
) O
to O
8 O
. O
93 O
x O
10 O
( O
- O
3 O
) O
h O
( O
- O
1 O
) O
. O

Solution O
effect O
on O
diazonium B
- O
modified O
Au B
( I
111 I
) I
: O
reactions O
and O
structures O
. O

Surface O
modifications O
of O
a O
Au B
( I
111 I
) I
electrode O
with O
4 B
- I
bromobenzenediazoniu I
tetrafluoroborate I
( O
BBD B
) O
in O
acetonitrile B
( O
ACN B
) O
and O
0 O
. O
1 O
M O
HClO4 B
have O
been O
characterized O
by O
scanning O
tunneling O
microscopy O
( O
STM O
) O
. O

Surface O
modifications O
of O
a O
Au B
( I
111 I
) I
electrode O
with O
4 B
- I
bromobenzenediazoniu I
tetrafluoroborate I
( O
BBD B
) O
in O
acetonitrile B
( O
ACN B
) O
and O
0 O
. O
1 O
M O
HClO4 B
have O
been O
characterized O
by O
scanning O
tunneling O
microscopy O
( O
STM O
) O
. O

The O
plant O
growth O
regulator O
ethephon B
( O
2 B
- I
chloroethylphosphoni I
acid I
) O
inhibits O
human O
butyrylcholinesteras O
( O
BChE O
) O
by O
making O
a O
covalent O
adduct O
on O
the O
active O
site O
serine B
198 O
. O

Antagonistic O
effects O
of O
cytotoxicity O
were O
mainly O
found O
between O
Cr B
( I
VI I
) I
and O
Ni B
( I
II I
) I
, O
and O
synergistic O
effects O
of O
DNA O
damage O
and O
oxidative O
stress O
were O
partially O
found O
between O
these O
two O
compounds O
. O

Antagonistic O
effects O
of O
cytotoxicity O
were O
mainly O
found O
between O
Cr B
( I
VI I
) I
and O
Ni B
( I
II I
) I
, O
and O
synergistic O
effects O
of O
DNA O
damage O
and O
oxidative O
stress O
were O
partially O
found O
between O
these O
two O
compounds O
. O

It O
is O
based O
on O
the O
induction O
of O
micellar O
organised O
media O
by O
using O
Triton B
X I
- I
100 I
as O
an O
extraction O
solvent O
. O

Nitric B
oxide I
( O
NO B
) O
and O
prostaglandin B
E2 I
( O
PGE B
( I
2 I
) I
) O
, O
downstream O
products O
, O
were O
also O
suppressed O
in O
dose O
- O
dependent O
manners O
, O
except O
for O
WL O
and O
WW O
. O

Use O
of O
partially O
dephosphorylated O
beta O
- O
casein O
to O
stabilise O
oil O
- O
in O
- O
water O
emulsions O
resulted O
in O
larger O
fat O
globules O
compared O
to O
control O
beta O
- O
casein O
, O
but O
such O
globules O
were O
less O
susceptible O
to O
aggregation O
in O
the O
presence O
of O
15 O
or O
30 O
mM O
CaCl B
( I
2 I
) I
. O

Absorption O
and O
urinary O
excretion O
of O
A B
- I
type I
procyanidin I
oligomers O
from O
Litchi O
chinensis O
pericarp O
in O
rats O
by O
selected O
ion O
monitoring O
liquid O
chromatography O
- O
mass O
spectrometry O
. O

It O
was O
demonstrated O
that O
the O
main O
components O
in O
LPOPC O
were O
( B
- I
) I
- I
epicatechin I
, O
A B
- I
type I
procyanidin I
dimers O
, O
trimers O
and O
tetramers O
. O

( B
13 I
) I
C I
/ O
( B
12 I
) I
C I
analysis O
was O
conducted O
on O
these O
adulterated O
honey O
samples O
using O
an O
isotope O
ratio O
mass O
spectrometer O
in O
combination O
with O
an O
elemental O
analyser O
( O
EA O
- O
IRMS O
) O
. O

( B
13 I
) I
C I
/ O
( B
12 I
) I
C I
analysis O
was O
conducted O
on O
these O
adulterated O
honey O
samples O
using O
an O
isotope O
ratio O
mass O
spectrometer O
in O
combination O
with O
an O
elemental O
analyser O
( O
EA O
- O
IRMS O
) O
. O

A O
high O
density O
polyethylene B
( O
HDPE O
) O
/ O
calcium B
carbonate I
( O
CaCO B
( I
3 I
) I
) O
film O
containing O
TiO B
( I
2 I
) I
was O
prepared O
via O
blown O
film O
extrusion O
process O
. O

A O
high O
density O
polyethylene B
( O
HDPE O
) O
/ O
calcium B
carbonate I
( O
CaCO B
( I
3 I
) I
) O
film O
containing O
TiO B
( I
2 I
) I
was O
prepared O
via O
blown O
film O
extrusion O
process O
. O

The O
photocatalytic O
properties O
of O
this O
film O
were O
evaluated O
by O
voltammetric O
, O
UV O
- O
Vis O
spectrophotometric O
and O
gas O
chromatographic O
measurements O
following O
the O
decomposition O
rate O
of O
suitably O
selected O
molecular O
probes O
, O
such O
as O
4 B
- I
hydroxybenzoic I
acid I
and O
methylene B
blue I
. O

The O
film O
containing O
1 O
% O
w O
/ O
w O
of O
TiO B
( I
2 I
) I
displayed O
a O
profitable O
and O
reproducible O
photoinduced O
degradation O
activity O
towards O
target O
organic O
compounds O
. O

A O
container O
consisting O
of O
a O
multilayer O
material O
, O
where O
the O
layer O
brought O
in O
contact O
with O
the O
food O
, O
made O
from O
the O
HDPE O
+ O
CaCO B
( I
3 I
) I
+ O
TiO B
( I
2 I
) I
composite O
matrix O
, O
was O
able O
to O
provide O
a O
greater O
maintenance O
of O
the O
original O
cheese O
structure O
than O
a O
rigid O
container O
currently O
used O
, O
mainly O
due O
to O
the O
inhibition O
of O
lactic B
acid I
bacteria O
and O
coliforms O
. O

A O
container O
consisting O
of O
a O
multilayer O
material O
, O
where O
the O
layer O
brought O
in O
contact O
with O
the O
food O
, O
made O
from O
the O
HDPE O
+ O
CaCO B
( I
3 I
) I
+ O
TiO B
( I
2 I
) I
composite O
matrix O
, O
was O
able O
to O
provide O
a O
greater O
maintenance O
of O
the O
original O
cheese O
structure O
than O
a O
rigid O
container O
currently O
used O
, O
mainly O
due O
to O
the O
inhibition O
of O
lactic B
acid I
bacteria O
and O
coliforms O
. O

But O
models O
for O
stearic B
and I
unsaturated I
acids I
are O
less O
accurate O
, O
with O
values O
of O
R O
( O
cv O
) O
from O
0 O
. O
67440 O
to O
0 O
. O
69114 O
, O
and O
R O
( O
2 O
) O
from O
0 O
. O
6834 O
to O
0 O
. O
7587 O
. O

Detection O
, O
isolation O
and O
characterisation O
of O
cyclolinopeptides B
J I
and I
K I
in O
ageing O
flax O
. O

Concentrations O
of O
PCDD B
/ I
Fs I
, O
dioxin B
- I
like I
PCBs I
, O
PBDEs B
, O
and O
hexachlorobenzene B
in O
fat O
samples O
from O
cattle O
of O
different O
ages O
and O
gender O
in O
Korea O
. O

Gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
is O
a O
non O
- O
protein O
amino B
acid I
with O
bioactive O
functions O
in O
humans O
. O

Ascorbic B
and I
lactic I
acids I
interfered O
with O
ferric B
ions O
, O
thus O
significantly O
affecting O
blue O
colour O
evolution O
and O
stability O
. O

PBO B
) O
, O
or O
the O
non O
- O
carcinogenic O
hepatotoxicants O
acetaminophen B
and O
alpha B
- I
naphthyl I
isothiocyanate I
, O
for O
28 O
days O
. O

Chlorocarbonylthio B
- I
and I
isothiocyanate I
( O
ClC B
( I
O I
) I
SCN I
and O
ClC B
( I
O I
) I
NCS I
) O
have O
been O
isolated O
and O
characterized O
by O
IR O
( O
Ar B
matrix O
, O
gas O
) O
, O
Raman O
( O
liquid O
) O
, O
( B
13 I
) I
C I
NMR O
and O
UV O
- O
visible O
spectroscopies O
. O

Chlorocarbonylthio B
- I
and I
isothiocyanate I
( O
ClC B
( I
O I
) I
SCN I
and O
ClC B
( I
O I
) I
NCS I
) O
have O
been O
isolated O
and O
characterized O
by O
IR O
( O
Ar B
matrix O
, O
gas O
) O
, O
Raman O
( O
liquid O
) O
, O
( B
13 I
) I
C I
NMR O
and O
UV O
- O
visible O
spectroscopies O
. O

Properties O
have O
been O
discussed O
in O
terms O
of O
the O
valence O
electronic O
structure O
, O
including O
the O
analysis O
of O
the O
He B
( I
I I
) I
photoelectron O
spectrum O
of O
ClC B
( I
O I
) I
SCN I
. O

Potential O
- O
dependent O
interaction O
of O
DOPC B
liposomes O
with O
an O
octadecanol B
- O
covered O
Au B
( I
111 I
) I
surface O
investigated O
using O
electrochemical O
methods O
coupled O
with O
in O
situ O
fluorescence O
microscopy O
. O

The O
potential O
- O
controlled O
incorporation O
of O
DOPC B
liposomes O
( O
100 O
nm O
diameter O
) O
into O
an O
adsorbed O
octadecanol B
layer O
on O
Au B
( I
111 I
) I
was O
studied O
using O
electrochemical O
and O
in O
situ O
fluorescence O
microscopy O
. O

Triazolo B
and I
imidazo I
dihydropyrazolopyrim I
potassium B
channel O
antagonists O
. O

Previously O
disclosed O
C6 O
amido B
and I
benzimidazole I
dihydropyrazolopyrim I
were O
potent O
and O
selective O
blockers O
of O
IKur O
current O
. O

Syntheses O
and O
SAR O
for O
C6 O
triazolo B
and I
imidazo I
dihydropyrazolopyrim I
series O
are O
described O
. O

11 B
beta I
- I
Hydroxysteroid I
dehydrogenase O
type O
1 O
contributes O
to O
the O
balance O
between O
7 B
- I
keto I
- I
and I
7 I
- I
hydroxy I
- I
oxysterols I
in O
vivo O
. O

11 B
beta I
- I
Hydroxysteroid I
dehydrogenase O
1 O
( O
11 O
beta O
HSD1 O
; O
EC O
1 O
. O
1 O
. O
1 O
. O
146 O
) O
generates O
active O
glucocorticoids O
from O
inert O
11 B
- I
keto I
metabolites O
. O

Administration O
of O
the O
angiotensin B
IV I
receptor O
antagonist O
, O
divalinal B
- I
Ang I
IV I
( O
20 O
nmol O
, O
i O
. O
c O
. O
v O
. O
) O
, O
reduced O
( O
but O
did O
not O
abolish O
) O
novel O
object O
recognition O
; O
however O
, O
this O
antagonist O
completely O
blocked O
the O
procognitive O
effects O
of O
angiotensin B
IV I
( O
0 O
. O
1 O
nmol O
, O
i O
. O
c O
. O
v O
. O
) O
in O
this O
task O
. O

Rotorod O
testing O
demonstrated O
no O
locomotor O
effects O
with O
any O
angiotensin B
IV I
or O
divalinal B
- I
Ang I
IV I
dose O
tested O
. O

Three O
new O
norlignans B
, O
glechomols B
A I
- I
C I
( O
1 O
- O
3 O
, O
respectively O
) O
, O
together O
with O
a O
known O
compound O
, O
4 B
- I
ethylcatechol I
( O
4 O
) O
, O
were O
isolated O
from O
the O
ethyl B
acetate I
extract O
of O
Glechoma O
longituba O
( O
NaKai O
) O
Kupr O
. O

Glechomols B
A I
- I
C I
were O
the O
first O
norlignans B
reported O
from O
genus O
Glechoma O
, O
and O
compound O
4 O
was O
also O
isolated O
from O
genus O
Glechoma O
for O
the O
first O
time O
. O

Danshen O
possesses O
lipid O
- O
soluble O
biologically O
active O
components O
with O
a O
structure O
similar O
to O
17 B
beta I
- I
estrodiol I
( O
E2 O
) O
. O

Cardiomyoblast O
cells O
pretreated O
with O
Fulvestrant B
( O
ICI B
182 I
, I
780 I
) O
, O
an O
estrogen B
receptor O
antagonist O
was O
applied O
to O
investigate O
the O
estrogenic O
activity O
of O
Danshen O
. O

In O
order O
to O
determine O
an O
accurate O
equilibrium O
structure O
for O
1 B
, I
3 I
, I
4 I
- I
oxadiazole I
, O
microwave O
transitions O
and O
ground O
- O
state O
rotational O
constants O
are O
reported O
for O
the O
parent O
species O
and O
for O
the O
( B
18 I
) I
O I
isotopologue O
measured O
in O
natural O
abundance O
. O

These O
rotational O
constants O
along O
with O
those O
of O
the O
( B
13 I
) I
C I
, O
( B
15 I
) I
N I
, O
and O
D1 O
species O
were O
used O
together O
with O
vibration O
- O
rotation O
constants O
calculated O
from O
a O
cubic O
force O
field O
calculated O
at O
the O
B3LYP O
/ O
6 O
- O
311 O
+ O
G O
( O
3df O
, O
2pd O
) O
level O
of O
theory O
to O
derive O
a O
semiexperimental O
equilibrium O
structure O
. O

These O
rotational O
constants O
along O
with O
those O
of O
the O
( B
13 I
) I
C I
, O
( B
15 I
) I
N I
, O
and O
D1 O
species O
were O
used O
together O
with O
vibration O
- O
rotation O
constants O
calculated O
from O
a O
cubic O
force O
field O
calculated O
at O
the O
B3LYP O
/ O
6 O
- O
311 O
+ O
G O
( O
3df O
, O
2pd O
) O
level O
of O
theory O
to O
derive O
a O
semiexperimental O
equilibrium O
structure O
. O

All O
elements O
of O
the O
( B
14 I
) I
N I
nuclear O
quadrupole O
coupling O
tensor O
have O
been O
determined O
. O

PtCl2 B
- O
Catalyzed O
Tandem O
Enyne B
Cyclization O
/ O
1 B
, I
2 I
Ester I
Migration O
Reaction O
Controlled O
by O
Substituent O
Effects O
of O
All B
- I
Carbon I
1 I
, I
6 I
- I
Enynyl I
Esters I
. O

In O
female O
, O
but O
not O
male O
hearts O
, O
acute O
exposure O
to O
1nM O
BPA B
, O
either O
alone O
or O
combined O
with O
1nM O
17 B
beta I
- I
estradiol I
( O
E2 O
) O
, O
during O
reperfusion O
resulted O
in O
a O
marked O
increase O
in O
the O
duration O
of O
sustained O
ventricular O
arrhythmias O
. O

Effect O
of O
Ketoconazole B
on O
the O
Pharmacokinetics O
of O
the O
11 B
beta I
- I
Hydroxysteroid I
Dehydrogenase O
Type O
1 O
Inhibitor O
ABT B
- I
384 I
and O
Its O
Two O
Active O
Metabolites O
in O
Healthy O
Volunteers O
: O
Population O
Analysis O
of O
Data O
from O
a O
Drug O
- O
Drug O
Interaction O
Study O
. O

ABT B
- I
384 I
[ O
1 B
- I
piperazineacetamide I
, I
N I
- I
[ I
5 I
- I
( I
aminocarbonyl I
) I
tricyclo I
[ I
3 I
. I
3 I
. I
1 I
. I
13 I
, I
7 I
] I
dec I
- I
2 I
- I
yl I
] I
- I
alpha I
, I
alpha I
- I
dimethyl I
- I
4 I
- I
[ I
5 I
- I
( I
trifluoromethyl I
) I
- I
2 I
- I
pyridinyl I
] I
- O
, O
stereoisomer O
] O
is O
a O
potent O
and O
selective O
inhibitor O
of O
11 B
beta I
- I
hydroxysteroid I
dehydrogenase O
type O
1 O
( O
HSD O
- O
1 O
) O
. O

Phytochemical O
investigation O
of O
CHCl B
( I
3 I
) I
: O
MeOH B
( O
1 O
: O
1 O
) O
extract O
from O
the O
rhizomes O
of O
Nardostachys O
jatamansi O
led O
to O
the O
isolation O
of O
two O
new O
sesquiterpenoids B
( O
5 O
and O
6 O
) O
, O
along O
with O
six O
known O
compounds O
( O
1 O
- O
4 O
, O
7 O
, O
and O
8 O
) O
. O

Coumarin B
7 O
- O
hydroxylation O
, O
catalyzed O
by O
P450 O
2A13 O
, O
was O
strongly O
inhibited O
by O
2 B
' I
- I
methoxy I
- I
5 I
, I
7 I
- I
dihydroxyflavone I
, O
2 B
- I
ethynylnaphthalene I
, O
2 B
' I
- I
methoxyflavone I
, O
2 B
- I
naphththalene I
propargyl I
ether I
, O
acenaphthene B
, O
acenaphthylene B
, O
naphthalene B
, O
1 B
- I
acetylpyrene I
, O
flavanone B
, O
chrysin B
, O
3 B
- I
ethynylphenanthrene I
, O

Discovery O
of O
biological O
evaluation O
of O
pyrazole B
/ I
imidazole I
amides I
as O
mGlu5 O
receptor O
negative O
allosteric O
modulators O
. O

Combined O
nano O
zinc B
oxide I
and O
titanium B
dioxide I
[ O
nano O
( O
ZnO B
- O
TiO B
( I
2 I
) I
) O
] O
has O
been O
reported O
first O
time O
for O
the O
synthesis O
of O
novel O
series O
of O
4 B
, I
5 I
, I
6 I
, I
7 I
- I
tetrahydro I
- I
6 I
- I
( I
( I
5 I
- I
substituted I
- I
1 I
, I
3 I
, I
4 I
- I
oxadiazol I
- I
2 I
- I
yl I
) I
methyl I
) I
thieno I
[ I
2 I
, I
3 I
- I
c I
] I
pyridine I
. O

Among O
the O
synthesized O
compounds O
, O
2 B
, I
6 I
dichlorophenyl I
analogue O
( O
7f O
) O
, O
4 B
fluorophenyl I
analogue O
( O
7k O
) O
and O
2 B
, I
6 I
dichlorophenyl I
analogue O
( O
7l O
) O
shows O
promising O
antibacterial O
as O
well O
as O
antifungal O
activity O
whereas O
thiophene B
substituted O
compound O
( O
7j O
) O
shows O
promising O
antibacterial O
activity O
. O

Among O
the O
synthesized O
compounds O
, O
2 B
, I
6 I
dichlorophenyl I
analogue O
( O
7f O
) O
, O
4 B
fluorophenyl I
analogue O
( O
7k O
) O
and O
2 B
, I
6 I
dichlorophenyl I
analogue O
( O
7l O
) O
shows O
promising O
antibacterial O
as O
well O
as O
antifungal O
activity O
whereas O
thiophene B
substituted O
compound O
( O
7j O
) O
shows O
promising O
antibacterial O
activity O
. O

In O
a O
previous O
study O
of O
non O
- O
peptide O
, O
guanide B
- O
based O
CXCR4 O
- O
binding O
compounds O
, O
spermine B
and I
spermidine I
phenylguanides I
inhibited O
HIV O
- O
1 O
entry O
at O
low O
micromolar O
concentrations O
. O

Modulation O
of O
A O
- O
type O
K B
( I
+ I
) I
channels O
by O
the O
short O
- O
chain O
cobrotoxin O
through O
the O
protein O
kinase O
C O
- O
delta O
isoform O
decreases O
membrane O
excitability O
in O
dorsal O
root O
ganglion O
neurons O
. O

A O
- O
type O
K B
( I
+ I
) I
channels O
are O
crucial O
in O
controlling O
neuronal O
excitability O
, O
and O
their O
regulation O
in O
sensory O
neurons O
may O
alter O
pain O
sensation O
. O

In O
this O
study O
, O
we O
identified O
the O
functional O
role O
of O
cobrotoxin O
, O
the O
short O
- O
chain O
alpha O
- O
neurotoxin O
isolated O
from O
Naja O
atra O
venom O
, O
which O
acts O
in O
the O
regulation O
of O
the O
transient O
A O
- O
type O
K B
( I
+ I
) I
currents O
( O
IA O
) O
and O
membrane O
excitability O
in O
dorsal O
root O
ganglion O
( O
DRG O
) O
neurons O
via O
the O
activation O
of O
the O
muscarinic O
M3 O
receptor O
( O
M3R O
) O
. O

Our O
results O
showed O
that O
cobrotoxin O
increased O
IA O
in O
a O
concentration O
- O
dependent O
manner O
, O
whereas O
the O
sustained O
delayed O
rectifier O
K B
( I
+ I
) I
currents O
( O
IDR O
) O
were O
not O
affected O
. O

A O
simple O
method O
for O
fabricating O
patterned O
curvilinear O
microstructures O
in O
poly B
( I
dimethylsiloxane I
) I
by O
selective O
wetting O
. O

The O
fabrication O
of O
patterned O
microstructures O
in O
poly B
( I
dimethylsiloxane I
) I
( O
PDMS B
) O
is O
a O
prerequisite O
for O
soft O
lithography O
. O

Fluorine B
- O
implanting O
improved O
the O
surface O
hydrophobicity O
of O
the O
zeolite B
and O
altered O
the O
electropositivity O
nearby O
the O
tetrahedral O
Ti B
sites O
through O
forming O
the O
SiO3 B
/ O
2F B
and O
SiO4 B
/ O
2F B
( I
- I
) I
units O
. O

The O
negative O
effect O
of O
SiO4 B
/ O
2F B
( I
- I
) I
units O
in O
F B
- I
Ti I
- O
MWW O
was O
eliminated O
selectively O
by O
convenient O
anion O
- O
exchange O
with O
various O
alkali B
chlorides I
. O

Molecular O
interactions O
between O
lecithin O
and O
bile B
salts I
/ I
acids I
in O
oils O
and O
their O
effects O
on O
reverse O
micellization O
. O

We O
used O
Fourier O
transform O
infrared O
spectroscopy O
to O
investigate O
the O
interactions O
between O
lecithin O
and O
bile B
salts I
/ I
acids I
and O
found O
that O
different O
bile B
salts I
/ I
acids I
employ O
different O
functional O
groups O
to O
form O
hydrogen B
bonds O
with O
lecithin O
. O

We O
used O
Fourier O
transform O
infrared O
spectroscopy O
to O
investigate O
the O
interactions O
between O
lecithin O
and O
bile B
salts I
/ I
acids I
and O
found O
that O
different O
bile B
salts I
/ I
acids I
employ O
different O
functional O
groups O
to O
form O
hydrogen B
bonds O
with O
lecithin O
. O

Such O
effects O
determine O
the O
relative O
positions O
of O
the O
bile B
salts I
/ I
acids I
in O
the O
headgroups O
of O
lecithin O
, O
thus O
resulting O
in O
varying O
efficiencies O
to O
alter O
the O
effective O
critical O
packing O
parameter O
for O
the O
formation O
of O
wormlike O
micelles O
. O

An O
assembly O
consisting O
of O
three O
units O
, O
that O
is O
, O
a O
meso B
- I
substituted I
corrole I
( O
) O
, O
1 B
, I
8 I
naphthaleneimide I
( O
) O
, O
and O
a O
Zn B
porphyrin B
( O
) O
, O
has O
been O
synthesized O
. O

An O
assembly O
consisting O
of O
three O
units O
, O
that O
is O
, O
a O
meso B
- I
substituted I
corrole I
( O
) O
, O
1 B
, I
8 I
naphthaleneimide I
( O
) O
, O
and O
a O
Zn B
porphyrin B
( O
) O
, O
has O
been O
synthesized O
. O

For O
the O
current O
study O
the O
pigment O
- O
protein O
complexes O
were O
stabilized O
in O
the O
detergent O
buffer O
solution O
using O
a O
relatively O
mild O
detergent O
( O
dodecyl B
- I
beta I
- I
D I
- I
maltoside I
( O
DDM B
) O
instead O
of O
lauryldimethylamine B
N I
- I
oxide I
( O
LDAO B
) O
) O
. O

Here O
, O
we O
developed O
a O
straightforward O
, O
sensitive O
, O
and O
quantitative O
assay O
for O
the O
colorimetric O
and O
spectroscopic O
detection O
of O
various O
ROS O
and O
RNS O
such O
as O
H2O2 B
, O
. B
OH I
, O
( B
- I
) I
OCl I
, O
NO B
. I
, O
and O
O2 B
( I
- I
) I
using O
glutathione B
- O
modified O
gold O
nanoparticles O
( O
GSH B
- O
AuNPs O
) O
. O

Here O
, O
we O
developed O
a O
straightforward O
, O
sensitive O
, O
and O
quantitative O
assay O
for O
the O
colorimetric O
and O
spectroscopic O
detection O
of O
various O
ROS O
and O
RNS O
such O
as O
H2O2 B
, O
. B
OH I
, O
( B
- I
) I
OCl I
, O
NO B
. I
, O
and O
O2 B
( I
- I
) I
using O
glutathione B
- O
modified O
gold O
nanoparticles O
( O
GSH B
- O
AuNPs O
) O
. O

The O
crystal O
structure O
of O
this O
compound O
in O
complex O
with O
human O
HGPRT O
shows O
that O
it O
fills O
or O
partially O
fills O
three O
critical O
locations O
in O
the O
active O
site O
: O
the O
binding O
sites O
of O
the O
purine B
base O
, O
the O
5 B
' I
- I
phosphate I
group O
, O
and O
pyrophosphate B
. O

In O
this O
study O
, O
we O
designed O
and O
synthesized O
nine O
new O
derivatives O
of O
17 B
beta I
- I
estradiol I
( O
E2 O
) O
with O
a O
bulky O
side O
chain O
attached O
to O
its O
C O
- O
7 O
alpha O
position O
, O
and O
determined O
their O
ER O
antagonistic O
activity O
using O
in O
vitro O
bioassays O
. O

Potassium B
( O
K B
( I
+ I
) I
) O
influx O
into O
pollen O
tubes O
via O
K B
( I
+ I
) I
transporters O
is O
essential O
for O
pollen O
tube O
growth O
; O
however O
, O
the O
mechanism O
by O
which O
K B
( I
+ I
) I
transporters O
are O
regulated O
in O
pollen O
tubes O
remains O
unknown O
. O

Potassium B
( O
K B
( I
+ I
) I
) O
influx O
into O
pollen O
tubes O
via O
K B
( I
+ I
) I
transporters O
is O
essential O
for O
pollen O
tube O
growth O
; O
however O
, O
the O
mechanism O
by O
which O
K B
( I
+ I
) I
transporters O
are O
regulated O
in O
pollen O
tubes O
remains O
unknown O
. O

Potassium B
( O
K B
( I
+ I
) I
) O
influx O
into O
pollen O
tubes O
via O
K B
( I
+ I
) I
transporters O
is O
essential O
for O
pollen O
tube O
growth O
; O
however O
, O
the O
mechanism O
by O
which O
K B
( I
+ I
) I
transporters O
are O
regulated O
in O
pollen O
tubes O
remains O
unknown O
. O

Here O
, O
we O
report O
that O
Arabidopsis O
thaliana O
Ca B
( I
2 I
+ I
) I
- O
dependent O
protein O
kinase11 O
( O
CPK11 O
) O
and O
CPK24 O
are O
involved O
in O
Ca B
( I
2 I
+ I
) I
- O
dependent O
regulation O
of O
the O
inward O
K B
( I
+ I
) I
( O
K B
( I
+ I
) I
in O
) O
channels O
in O
pollen O
tubes O
. O

Here O
, O
we O
report O
that O
Arabidopsis O
thaliana O
Ca B
( I
2 I
+ I
) I
- O
dependent O
protein O
kinase11 O
( O
CPK11 O
) O
and O
CPK24 O
are O
involved O
in O
Ca B
( I
2 I
+ I
) I
- O
dependent O
regulation O
of O
the O
inward O
K B
( I
+ I
) I
( O
K B
( I
+ I
) I
in O
) O
channels O
in O
pollen O
tubes O
. O

Using O
patch O
- O
clamp O
analysis O
, O
we O
demonstrated O
that O
K B
( I
+ I
) I
in O
currents O
of O
pollen O
tube O
protoplasts O
were O
inhibited O
by O
elevated O
[ O
Ca B
( I
2 I
+ I
) I
] O
cyt O
. O

However O
, O
disruption O
of O
CPK11 O
or O
CPK24 O
completely O
impaired O
the O
Ca B
( I
2 I
+ I
) I
- O
dependent O
inhibition O
of O
K B
( I
+ I
) I
in O
currents O
and O
enhanced O
pollen O
tube O
growth O
. O

Electrophysiological O
assays O
demonstrated O
that O
the O
Shaker O
pollen O
K B
( I
+ I
) I
in O
channel O
is O
the O
main O
contributor O
to O
pollen O
tube O
K B
( I
+ I
) I
in O
currents O
and O
acts O
as O
the O
downstream O
target O
of O
the O
CPK11 O
- O
CPK24 O
pathway O
. O

Electrophysiological O
assays O
demonstrated O
that O
the O
Shaker O
pollen O
K B
( I
+ I
) I
in O
channel O
is O
the O
main O
contributor O
to O
pollen O
tube O
K B
( I
+ I
) I
in O
currents O
and O
acts O
as O
the O
downstream O
target O
of O
the O
CPK11 O
- O
CPK24 O
pathway O
. O

We O
conclude O
that O
CPK11 O
and O
CPK24 O
together O
mediate O
the O
Ca B
( I
2 I
+ I
) I
- O
dependent O
inhibition O
of O
K B
( I
+ I
) I
in O
channels O
and O
participate O
in O
the O
regulation O
of O
pollen O
tube O
growth O
in O
Arabidopsis O
. O

Steroids B
were O
analyzed O
, O
after O
extraction O
and O
enzymatic O
conjugate O
hydrolysis O
, O
as O
methyloxime B
- I
trimethylsilyl I
ether I
derivatives O
on O
gas O
- O
chromatographs O
coupled O
to O
quadrupole O
and O
ion O
- O
trap O
mass O
- O
spectrometers O
. O

To O
follow O
the O
reaction O
with O
the O
peptides O
and O
characterize O
more O
easily O
intermediates O
and O
adducts O
, O
the O
molecule O
was O
first O
( B
13 I
) I
C I
isotopically O
substituted O
at O
the O
most O
probable O
reactive O
position O
. O

The O
structure O
of O
the O
PDEA B
- I
grafted I
GO I
( O
GO B
- I
PDEA I
) O
were O
examined O
by O
Fourier O
- O
transform O
infrared O
spectroscopy O
, O
proton O
nuclear O
magnetic O
resonance O
spectroscopy O
, O
X O
- O
ray O
photoelectron O
spectroscopy O
, O
thermogravimetric O
analysis O
and O
atomic O
force O
microscopy O
. O

The O
PL O
property O
was O
further O
polished O
, O
and O
the O
QY O
was O
improved O
to O
~ O
80 O
% O
through O
the O
variance O
of O
the O
prepared O
conditions O
such O
as O
the O
ratio O
of O
ligand O
to O
metal O
ion O
and O
HTe B
( I
- I
) I
to O
metal O
ion O
, O
pH O
value O
, O
and O
temperature O
. O

Supramolecular O
cl B
. O
. O
. O
h B
and O
o B
. O
. O
. O
h B
interactions O
in O
self O
- O
assembled O
1 B
, I
5 I
- I
dichloroanthraquinon I
layers O
on O
au B
( I
111 I
) I
. O

Here O
, O
we O
study O
the O
supramolecular O
interactions O
of O
1 B
, I
5 I
- I
dichloroanthraquinon I
molecules O
on O
Au B
( I
111 I
) I
, O
including O
Cl B
ligands O
, O
by O
using O
STM O
. O

Their O
relative O
configurations O
were O
established O
using O
analysis O
of O
NOESY O
correlations O
and O
coupling O
constants O
observed O
in O
( B
1 I
) I
H I
NMR O
. O

Using O
a O
recombinant O
phospholipase O
- O
D O
from O
the O
venom O
gland O
of O
L O
. O
intermedia O
( O
LiRecDT1 O
) O
in O
phospholipid O
- O
degrading O
kinetic O
experiments O
, O
we O
determined O
that O
this O
phospholipase O
- O
D O
mainly O
hydrolyzes O
synthetic O
sphingomyelin B
in O
a O
time O
- O
dependent O
manner O
, O
generating O
ceramide B
1 I
- I
phosphate I
plus O
choline B
, O
as O
well O
as O
lysophosphatidylchol B
, O
generating O
lysophosphatidic B
acid I
plus O
choline B
, O
but O
exhibits O
little O
activity O
against O

( B
1 I
) I
H I
NMR O
spectroscopy O
was O
applied O
to O
investigate O
the O
changes O
of O
cerebral O
metabolites O
in O
brain O
hippocampus O
, O
nucleus O
accumbens O
( O
NAC O
) O
and O
prefrontal O
cortex O
( O
PFC O
) O
of O
the O
rats O
subjected O
to O
subcutaneous O
twice O
- O
daily O
injections O
of O
2 O
. O
5mg O
/ O
kg O
methamphetamine B
( O
MAP B
) O
for O
7 O
days O
. O

Since O
complexation O
of O
the O
ligated O
ODNs O
with O
hemin B
in O
the O
presence O
of O
K B
( I
+ I
) I
showed O
strong O
soret O
band O
absorption O
and O
also O
catalyzed O
the O
H B
( I
2 I
) I
O I
( I
2 I
) I
- O
mediated O
oxidation O
of O
luminol B
, O
it O
appears O
that O
the O
quadruplex O
formed O
from O
ligated O
ODNs O
showed O
a O
function O
similar O
to O
native O
DNA O
quadruplex O
. O

The O
aggregation O
and O
solubilization O
of O
four O
structurally O
related O
meso B
- I
tetraphenyl I
porphyrin I
photosensitizers O
with O
nonionic O
( O
4 B
- I
hydroxy I
) O
, O
anionic O
( O
4 B
- I
sulphonate I
; O
4 B
- I
carboxy I
) O
and O
cationic O
( O
4 B
- I
trimethylanilinium I
) O
substituents O
were O
evaluated O
in O
various O
vehicles O
by O
use O
of O
UV O
- O
Vis O
spectroscopy O
. O

Reversible O
addition O
- O
fragmentation O
chain O
transfer O
( O
RAFT O
) O
polymerization O
was O
used O
to O
synthesize O
two O
various O
sized O
water O
- O
soluble O
block O
copolymer O
of O
oligoethylene B
glycol I
methylether I
methacylate I
and O
methyl B
acrylic I
acid I
( O
POEGMEMA35 B
- I
b I
- I
PMAA200 I
and O
POEGMEMA26 B
- I
b I
- I
PMAA90 I
) O
. O

We O
report O
here O
the O
synthesis O
and O
in O
vitro O
validation O
of O
a O
Gd B
( I
III I
) I
- O
based O
contrast O
agent O
designed O
to O
act O
as O
an O
MRI O
responsive O
probe O
for O
imaging O
the O
activity O
of O
the O
enzyme O
glutamic B
acid I
decarboxylase O
( O
GAD O
) O
present O
in O
neurons O
. O

Upon O
the O
action O
of O
the O
enzyme O
, O
the O
Gd B
( I
III I
) I
complex O
increases O
its O
hydration O
sphere O
and O
takes O
on O
a O
residual O
positive O
charge O
that O
promotes O
its O
binding O
to O
endogenous O
macromolecules O
. O

In O
the O
present O
study O
, O
we O
focused O
on O
[ O
TBP O
] O
/ O
[ O
Au B
( I
III I
) I
] O
ratios O
of O
1 O
- O
5 O
( O
= O
~ O
1 O
mM O
HAuCl4 B
) O
and O
seed O
sizes O
~ O
20 O
nm O
. O

The O
electronic O
structure O
of O
Mn B
@ O
Si14 B
( I
+ I
) I
is O
determined O
using O
DFT O
and O
CASPT2 O
/ O
CASSCF O
( O
14 O
, O
15 O
) O
computations O
with O
large O
basis O
sets O
. O

The O
endohedrally O
Mn B
- I
doped I
Si I
cationic O
cluster O
has O
a O
D3h O
fullerene B
- I
like O
structure O
featuring O
a O
closed O
- O
shell O
singlet O
ground O
state O
with O
a O
singlet O
- O
triplet O
gap O
of O
~ O
1 O
eV O
. O

Full O
occupation O
of O
[ O
2S O
, O
2P O
, O
2D O
] O
shell O
orbitals O
by O
18 O
delocalized O
electrons O
confers O
the O
doped O
Mn B
@ O
Si14 B
( I
+ I
) I
cluster O
a O
spherically O
aromatic O
character O
. O

Sensing O
of O
biologically O
important O
cations O
such O
as O
na B
( I
+ I
) I
, O
k B
( I
+ I
) I
, O
ca B
( I
2 I
+ I
) I
, O
cu B
( I
2 I
+ I
) I
, O
and O
fe B
( I
3 I
+ I
) I
using O
magnetic O
nanoemulsions O
. O

Sensing O
of O
biologically O
important O
cations O
such O
as O
na B
( I
+ I
) I
, O
k B
( I
+ I
) I
, O
ca B
( I
2 I
+ I
) I
, O
cu B
( I
2 I
+ I
) I
, O
and O
fe B
( I
3 I
+ I
) I
using O
magnetic O
nanoemulsions O
. O

The O
sensor O
shows O
good O
selectivity O
to O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
, O
Ca B
( I
2 I
+ I
) I
, O
Cu B
( I
2 I
+ I
) I
, O
and O
Fe B
( I
3 I
+ I
) I
ions O
and O
offers O
a O
rapid O
response O
compared O
to O
conventional O
techniques O
. O

The O
sensor O
shows O
good O
selectivity O
to O
Na B
( I
+ I
) I
, O
K B
( I
+ I
) I
, O
Ca B
( I
2 I
+ I
) I
, O
Cu B
( I
2 I
+ I
) I
, O
and O
Fe B
( I
3 I
+ I
) I
ions O
and O
offers O
a O
rapid O
response O
compared O
to O
conventional O
techniques O
. O

Three O
new O
19 B
- I
hydroxy I
steroidal I
glycosides I
, O
namely O
, O
junceellosides B
E I
- I
G I
( O
2 O
- O
4 O
) O
, O
were O
isolated O
together O
with O
the O
known O
analogue O
junceelloside B
C I
( O
1 O
) O
from O
the O
South O
China O
Sea O
gorgonian O
Dichotella O
gemmacea O
. O

A O
series O
of O
no O
- O
chlorine B
and O
oxygen B
- O
rich O
hydrazine B
derivatives O
( O
hydrazine B
modified O
with O
- O
NO2 B
and O
NO3 B
( I
- I
) I
groups O
) O
was O
designed O
and O
optimized O
to O
obtain O
molecular O
geometries O
and O
electronic O
structures O
at O
density O
functional O
theory O
- O
B3PW91 O
/ O
6 O
- O
311 O
+ O
+ O
G O
( O
3df O
, O
3pd O
) O
level O
. O

Phytochemical O
study O
on O
the O
constituents O
of O
the O
heartwood O
of O
Pterocarpus O
soyauxii O
led O
to O
the O
isolation O
of O
five O
new O
isoflavonoids B
and O
one O
new O
3 B
- I
arylcoumarin I
, O
pterosonins B
A I
- I
F I
( O
1 O
- O
6 O
) O
, O
together O
with O
17 O
known O
analogues O
, O
among O
which O
8 O
, O
9 O
, O
and O
18 O
were O
reported O
as O
natural O
products O
for O
the O
first O
time O
. O

The O
induction O
of O
mitochondria O
- O
mediated O
apoptosis O
in O
cancer O
cells O
by O
ruthenium B
( I
ii I
) I
asymmetric O
complexes O
. O

Four O
ruthenium B
( I
ii I
) I
asymmetric O
complexes O
, O
[ B
Ru I
( I
bpy I
) I
2 I
( I
PAIDH I
) I
] I
( I
2 I
+ I
) I
( O
bpy B
= O
2 B
, I
2 I
' I
- I
bipyridine I
, O
PAIDH B
= O
2 B
- I
pyridyl I
- I
1H I
- I
anthra I
[ I
1 I
, I
2 I
- I
d I
] I
imidazole I
- I
6 I
, I
11 I
- I
dione I
, O
) O
, O
[ B
Ru I
( I
phen I
) I
2 I
( I
PAIDH I
) I
] I
( I
2 I
+ I
) I
( O
phen B
= O
1 B
, I
10 I
- I
phenanthroline I
, O
) O
, O
[ B
Ru I
( I
dmp I
) I
2 I
( I

Computational O
study O
of O
the O
coordination O
of O
methane B
to O
first O
row O
transition B
metal I
dication I
complexes I
. O

The O
coordination O
of O
methane B
, O
the O
first O
step O
in O
methane B
activation O
, O
to O
coordinately O
unsaturated O
first O
row O
transition B
metal I
dication I
complexes I
has O
been O
studied O
computationally O
to O
determine O
the O
most O
stable O
metal O
- O
methane B
interaction O
. O

Nickel B
sulfide I
/ O
nitrogen B
- I
doped I
graphene I
composites O
: O
phase O
- O
controlled O
synthesis O
and O
high O
performance O
anode O
materials O
for O
lithium B
ion O
batteries O
. O

Phase O
- O
controlled O
nickel B
sulfide I
( O
Ni3 B
S4 I
and O
NiS1 B
. I
03 I
) O
nanoparticle O
( O
NP O
) O
/ O
nitrogen B
- I
doped I
graphene I
( O
NG O
) O
composites O
are O
prepared O
through O
a O
facile O
one O
- O
pot O
hydrothermal O
process O
. O

( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
analysis O
of O
2 B
- I
acetamido I
- I
3 I
- I
mercapto I
- I
3 I
- I
methyl I
- I
N I
- I
aryl I
- I
butanamides I
and O
2 B
- I
acetamido I
- I
3 I
- I
methyl I
- I
3 I
- I
nitrososulfanyl I
- I
N I
- I
aryl I
- I
butanamide I
derivatives O
. O

( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
analysis O
of O
2 B
- I
acetamido I
- I
3 I
- I
mercapto I
- I
3 I
- I
methyl I
- I
N I
- I
aryl I
- I
butanamides I
and O
2 B
- I
acetamido I
- I
3 I
- I
methyl I
- I
3 I
- I
nitrososulfanyl I
- I
N I
- I
aryl I
- I
butanamide I
derivatives O
. O

The O
complete O
assignment O
of O
the O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
spectra O
of O
various O
2 B
- I
acetamido I
- I
3 I
- I
mercapto I
- I
3 I
- I
methyl I
- I
N I
- I
aryl I
- I
butanamides I
and O
2 B
- I
acetamide I
- I
3 I
- I
methyl I
- I
3 I
- I
nitrososulfanyl I
- I
N I
- I
aryl I
- I
butanamides I
with O
p B
- I
methoxy I
, O
o B
- I
chloro I
and O
m B
- I
chloro I
substituents O
is O
reported O
. O

The O
complete O
assignment O
of O
the O
( B
1 I
) I
H I
and O
( B
13 I
) I
C I
NMR O
spectra O
of O
various O
2 B
- I
acetamido I
- I
3 I
- I
mercapto I
- I
3 I
- I
methyl I
- I
N I
- I
aryl I
- I
butanamides I
and O
2 B
- I
acetamide I
- I
3 I
- I
methyl I
- I
3 I
- I
nitrososulfanyl I
- I
N I
- I
aryl I
- I
butanamides I
with O
p B
- I
methoxy I
, O
o B
- I
chloro I
and O
m B
- I
chloro I
substituents O
is O
reported O
. O

Four O
new O
4 B
- I
hydroxy I
- I
2 I
- I
pyridone I
alkaloids I
, O
didymellamides B
A I
- I
D I
( O
1 O
- O
4 O
) O
, O
were O
isolated O
from O
the O
marine O
- O
derived O
fungus O
Stagonosporopsis O
cucurbitacearum O
. O

Calcium B
( I
II I
) I
precipitates O
with O
palmitate B
( O
Pal B
( I
- I
) I
) O
, O
a O
process O
affecting O
calcium B
absorption O
in O
the O
gut O
, O
in O
a O
first O
- O
order O
reaction O
, O
as O
followed O
by O
a O
calcium B
electrode O
in O
neutral O
aqueous O
solution O
for O
excess O
of O
calcium B
( I
II I
) I
, O
with O
a O
rate O
constant O
showing O
a O
minimum O
at O
physiological O
ionic O
strength O
of O
0 O
. O
32 O
+ O
/ O
- O
0 O
. O
09 O
d O
( O
- O
1 O
) O
at O
25 O
degrees O
C O
with O
a O
stoichiometry O
of O
1 O
. O
79 O
+ O
/ O
- O
0 O
. O
03 O
, O
lower O
than O
the O
expected O
1 O
: O
2 O
. O

Calcium B
( I
II I
) I
precipitates O
with O
palmitate B
( O
Pal B
( I
- I
) I
) O
, O
a O
process O
affecting O
calcium B
absorption O
in O
the O
gut O
, O
in O
a O
first O
- O
order O
reaction O
, O
as O
followed O
by O
a O
calcium B
electrode O
in O
neutral O
aqueous O
solution O
for O
excess O
of O
calcium B
( I
II I
) I
, O
with O
a O
rate O
constant O
showing O
a O
minimum O
at O
physiological O
ionic O
strength O
of O
0 O
. O
32 O
+ O
/ O
- O
0 O
. O
09 O
d O
( O
- O
1 O
) O
at O
25 O
degrees O
C O
with O
a O
stoichiometry O
of O
1 O
. O
79 O
+ O
/ O
- O
0 O
. O
03 O
, O
lower O
than O
the O
expected O
1 O
: O
2 O
. O

Calcium B
( I
II I
) I
precipitates O
with O
palmitate B
( O
Pal B
( I
- I
) I
) O
, O
a O
process O
affecting O
calcium B
absorption O
in O
the O
gut O
, O
in O
a O
first O
- O
order O
reaction O
, O
as O
followed O
by O
a O
calcium B
electrode O
in O
neutral O
aqueous O
solution O
for O
excess O
of O
calcium B
( I
II I
) I
, O
with O
a O
rate O
constant O
showing O
a O
minimum O
at O
physiological O
ionic O
strength O
of O
0 O
. O
32 O
+ O
/ O
- O
0 O
. O
09 O
d O
( O
- O
1 O
) O
at O
25 O
degrees O
C O
with O
a O
stoichiometry O
of O
1 O
. O
79 O
+ O
/ O
- O
0 O
. O
03 O
, O
lower O
than O
the O
expected O
1 O
: O
2 O
. O

It O
is O
also O
acknowledged O
that O
currents O
through O
Erg1 O
K B
( I
+ I
) I
channels O
in O
cardiac O
myocytes O
are O
important O
for O
electrical O
stability O
of O
the O
heart O
and O
alterations O
in O
its O
activity O
has O
been O
linked O
to O
the O
onset O
of O
a O
potentially O
life O
- O
threatening O
heart O
condition O
named O
long O
QT O
syndrome O
type O
2 O
. O

While O
unformulated O
drug O
exhibited O
poor O
solubility O
( O
0 O
. O
22 O
mu O
g O
/ O
mL O
in O
FaSSGF O
and O
4 O
. O
31 O
mu O
g O
/ O
mL O
in O
FaSSIF O
- O
V2 B
( I
PO4 I
) I
) O
and O
dissolved O
less O
than O
2 O
% O
in O
dissolution O
tests O
, O
the O
solubility O
of O
fenofibrate B
in O
the O
presence O
of O
the O
lipid O
excipients O
increased O
dramatically O
( O
e O
. O
g O
. O
, O
to O
65 O
. O
44 O
mu O
g O
/ O
mL O
in O
the O
presence O
of O
the O
Myritol B
318 I
/ O
TPGS B
/ O
Tween B
80 I
SMEDDS O
) O
and O
there O
was O
an O

Several O
other O
coagulopathic O
and O
myotoxic O
high O
mass O
proteins O
including O
a O
class O
PIII O
snake O
venom O
metalloproteinase O
, O
C O
- O
type O
lectin O
, O
l B
- I
amino I
acid I
oxidase O
, O
acetylcholinesterase O
and O
phospholipase O
B O
were O
also O
identified O
that O
may O
contribute O
to O
the O
overall O
toxicity O
of O
A O
. O
superbus O
venom O
. O

The O
active O
constituents O
of O
the O
plant O
were O
putatively O
identified O
as O
' O
bacosides B
A I
and I
B I
' O
in O
older O
publications O
. O

At O
the O
same O
time O
quality O
of O
many O
extracts O
and O
herbal O
products O
derived O
from O
the O
plant O
is O
still O
being O
determined O
based O
on O
the O
content O
of O
' O
bacosides B
A I
and I
B I
' O
. O

Two O
new O
tirucallane B
triterpenoids I
, O
aquilacallanes B
A I
- I
B I
( O
1 O
- O
2 O
) O
, O
together O
with O
15 O
known O
compounds O
( O
3 O
- O
17 O
) O
were O
isolated O
from O
the O
leaves O
of O
Aquilaria O
sinensis O
. O

The O
thermodynamically O
more O
stable O
[ B
Sc3 I
( I
3 I
, I
5 I
- I
DSB I
) I
2 I
( I
mu I
- I
O2H3 I
) I
( I
mu I
- I
OH I
) I
2 I
( I
H2O I
) I
2 I
] I
( O
from O
now O
on O
, O
( B
O2H3 I
) I
Sc I
- O
MOF O
; O
3 B
, I
5 I
- I
DSB I
= O
3 B
, I
5 I
- I
disulfobenzoic I
acid I
) O
was O
obtained O
as O
a O
pure O
and O
stable O
phase O
. O

It O
was O
impossible O
to O
isolate O
[ B
Sc3 I
( I
3 I
, I
5 I
- I
DSB I
) I
2 I
( I
mu I
- I
OH I
) I
3 I
( I
H2O I
) I
4 I
] I
as O
a O
pure O
phase O
, O
as O
it O
turned O
out O
to O
be O
the O
precursor O
of O
( B
O2H3 I
) I
Sc I
- O
MOF O
. O

Additionally O
, O
a O
third O
compound O
that O
appears O
at O
pH O
between O
3 O
. O
5 O
and O
4 O
, O
[ B
Sc3 I
( I
3 I
, I
5 I
- I
DSB I
) I
( I
mu I
- I
OH I
) I
6 I
( I
H2O I
) I
] I
and O
a O
fourth O
, O
[ B
Sc I
( I
3 I
, I
5 I
- I
DSB I
) I
( I
Phen I
) I
( I
H2O I
) I
] I
( I
H2O I
) I
, O
in O
whose O
formula O
neither O
OH B
groups O
nor O
H3O2 B
( I
- I
) I
anions O
appear O
, O
are O
reported O
for O
comparative O
purposes O
. O

A O
study O
of O
the O
( B
O2H3 I
) I
Sc I
- O
MOF O
electronic O
structure O
, O
and O
some O
heterogeneous O
catalytic O
tests O
in O
cyanosilylation O
of O
aldehydes B
reactions O
, O
are O
also O
reported O
. O

In O
all O
groups O
with O
low O
HDL O
- O
C O
levels O
, O
urinary O
excretion O
of O
17 B
- I
ketogenic I
steroids I
was O
reduced O
by O
33 O
% O
, O
27 O
% O
, O
and O
32 O
% O
compared O
with O
controls O
( O
all O
P O
< O
0 O
. O
04 O
) O
. O

Mastoid O
Obliteration O
Using O
Three O
- O
Dimensional O
Composite O
Scaffolds O
Consisting O
of O
Polycaprolactone B
/ O
beta B
- I
Tricalcium I
Phosphate I
/ O
Collagen O
Nanofibers O
: O
An O
In O
Vitro O
and O
In O
Vivo O
Study O
. O

Areas O
covered O
: O
Carbonic O
anhydrases O
( O
EC O
4 O
. O
2 O
. O
1 O
. O
1 O
) O
are O
ubiquitous O
metalloenzymes O
that O
catalyze O
the O
reversible O
hydration O
/ O
dehydration O
of O
CO2 B
/ O
HCO3 B
( I
- I
) I
, O
respectively O
. O

AAPH B
mediated O
lutein B
fragmented O
ions O
were O
identified O
as O
551 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
- O
H2O B
) O
, O
391 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C22H32O I
) O
and O
276 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C12H20O I
) O
and O
its O
isomers O
as O
13 B
- I
Z I
lutein I
, O
13 B
- I
Z I
zeaxanthin I
, O
13 B
' I
- I
Z I
zeaxanthin I
and O
all B
- I
E I
zeaxanthin I
. O

AAPH B
mediated O
lutein B
fragmented O
ions O
were O
identified O
as O
551 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
- O
H2O B
) O
, O
391 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C22H32O I
) O
and O
276 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C12H20O I
) O
and O
its O
isomers O
as O
13 B
- I
Z I
lutein I
, O
13 B
- I
Z I
zeaxanthin I
, O
13 B
' I
- I
Z I
zeaxanthin I
and O
all B
- I
E I
zeaxanthin I
. O

AAPH B
mediated O
lutein B
fragmented O
ions O
were O
identified O
as O
551 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
- O
H2O B
) O
, O
391 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C22H32O I
) O
and O
276 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C12H20O I
) O
and O
its O
isomers O
as O
13 B
- I
Z I
lutein I
, O
13 B
- I
Z I
zeaxanthin I
, O
13 B
' I
- I
Z I
zeaxanthin I
and O
all B
- I
E I
zeaxanthin I
. O

AAPH B
mediated O
lutein B
fragmented O
ions O
were O
identified O
as O
551 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
- O
H2O B
) O
, O
391 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C22H32O I
) O
and O
276 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C12H20O I
) O
and O
its O
isomers O
as O
13 B
- I
Z I
lutein I
, O
13 B
- I
Z I
zeaxanthin I
, O
13 B
' I
- I
Z I
zeaxanthin I
and O
all B
- I
E I
zeaxanthin I
. O

AAPH B
mediated O
lutein B
fragmented O
ions O
were O
identified O
as O
551 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
- O
H2O B
) O
, O
391 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C22H32O I
) O
and O
276 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C12H20O I
) O
and O
its O
isomers O
as O
13 B
- I
Z I
lutein I
, O
13 B
- I
Z I
zeaxanthin I
, O
13 B
' I
- I
Z I
zeaxanthin I
and O
all B
- I
E I
zeaxanthin I
. O

AAPH B
mediated O
lutein B
fragmented O
ions O
were O
identified O
as O
551 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
- O
H2O B
) O
, O
391 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C22H32O I
) O
and O
276 O
( O
M O
( O
+ O
) O
+ O
H B
( I
+ I
) I
+ O
O2 B
- I
C12H20O I
) O
and O
its O
isomers O
as O
13 B
- I
Z I
lutein I
, O
13 B
- I
Z I
zeaxanthin I
, O
13 B
' I
- I
Z I
zeaxanthin I
and O
all B
- I
E I
zeaxanthin I
. O

The O
successful O
encapsulation O
of O
AuNPs O
within O
poly B
( I
divinylbenzene I
) I
was O
confirmed O
by O
UV O
- O
visible O
spectroscopy O
and O
from O
TEM O
images O
. O

The O
morphological O
changes O
were O
photographed O
based O
on O
staining O
lipid O
accumulation O
by O
Oil B
- I
Red I
O I
in O
RGZ B
( O
1 O
micro O
mol O
/ O
l O
) O
- O
treated O
3T3 O
- O
L1 O
cells O
without O
or O
with O
various O
concentrations O
of O
6 B
- I
gingerol I
on O
differentiation O
day O
8 O
. O

PHARMACODYNAMIC O
EFFECTS O
OF O
A O
D B
- I
AMINO I
ACID I
OXIDASE O
INHIBITOR O
INDICATE O
A O
SPINAL O
SITE O
OF O
ACTION O
IN O
RAT O
MODELS O
OF O
NEUROPATHIC O
PAIN O
. O

Inhibition O
of O
D B
- I
amino I
acid I
oxidase O
( O
DAAO O
) O
activity O
is O
a O
potential O
target O
for O
the O
treatment O
of O
chronic O
pain O
. O

Radiolabeling O
with O
fluorine B
- I
18 I
( O
( B
18 I
) I
F I
) O
facilitated O
production O
of O
2 B
- I
( I
5 I
, I
7 I
- I
diethyl I
- I
2 I
- I
( I
4 I
- I
( I
2 I
- I
[ I
( I
18 I
) I
F I
] I
fluoroethoxy I
) I
phenyl I
) I
pyrazolo I
[ I
1 I
, I
5 I
- I
a I
] I
pyrimidin I
- I
3 I
- I
yl I
) I
- I
N I
, I
N I
- I
diethylacetamide I
( O
( B
18 I
) I
F I
- O
6b O
) O
in O
high O
radiochemical O
yield O
and O
specific O
activity O
. O

Radiolabeling O
with O
fluorine B
- I
18 I
( O
( B
18 I
) I
F I
) O
facilitated O
production O
of O
2 B
- I
( I
5 I
, I
7 I
- I
diethyl I
- I
2 I
- I
( I
4 I
- I
( I
2 I
- I
[ I
( I
18 I
) I
F I
] I
fluoroethoxy I
) I
phenyl I
) I
pyrazolo I
[ I
1 I
, I
5 I
- I
a I
] I
pyrimidin I
- I
3 I
- I
yl I
) I
- I
N I
, I
N I
- I
diethylacetamide I
( O
( B
18 I
) I
F I
- O
6b O
) O
in O
high O
radiochemical O
yield O
and O
specific O
activity O
. O

In O
vivo O
studies O
of O
( B
18 I
) I
F I
- O
6b O
were O
performed O
which O
illuminated O
this O
agent O
as O
an O
improved O
probe O
for O
molecular O
imaging O
of O
TSPO O
- O
expressing O
cancers O
. O

A O
new O
compound O
1 O
( O
named O
botryosphaerin B
F I
) O
, O
along O
with O
other O
three O
known O
compounds O
2 O
( O
13 B
, I
14 I
, I
15 I
, I
16 I
- I
tetranorlabd I
- I
7 I
- I
ene I
- I
19 I
, I
6b I
: I
12 I
, I
17 I
- I
diolide I
) O
, O
3 O
( O
botryosphaerin B
B I
) O
and O
4 O
( O
LL B
- I
Z1271 I
beta I
) O
, O
has O
been O
isolated O
from O
the O
mangrove O
fungus O
Aspergillus O
terreus O
( O
No O
. O
GX7 O
- O
3B O
) O
. O

Baeckein B
E I
, O
a O
new O
bioactive O
C B
- I
methylated I
biflavonoid I
from O
the O
roots O
of O
Baeckea O
frutescens O
. O

A O
phytochemical O
study O
of O
Baeckea O
frutescens O
afforded O
a O
new O
biflavonoid B
named O
as O
baeckein B
E I
( O
1 O
) O
, O
along O
with O
four O
known O
C B
- I
methylated I
flavonols I
, O
baeckeins B
A I
( O
2 O
) O
and O
B O
( O
3 O
) O
, O
6 B
- I
methylquercetin I
( O
6 O
) O
and O
6 B
- I
methylquercetin I
- I
4 I
' I
- I
O I
- I
beta I
- I
d I
- I
glucopyranoside I
( O
7 O
) O
, O
and O
two O
known O
biflavonoids O
baeckeins B
C I
( O
4 O
) O
and O
D O
( O
5 O
) O
. O

Characterization O
of O
the O
first O
K B
( I
+ I
) I
channel O
blockers O
from O
the O
venom O
of O
the O
Moroccan O
scorpion O
Buthus O
occitanus O
Paris O
. O

The O
availability O
of O
a O
large O
variety O
of O
specific O
blockers O
, O
which O
inhibit O
different O
K B
( I
+ I
) I
currents O
, O
would O
help O
to O
elucidate O
their O
differences O
in O
physiological O
function O
. O

Short O
peptide O
toxins O
isolated O
from O
scorpion O
venoms O
are O
able O
to O
block O
voltage O
- O
dependent O
or O
Ca B
( I
2 I
+ I
) I
- O
activated O
K B
( I
+ I
) I
channels O
. O

They O
were O
further O
pharmacologically O
characterized O
by O
competition O
using O
( B
125 I
) I
I I
- O
KTX O
bound O
to O
its O
specific O
binding O
sites O
on O
rat O
brain O
synaptosomes O
. O

A O
single O
component O
( O
4161 O
Da O
) O
inhibited O
totally O
the O
( B
125 I
) I
I I
- O
KTX O
binding O
and O
with O
high O
- O
affinity O
( O
IC50 O
= O
0 O
. O
1 O
nM O
) O
, O
while O
the O
two O
other O
components O
poorly O
competed O
with O
( O
IC50 O
> O
100 O
nM O
) O
. O

The O
mycotoxin B
T I
- I
2 I
inhibits O
hepatic O
cytochrome O
P4503A O
activity O
in O
pigs O
. O

It O
was O
therefore O
the O
aim O
of O
the O
present O
study O
to O
investigate O
the O
effect O
of O
T B
- I
2 I
toxin I
, O
an O
emerging O
and O
potent O
Fusarium O
mycotoxin O
, O
on O
the O
enzymatic O
activity O
of O
cytochrome O
P4503A O
( O
CYP3A O
) O
metabolizing O
enzymes O
in O
the O
liver O
of O
pigs O
. O

In O
addition O
, O
a O
yeast O
- O
derived O
feed O
additive O
that O
claims O
to O
bind O
T B
- I
2 I
toxin I
was O
included O
in O
the O
study O
to O
evaluate O
its O
efficacy O
. O

Our O
results O
demonstrated O
that O
a O
14 O
- O
days O
intake O
of O
T B
- I
2 I
toxin I
contaminated O
feed O
at O
a O
dose O
of O
903 O
mu O
g O
/ O
kg O
feed O
, O
whether O
or O
not O
combined O
with O
the O
mycotoxin O
binder O
, O
results O
in O
a O
substantial O
inhibition O
of O
the O
CYP3A O
activity O
in O
the O
liver O
of O
pigs O
. O

Absorption O
, O
distribution O
, O
metabolism O
, O
and O
excretion O
properties O
of O
two O
unformulated O
model O
siRNAs O
were O
determined O
using O
a O
single O
internal O
[ O
( B
3 I
) I
H I
] O
- O
radiolabeling O
procedure O
, O
where O
the O
full O
- O
length O
oligonucleotides O
were O
radiolabeled O
by O
Br B
/ O
( B
3 I
) I
H I
- O
exchange O
. O

Absorption O
, O
distribution O
, O
metabolism O
, O
and O
excretion O
properties O
of O
two O
unformulated O
model O
siRNAs O
were O
determined O
using O
a O
single O
internal O
[ O
( B
3 I
) I
H I
] O
- O
radiolabeling O
procedure O
, O
where O
the O
full O
- O
length O
oligonucleotides O
were O
radiolabeled O
by O
Br B
/ O
( B
3 I
) I
H I
- O
exchange O
. O

Tissue O
distribution O
, O
excretion O
, O
and O
mass O
balance O
of O
radioactivity O
were O
investigated O
in O
male O
CD O
- O
1 O
mice O
, O
following O
a O
single O
intravenous O
administration O
of O
the O
[ O
( B
3 I
) I
H I
] O
- O
siRNAs O
, O
at O
a O
target O
dose O
level O
of O
5 O
mg O
/ O
kg O
. O

In O
general O
, O
there O
was O
little O
difference O
in O
the O
distribution O
of O
total O
radiolabeled O
components O
after O
administration O
of O
the O
two O
unformulated O
[ O
( B
3 I
) I
H I
] O
- O
siRNAs O
. O

The O
radioactivity O
was O
rapidly O
and O
widely O
distributed O
throughout O
the O
body O
, O
and O
remained O
detectable O
in O
all O
tissues O
investigated O
at O
later O
time O
points O
( O
24 O
and O
48 O
hours O
for O
[ O
( B
3 I
) I
H I
] O
- O
MRP4 O
and O
[ O
( B
3 I
) I
H I
] O
- O
SSB O
siRNA O
, O
respectively O
) O
. O

The O
radioactivity O
was O
rapidly O
and O
widely O
distributed O
throughout O
the O
body O
, O
and O
remained O
detectable O
in O
all O
tissues O
investigated O
at O
later O
time O
points O
( O
24 O
and O
48 O
hours O
for O
[ O
( B
3 I
) I
H I
] O
- O
MRP4 O
and O
[ O
( B
3 I
) I
H I
] O
- O
SSB O
siRNA O
, O
respectively O
) O
. O

A O
nearly O
complete O
mass O
balance O
was O
obtained O
for O
the O
[ O
( B
3 I
) I
H I
] O
- O
SSB O
siRNA O
and O
renal O
excretion O
was O
the O
main O
route O
of O
elimination O
( O
38 O
% O
) O
. O

An O
improved O
potency O
was O
found O
for O
second O
type O
derived O
from O
sulfonylated B
3 I
- I
amindinophenylalanyl I
derivates O
. O

Pooled O
sensitivity O
and O
specificity O
of O
( B
99m I
) I
Tc I
- I
MIBI I
scan O
in O
detecting O
malignant O
thyroid O
nodules O
were O
85 O
. O
1 O
% O
[ O
95 O
% O
confidence O
interval O
( O
95 O
% O
CI O
) O
: O
81 O
. O
1 O
- O
88 O
. O
5 O
% O
] O
and O
45 O
. O
7 O
% O
( O
95 O
% O
CI O
: O
42 O
. O
7 O
- O
48 O
. O
7 O
% O
) O
, O
respectively O
, O
on O
a O
per O
lesion O
- O
based O
analysis O
, O
irrespective O
of O
eventual O
results O
of O
previous O
technetium B
pertechnetate I
( O
( B
99m I
) I
TcO4 I
) O
or O
iodine B
- I
123 I
( O
( B
123 I
) I
I I
) O
scan O
. O

Pooled O
sensitivity O
and O
specificity O
of O
( B
99m I
) I
Tc I
- I
MIBI I
scan O
in O
detecting O
malignant O
thyroid O
nodules O
were O
85 O
. O
1 O
% O
[ O
95 O
% O
confidence O
interval O
( O
95 O
% O
CI O
) O
: O
81 O
. O
1 O
- O
88 O
. O
5 O
% O
] O
and O
45 O
. O
7 O
% O
( O
95 O
% O
CI O
: O
42 O
. O
7 O
- O
48 O
. O
7 O
% O
) O
, O
respectively O
, O
on O
a O
per O
lesion O
- O
based O
analysis O
, O
irrespective O
of O
eventual O
results O
of O
previous O
technetium B
pertechnetate I
( O
( B
99m I
) I
TcO4 I
) O
or O
iodine B
- I
123 I
( O
( B
123 I
) I
I I
) O
scan O
. O

A O
sub O
- O
analysis O
restricted O
to O
data O
on O
hypofunctioning O
nodules O
on O
( B
99m I
) I
TcO4 I
or O
( B
123 I
) I
I I
scans O
was O
performed O
: O
pooled O
sensitivity O
and O
specificity O
of O
( B
99m I
) I
Tc I
- I
MIBI I
scan O
in O
these O
nodules O
were O
82 O
. O
1 O
% O
( O
95 O
% O
CI O
: O
77 O
. O
2 O
- O
86 O
. O
3 O
% O
) O
and O
62 O
. O
8 O
% O
( O
95 O
% O
CI O
: O
58 O
. O
9 O
- O
66 O
. O
7 O
% O
) O
, O
respectively O
, O
on O
a O
per O
lesion O
- O
based O
analysis O
. O

A O
sub O
- O
analysis O
restricted O
to O
data O
on O
hypofunctioning O
nodules O
on O
( B
99m I
) I
TcO4 I
or O
( B
123 I
) I
I I
scans O
was O
performed O
: O
pooled O
sensitivity O
and O
specificity O
of O
( B
99m I
) I
Tc I
- I
MIBI I
scan O
in O
these O
nodules O
were O
82 O
. O
1 O
% O
( O
95 O
% O
CI O
: O
77 O
. O
2 O
- O
86 O
. O
3 O
% O
) O
and O
62 O
. O
8 O
% O
( O
95 O
% O
CI O
: O
58 O
. O
9 O
- O
66 O
. O
7 O
% O
) O
, O
respectively O
, O
on O
a O
per O
lesion O
- O
based O
analysis O
. O

Biological O
evaluation O
revealed O
that O
most O
tested O
compounds O
were O
potent O
dipeptidyl O
peptidase O
4 O
( O
DPP O
- O
4 O
) O
inhibitors O
, O
among O
them O
, O
the O
cyclopropyl B
- I
substituted I
phenylalanine I
derivative O
11h O
displayed O
the O
most O
potent O
DPP O
- O
4 O
inhibitory O
activity O
with O
an O
IC50 O
value O
of O
0 O
. O
247 O
mu O
M O
. O

O B
- I
heterocyclic I
embeurekols I
from O
Embellisia O
eureka O
, O
an O
endophyte O
of O
Cladanthus O
arabicus O
. O

While O
the O
antiendotoxic O
peptide O
GKY25 O
( O
GKYGFYTHVFRLKKWIQKVI O
) O
displayed O
significant O
binding O
to O
both O
LPS O
and O
lipid O
A O
, O
so O
did O
two O
control O
peptides O
with O
either O
selected O
D B
- I
amino I
acid I
substitutions O
or O
with O
maintained O
composition O
but O
scrambled O
sequence O
, O
both O
displaying O
strongly O
attenuated O
antiendotoxic O
effects O
. O

Attenuated O
total O
reflection O
Fourier O
transform O
infrared O
( O
ATR O
- O
FTIR O
) O
spectroscopy O
was O
used O
to O
investigate O
the O
binding O
of O
Na B
( I
+ I
) I
and O
Ca B
( I
2 I
+ I
) I
cations O
to O
bovine O
cytochrome O
c O
oxidase O
in O
its O
fully O
oxidized O
and O
partially O
reduced O
, O
cyanide B
- O
ligated O
( O
a O
( O
2 O
+ O
) O
a3 O
( O
3 O
+ O
) O
- O
CN B
) O
( O
mixed O
valence O
) O
forms O
. O

Dissociation O
constants O
for O
Na B
( I
+ I
) I
and O
Ca B
( I
2 I
+ I
) I
with O
the O
oxidized O
enzyme O
were O
1 O
. O
2 O
mM O
and O
11 O
mu O
M O
, O
respectively O
and O
Na B
( I
+ I
) I
binding O
appeared O
to O
involve O
cooperative O
binding O
of O
two O
Na B
( I
+ I
) I
. O

Dissociation O
constants O
for O
Na B
( I
+ I
) I
and O
Ca B
( I
2 I
+ I
) I
with O
the O
oxidized O
enzyme O
were O
1 O
. O
2 O
mM O
and O
11 O
mu O
M O
, O
respectively O
and O
Na B
( I
+ I
) I
binding O
appeared O
to O
involve O
cooperative O
binding O
of O
two O
Na B
( I
+ I
) I
. O

Dissociation O
constants O
for O
Na B
( I
+ I
) I
and O
Ca B
( I
2 I
+ I
) I
with O
the O
oxidized O
enzyme O
were O
1 O
. O
2 O
mM O
and O
11 O
mu O
M O
, O
respectively O
and O
Na B
( I
+ I
) I
binding O
appeared O
to O
involve O
cooperative O
binding O
of O
two O
Na B
( I
+ I
) I
. O

The O
Na B
( I
+ I
) I
- O
induced O
binding O
spectrum O
showed O
much O
weaker O
amide B
I O
/ O
II O
and O
heme B
a I
changes O
but O
had O
similar O
shifts O
assignable O
to O
carboxylate B
and O
arginine B
residues O
. O

The O
implications O
of O
Ca B
( I
2 I
+ I
) I
/ O
Na B
( I
+ I
) I
ion O
binding O
are O
discussed O
in O
terms O
of O
structure O
and O
possible O
modulation O
of O
core O
catalytic O
function O
. O

A O
- O
site O
binding O
, O
peptidyl O
transferase O
activity O
, O
and O
termination O
of O
peptide O
chain O
synthesis O
underwent O
less O
pronounced O
but O
measurable O
reductions O
, O
a O
finding O
which O
explains O
why O
poly B
( I
Phe I
) I
- O
synthesis O
in O
ribosomes O
isolated O
from O
exposed O
mussels O
is O
reduced O
by O
70 O
% O
. O

Another O
fragment O
, O
3 B
- I
indolepropionic I
acid I
( O
1F1 O
- O
N O
) O
, O
predicted O
by O
AutoDock O
calculations O
and O
confirmed O
in O
a O
novel O
inhibition O
of O
nucleation O
crystallization O
assay O
, O
exploits O
the O
same O
interactions O
in O
the O
flap O
site O
in O
two O
crystal O
structures O
. O

Here O
, O
we O
found O
that O
the O
sensitivity O
of O
Nax O
channels O
to O
[ O
Na B
( I
+ I
) I
] O
o O
is O
dose O
- O
dependently O
enhanced O
by O
endothelin O
- O
3 O
( O
ET O
- O
3 O
) O
. O

Nax O
channels O
began O
to O
open O
when O
[ O
Na B
( I
+ I
) I
] O
o O
exceeded O
~ O
150 O
mM O
without O
ET O
- O
3 O
, O
but O
opened O
fully O
at O
a O
physiological O
[ O
Na B
( I
+ I
) I
] O
o O
( O
135 O
- O
145 O
mM O
) O
with O
1 O
nM O
ET O
- O
3 O
. O

Nax O
channels O
began O
to O
open O
when O
[ O
Na B
( I
+ I
) I
] O
o O
exceeded O
~ O
150 O
mM O
without O
ET O
- O
3 O
, O
but O
opened O
fully O
at O
a O
physiological O
[ O
Na B
( I
+ I
) I
] O
o O
( O
135 O
- O
145 O
mM O
) O
with O
1 O
nM O
ET O
- O
3 O
. O

These O
results O
indicate O
that O
ET O
- O
3 O
expression O
in O
the O
SFO O
is O
tightly O
coupled O
with O
body O
- O
fluid O
homeostasis O
through O
modulation O
of O
the O
[ O
Na B
( I
+ I
) I
] O
o O
sensitivity O
of O
Nax O
. O

Bbil O
- O
TX O
( O
5 O
mu O
g O
/ O
ml O
) O
- O
induced O
blockade O
was O
markedly O
inhibited O
at O
22 O
- O
24 O
degrees O
C O
and O
pretreatment O
with O
p B
- I
bromophenacyl I
bromide I
( O
p B
- I
BPB I
) O
abolished O
the O
neuromuscular O
blockade O
. O

Addition O
of O
10 O
mu O
M O
of O
progesterone B
, O
5 B
alpha I
- I
dihydroprogesterone I
( O
5 B
alpha I
- I
DHP I
) O
or O
allopregnanolone B
( O
3 B
alpha I
, I
5 I
alpha I
- I
tetrahydroprogestero I
) O
to O
the O
medium O
at O
the O
time O
of O
injury O
rescued O
the O
spinal O
cord O
slices O
from O
the O
effects O
of O
damage O
. O

Addition O
of O
10 O
mu O
M O
of O
progesterone B
, O
5 B
alpha I
- I
dihydroprogesterone I
( O
5 B
alpha I
- I
DHP I
) O
or O
allopregnanolone B
( O
3 B
alpha I
, I
5 I
alpha I
- I
tetrahydroprogestero I
) O
to O
the O
medium O
at O
the O
time O
of O
injury O
rescued O
the O
spinal O
cord O
slices O
from O
the O
effects O
of O
damage O
. O

These O
effects O
were O
not O
due O
to O
its O
bioconversion O
to O
5 B
alpha I
- I
DHP I
nor O
to O
allopregnanolone B
, O
as O
supported O
by O
the O
finasteride B
, O
an O
inhibitor O
of O
5 O
alpha O
- O
reductase O
enzymes O
, O
and O
by O
the O
absence O
of O
5 O
alpha O
- O
reduced O
progesterone B
metabolites O
in O
the O
slices O
analyzed O
by O
gas O
chromatography O
- O
mass O
spectrometry O
. O

Its O
effects O
were O
not O
due O
to O
its O
bioconversion O
back O
to O
5 B
alpha I
- I
DHP I
, O
which O
can O
activate O
gene O
transcription O
via O
PR O
, O
because O
they O
were O
still O
observed O
in O
slices O
from O
knockout O
PR O
( O
- O
/ O
- O
) O
mice O
. O

A O
novel O
method O
for O
preparing O
complete O
antigens O
of O
gonyautoxin B
2 I
, I
3 I
and O
their O
feature O
of O
immunogenicity O
. O

Novel O
4 B
- I
( I
4 I
- I
bromophenyl I
) I
phthalazine I
derivatives O
connected O
via O
an O
alkyl B
spacer O
to O
amine B
or O
N B
- I
substituted I
piperazine I
were O
designed O
and O
synthesized O
as O
promising O
alpha O
- O
adrenoceptor O
antagonists O
. O

17 B
beta I
- I
estradiol I
activates O
glucose B
uptake O
via O
GLUT4 O
translocation O
and O
PI3K O
/ O
Akt O
signaling O
pathway O
in O
MCF O
- O
7 O
cells O
. O

This O
study O
was O
designed O
to O
test O
the O
rapid O
effects O
of O
17 B
beta I
- I
estradiol I
( O
E2 O
) O
or O
its O
membrane O
- O
impermeable O
form O
conjugated O
with O
bovine O
serum O
albumin O
( O
E2BSA O
) O
on O
glucose B
uptake O
in O
a O
positive O
estrogen B
receptor O
( O
ER O
) O
breast O
cancer O
cell O
line O
, O
through O
the O
possible O
relationship O
between O
key O
components O
of O
the O
PI3K O
/ O
Akt O
signaling O
pathway O
and O
acute O
steroid B
treatment O
. O

Then O
10nM O
of O
17 B
beta I
- I
estradiol I
or O
estradiol B
BSA O
conjugated O
were O
administrated O
before O
obtaining O
the O
cell O
lysates O
. O

The O
aim O
of O
this O
study O
was O
to O
evaluate O
the O
effect O
of O
long O
- O
chain O
omega B
- I
3 I
polyunsaturated I
fatty I
acid I
( O
n B
- I
3 I
PUFA I
) O
supplementation O
on O
metabolic O
state O
and O
gene O
expression O
in O
subcutaneous O
adipose O
tissues O
of O
obese O
adolescents O
. O

Obese O
adolescents O
( O
n O
= O
26 O
, O
10 O
girls O
and O
16 O
boys O
) O
aged O
12 O
. O
4 O
+ O
/ O
- O
2 O
. O
1 O
years O
were O
assigned O
to O
a O
12 O
- O
week O
regimen O
of O
n B
- I
3 I
PUFA I
intake O
. O

After O
12 O
weeks O
, O
n B
- I
3 I
PUFA I
consumption O
was O
associated O
with O
decreased O
body O
mass O
index O
( O
29 O
. O
7 O
+ O
/ O
- O
4 O
. O
6 O
vs O
. O
27 O
. O
8 O
+ O
/ O
- O
4 O
. O
4 O
kg O
/ O
m O
( O
2 O
) O
; O
P O
< O
0 O
. O
001 O
) O
, O
waist O
circumference O
( O
93 O
. O
2 O
+ O
/ O
- O
9 O
. O
9 O
vs O
. O
90 O
. O
5 O
+ O
/ O
- O
10 O
. O
0 O
cm O
; O
P O
< O
0 O
. O
003 O
) O
, O
hip O
circumference O
( O
102 O
. O
9 O
+ O
/ O
- O
10 O
. O
9 O
vs O
. O
101 O
. O
1 O
+ O
/ O
- O
10 O
. O
9 O
cm O
; O
P O
< O
0 O
. O
014 O
) O
, O

Our O
study O
demonstrated O
that O
n B
- I
3 I
PUFA I
consumption O
and O
dietary O
restriction O
improved O
the O
anthropometric O
parameters O
and O
decreased O
the O
triglycerides B
levels O
of O
the O
adolescents O
, O
suggesting O
a O
reduction O
in O
hypoxia O
in O
subcutaneous O
adipose O
tissue O
. O

Analysis O
of O
the O
reaction O
progress O
by O
powder O
X O
- O
ray O
diffraction O
, O
solid O
- O
state O
( B
13 I
) I
C I
CPMAS O
NMR O
, O
solid O
- O
state O
FTIR O
spectroscopy O
, O
and O
thermal O
analysis O
has O
revealed O
that O
solid O
- O
to O
- O
solid O
reactions O
proceed O
either O
through O
metastable O
phases O
susceptible O
to O
amorphization O
or O
by O
mechanisms O
that O
involve O
a O
reconstructive O
phase O
transition O
that O
culminates O
in O
the O
formation O
of O
the O
stable O
phase O
of O
the O
product O
. O

We O
hypothesize O
that O
organic O
deposition O
results O
from O
the O
interaction O
of O
Mo B
( I
VI I
) I
with O
proteins O
in O
the O
surrounding O
solution O
. O

The O
photocytotoxicity O
of O
BaP B
, O
3 B
- I
OH I
- I
BaP I
, O
BaP B
t I
- I
7 I
, I
8 I
- I
diol I
, O
BaP B
trans I
- I
7 I
, I
8 I
- I
diol I
- I
anti I
- I
9 I
, I
10 I
- I
epoxide I
( O
BPDE B
) O
, O
and O
BaP B
( I
7 I
, I
10 I
/ I
8 I
, I
9 I
) I
tetrol I
in O
the O
HaCaT O
keratinocytes O
was O
examined O
. O

U B
- I
73122 I
, O
a O
phospholipase O
C O
( O
PLC O
) O
inhibitor O
, O
and O
2 B
- I
aminoethoxydiphenyl I
borate I
, O
an O
inositol B
1 I
, I
4 I
, I
5 I
trisphosphate I
( O
IP3 O
) O
receptor O
antagonist O
, O
attenuated O
hUII O
- O
induced O
MAP O
and O
RVR O
elevations O
, O
RBF O
and O
CBF O
reductions O
, O
but O
not O
MBF O
increase O
. O

The O
cytotoxic O
activity O
of O
the O
encapsulated O
cyclic B
dipeptides I
was O
tested O
against O
HeLa O
, O
low O
folate B
HeLa O
and O
MCF O
- O
7 O
cells O
and O
found O
to O
have O
limited O
improvement O
in O
activity O
. O

Leydig O
cells O
were O
treated O
with O
two O
concentrations O
of O
OP O
( O
10 O
( O
- O
4 O
) O
M O
, O
10 O
( O
- O
8 O
) O
M O
) O
alone O
or O
concomitantly O
with O
anti O
- O
estrogen B
ICI B
182 I
, I
780 I
( O
1 O
mu O
M O
) O
. O

1 B
, I
3 I
, I
4 I
- I
Oxadiazol I
- I
2 I
- I
ones I
as O
fatty B
- I
acid I
amide I
hydrolase O
and O
monoacylglycerol B
lipase O
inhibitors O
: O
Synthesis O
, O
in O
vitro O
evaluation O
and O
insight O
into O
potency O
and O
selectivity O
determinants O
by O
molecular O
modelling O
. O

We O
examined O
the O
concentration O
dependency O
and O
mechanism O
of O
action O
of O
DPHD B
relative O
to O
17 B
beta I
- I
estradiol I
in O
nontransformed O
human O
osteoblasts O
( O
h O
- O
OB O
) O
. O

Subsequently O
, O
DPHD B
accelerated O
production O
of O
bone O
structural O
genes O
, O
including O
COL1A1 O
and O
osteocalcin O
comparably O
to O
17 B
beta I
- I
estradiol I
. O

In O
h O
- O
OB O
, O
DPHD B
increased O
the O
osteoprotegerin O
to O
RANKL O
ratio O
and O
supported O
mineralization O
more O
efficiently O
than O
10nM O
17 B
beta I
- I
estradiol I
. O

Modeling O
the O
Conformational O
Preference O
of O
the O
Carbon B
- O
Bonded O
Covalent O
Adduct O
Formed O
upon O
Exposure O
of O
2 B
' I
- I
Deoxyguanosine I
to O
Ochratoxin B
A I
. O

A O
focus O
was O
placed O
on O
the O
influence O
of O
the O
C8 O
- O
modification O
of O
2 B
' I
- I
deoxyguanosine I
( O
dG O
) O
on O
the O
preferred O
relative O
arrangement O
of O
the O
nucleobase B
and O
the O
C8 O
- O
substituent O
and O
, O
more O
importantly O
, O
the O
anti O
/ O
syn O
conformational O
preference O
with O
respect O
to O
the O
glycosidic O
bond O
. O

Inclusion O
of O
the O
5 B
' I
- I
monophosphate I
group O
leads O
to O
an O
up O
to O
20 O
kJ O
mol O
( O
- O
1 O
) O
preference O
for O
the O
syn B
( I
nucleotide I
) I
conformation O
due O
to O
stabilizing O
base O
- O
phosphate B
interactions O
involving O
the O
amino B
group O
of O
guanine B
. O

Inclusion O
of O
the O
5 B
' I
- I
monophosphate I
group O
leads O
to O
an O
up O
to O
20 O
kJ O
mol O
( O
- O
1 O
) O
preference O
for O
the O
syn B
( I
nucleotide I
) I
conformation O
due O
to O
stabilizing O
base O
- O
phosphate B
interactions O
involving O
the O
amino B
group O
of O
guanine B
. O

Mycoleptodiscins B
A I
and I
B I
, O
Cytotoxic O
Alkaloids O
from O
the O
Endophytic O
Fungus O
Mycoleptodiscus O
sp O
. O

Novel O
films O
of O
ethylene B
- I
vinyl I
alcohol I
copolymer O
( O
EVOH B
) O
containing O
flavonoid B
- O
rich O
cocoa O
were O
developed O
. O

Histamine B
, O
putrescine B
cadaverine B
and O
cis B
- I
urocanic I
acid I
( O
UCA B
) O
have O
all O
been O
implicated O
or O
suggested O
in O
scombroid O
fish O
poisoning O
. O

The O
structure O
of O
galactan O
- O
rich O
RG O
I O
was O
confirmed O
by O
H B
( I
1 I
) I
NMR O
spectroscopy O
analysis O
. O

The O
seed O
oils O
from O
pea O
samples O
contained O
palmitic B
and I
stearic I
acids I
as O
major O
saturated B
fatty I
acids I
. O

All O
A O
. O
nomius O
and O
A O
. O
parasiticus O
isolates O
produced O
aflatoxins B
B I
and I
G I
, O
but O
not O
cyclopiazonic B
acid I
( O
CPA B
) O
. O

A O
series O
of O
novel O
ureido B
- I
sulfonamides I
was O
prepared O
by O
reaction O
of O
aminobenzenesulfonam B
with O
alkyl B
/ I
aryl I
isocyanate I
. O

Oil B
- I
red I
O I
staining O
and O
Lipid O
Analysis O
were O
employed O
to O
measure O
cellular O
content O
of O
triacylglycerides B
( O
TAG B
) O
and O
cholesterol B
. O

( B
1 I
) I
H I
NMR O
- O
based O
metabonomic O
analysis O
of O
the O
serum O
and O
urine O
of O
rats O
following O
subchronic O
exposure O
to O
dichlorvos B
, O
deltamethrin B
, O
or O
a O
combination O
of O
these O
two O
pesticides O
. O

In O
this O
study O
, O
we O
used O
single O
photon O
emission O
computed O
tomography O
( O
SPECT O
) O
to O
characterize O
the O
kinetics O
of O
extravasation O
of O
( B
111 I
) I
In I
- O
labeled O
bovine O
serum O
albumin O
( O
BSA O
) O
, O
a O
model O
macromolecular O
drug O
, O
in O
muscle O
treated O
with O
fUS O
and O
MBs O
. O

Six O
new O
sesquiterpenoids B
, O
aristoyunnolins B
A I
- I
F I
( O
1 O
- O
6 O
) O
, O
an O
artifact O
of O
isolation O
[ O
7 B
- I
O I
- I
ethyl I
madolin I
W I
( O
7 O
) O
] O
, O
and O
12 O
known O
analogues O
were O
isolated O
from O
stems O
of O
Aristolochia O
yunnanensis O
. O

Stable O
colloidal O
particles O
( O
< O
350nm O
) O
containing O
drug O
, O
polyvinylpyrrolidone B
( B
PVP I
) I
K12 I
and O
sodium B
dodecyl I
sulfate I
( O
SDS B
) O
in O
1 O
: O
2 O
. O
75 O
: O
0 O
. O
25 O
ratio O
were O
produced O
after O
2h O
of O
co O
- O
grinding O
. O

In O
the O
present O
study O
, O
a O
chemical O
derivatization O
of O
isomeric O
hydroxylated O
metabolites O
with O
2 B
- I
fluoro I
- I
N I
- I
methyl I
pyridinium I
p I
- I
toluenesulfonate I
was O
found O
to O
confer O
distinct O
theoretical O
CCS O
value O
on O
each O
isomer O
by O
forming O
corresponding O
N B
- I
methyl I
pyridine I
( O
NMP B
) O
derivative O
. O

Three O
metal O
complexes O
consisting O
of O
Li B
( I
+ I
) I
, O
Zn B
( I
2 I
+ I
) I
, O
and O
Al B
( I
3 I
+ I
) I
and O
quinolinol B
- I
functionalized I
l I
- I
glutamides I
( O
HQLG B
) O
, O
( O
abbreviated O
as O
LiHQLG B
, O
Zn B
( I
HQLG I
) I
2 I
, O
and O
Al B
( I
HQLG I
) I
3 I
) O
were O
found O
to O
form O
fluorescent O
metallogels O
in O
several O
organic O
solvents O
. O

Effects O
of O
17 B
alpha I
- I
ethynylestradiol I
- O
induced O
cholestasis O
on O
the O
pharmacokinetics O
of O
doxorubicin B
in O
rats O
: O
reduced O
biliary O
excretion O
and O
hepatic O
metabolism O
of O
doxorubicin B
. O

Since O
the O
prevalent O
hormonal O
combination O
therapy O
with O
estrogen B
analogues O
in O
cancer O
patients O
has O
frequency O
and O
possibility O
to O
induce O
the O
cholestasis O
, O
the O
frequent O
combination O
therapy O
with O
17 B
alpha I
- I
ethynylestradiol I
( O
EE O
, O
an O
oral O
contraceptive O
) O
and O
doxorubicin B
( O
an O
anticancer O
drug O
) O
might O
be O
monitored O
in O
aspect O
of O
efficacy O
and O
safety O
. O

In O
addition O
, O
we O
found O
that O
an O
oxygen B
extraction O
reaction O
by O
a O
CO B
molecule O
actually O
occurs O
for O
oxygen B
- O
rich O
clusters O
such O
as O
Ni6O7 B
( I
+ I
) I
and O
Ni8O9 B
( I
+ I
) I
. O

In O
addition O
, O
we O
found O
that O
an O
oxygen B
extraction O
reaction O
by O
a O
CO B
molecule O
actually O
occurs O
for O
oxygen B
- O
rich O
clusters O
such O
as O
Ni6O7 B
( I
+ I
) I
and O
Ni8O9 B
( I
+ I
) I
. O

A O
statistical O
approach O
for O
analyzing O
the O
development O
of O
( B
1 I
) I
H I
multiple O
- O
quantum O
coherence O
in O
solids O
. O

A O
novel O
statistical O
approach O
for O
analyzing O
( B
1 I
) I
H I
multiple O
- O
quantum O
( O
MQ O
) O
spin O
dynamics O
in O
so O
- O
called O
spin O
- O
counting O
solid O
- O
state O
NMR O
experiments O
is O
presented O
. O

The O
statistical O
approach O
is O
based O
on O
the O
percolation O
theory O
with O
Monte O
Carlo O
methods O
and O
is O
examined O
by O
applying O
it O
to O
the O
experimental O
results O
of O
three O
solid O
samples O
having O
unique O
hydrogen B
arrangement O
for O
1 O
- O
3 O
dimensions O
: O
the O
n B
- I
alkane I
/ O
d B
- I
urea I
inclusion O
complex O
as O
a O
one O
- O
dimensional O
( O
1D O
) O
system O
, O
whose O
( B
1 I
) I
H I
nuclei O
align O
approximately O
in O
1D O
, O
and O
magnesium B
hydroxide I
and O
adamantane B
as O
a O
two O
- O
dimensional O
( O
2D O
) O
and O
a O
three O
- O
dimensional O
( O
3D O
) O
system O
, O
respectively O
. O

Four O
lattice O
models O
, O
linear O
, O
honeycomb O
, O
square O
and O
cubic O
, O
are O
used O
to O
represent O
the O
( B
1 I
) I
H I
arrangement O
of O
the O
three O
samples O
. O

It O
is O
shown O
that O
a O
more O
realistic O
model O
representing O
the O
( B
1 I
) I
H I
arrangement O
of O
n B
- I
C20H42 I
/ O
d B
- I
urea I
can O
describe O
the O
result O
. O

The O
present O
approach O
can O
thus O
be O
used O
to O
determine O
( B
1 I
) I
H I
arrangement O
in O
solids O
. O

A O
sub O
- O
monolayer O
distribution O
of O
isolated O
molecular O
Fe14 B
( I
bta I
) I
6 I
nanomagnets O
is O
deposited O
intact O
on O
a O
Au B
( I
111 I
) I
surface O
and O
investigated O
by O
X O
- O
ray O
magnetic O
circular O
dichroism O
spectroscopy O
. O

( B
Aminoalkyl I
) I
fluoroindole I
derivatives O
were O
detected O
to O
be O
very O
potent O
MPO O
inhibitors O
; O
however O
, O
they O
also O
promote O
inhibition O
of O
the O
serotonin B
reuptake O
transporter O
( O
SERT O
) O
at O
the O
same O
concentration O
range O
. O

Two O
different O
dyes O
, O
1 B
- I
aminomethylpyrene I
( O
AMP B
) O
and O
5 B
- I
azidofluorescein I
( O
AF O
) O
, O
were O
covalently O
attached O
to O
the O
polymer O
brushes O
through O
aminolysis O
and O
dual O
desilylation O
/ O
copper B
( I
I I
) I
- O
catalyzed O
alkyne B
/ O
azide B
cycloaddition O
( O
CuAAC O
) O
in O
one O
pot O
. O

Although O
a O
2 O
nm O
thickness O
increase O
was O
observed O
for O
poly B
( I
PFPA I
) I
brushes O
after O
polymerization O
of O
TMSES B
, O
cross O
- O
contamination O
was O
not O
visible O
through O
fluorescence O
microscopy O
after O
functionalization O
. O

Isolated O
myofibers O
took O
up O
ethidium B
( O
Etd B
( I
+ I
) I
) O
and O
released O
small O
molecules O
( O
as O
ATP B
) O
during O
electrical O
stimulation O
. O

ATP B
release O
, O
Etd B
( I
+ I
) I
uptake O
, O
and O
potentiation O
induced O
by O
repetitive O
electrical O
stimulation O
were O
blocked O
by O
HC O
blockers O
and O
did O
not O
occur O
in O
muscles O
of O
pannexin1 O
knockout O
mice O
. O

Quantitative O
autoradiography O
was O
used O
to O
measure O
cytisine B
- O
sensitive O
[ B
( I
125 I
) I
I I
] I
epibatidine I
and O
[ O
( B
125 I
) I
I I
] O
alpha O
- O
bungarotoxin O
binding O
to O
alpha O
4 O
beta O
2 O
* O
and O
alpha O
7 O
nAChRs O
, O
respectively O
, O
in O
brain O
sections O
of O
drug O
- O
na O
i O
ve O
( O
n O
= O
6 O
) O
or O
nicotine B
treated O
( O
n O
= O
5 O
- O
7 O
) O
, O
wild O
- O
type O
and O
adenosine B
A2AR O
knockout O
mice O
. O

Effects O
of O
Dietary O
Factors O
on O
the O
Pharmacokinetics O
of O
( B
58 I
) I
Fe I
- O
labeled O
Hemin B
After O
Oral O
Administration O
in O
Normal O
Rats O
and O
the O
Iron B
- O
deficient O
Rats O
. O

In O
this O
study O
, O
a O
rapid O
, O
sensitive O
, O
and O
specific O
ICP O
- O
MS O
method O
for O
the O
determination O
of O
( B
58 I
) I
Fe I
originating O
from O
hemin B
in O
rat O
plasma O
was O
developed O
and O
a O
rat O
model O
of O
iron B
deficiency O
anemia O
was O
established O
. O

Mechanisms O
underlying O
the O
antisecretory O
action O
were O
studied O
through O
gastric O
H B
( I
+ I
) I
, O
K B
( I
+ I
) I
- O
ATPase O
activity O
of O
highly O
purified O
rabbit O
gastric O
microsomes O
and O
pylorus O
ligature O
method O
in O
rats O
. O

Mechanisms O
underlying O
the O
antisecretory O
action O
were O
studied O
through O
gastric O
H B
( I
+ I
) I
, O
K B
( I
+ I
) I
- O
ATPase O
activity O
of O
highly O
purified O
rabbit O
gastric O
microsomes O
and O
pylorus O
ligature O
method O
in O
rats O
. O

In O
vitro O
, O
the O
DFPT O
and O
piplartine B
inhibited O
the O
H B
( I
+ I
) I
, O
K B
( I
+ I
) I
- O
ATPase O
activity O
and O
, O
in O
vivo O
DFPT O
and O
piplartine B
also O
reduced O
basal O
gastric O
acid O
secretion O
, O
as O
well O
as O
that O
stimulated O
by O
pentagastrin B
. O

In O
vitro O
, O
the O
DFPT O
and O
piplartine B
inhibited O
the O
H B
( I
+ I
) I
, O
K B
( I
+ I
) I
- O
ATPase O
activity O
and O
, O
in O
vivo O
DFPT O
and O
piplartine B
also O
reduced O
basal O
gastric O
acid O
secretion O
, O
as O
well O
as O
that O
stimulated O
by O
pentagastrin B
. O

PURPOSE O
: O
Recent O
studies O
in O
patients O
with O
inflammatory O
bowel O
diseases O
( O
IBD O
) O
on O
thiopurine B
therapy O
suggest O
that O
too O
low O
6 B
- I
thioguanine I
nucleotide I
concentrations O
( O
6 B
- I
TGN I
) O
and O
too O
high O
methylmercaptopurine B
nucleotide I
concentrations O
( O
MMPN B
) O
can O
be O
reversed O
by O
a O
combination O
therapy O
of O
allopurinol B
and O
low O
- O
dose O
thiopurines B
. O

Protective O
effects O
of O
caffeic B
acid I
phenethyl I
ester I
on O
dose O
- O
dependent O
intoxication O
of O
rats O
with O
paraquat B
. O

We O
aimed O
to O
investigate O
the O
protective O
effects O
of O
different O
doses O
of O
caffeic B
acid I
phenethyl I
ester I
( O
CAPE B
) O
on O
PQ O
- O
intoxicated O
rats O
. O
Materials O
and O
methods O
: O
A O
total O
of O
80 O
rats O
were O
divided O
into O
the O
following O
eight O
groups O
, O
comprising O
10 O
rats O
in O
each O
group O
: O
group O
1 O
: O
control O
; O
group O
2 O
: O
administered O
with O
CAPE B
( O
10 O
micro O
mol O
/ O
kg O
) O
; O
group O
3 O
: O
administered O
with O
15 O
mg O
/ O
kg O
PQ O
( O
PQ15 O
group O
) O
; O
group O
4 O
: O
administered O
with O
30 O
mg O
/ O
kg O
PQ O
( O
PQ30 O
group O
) O
; O
group O
5 O
: O
administered O
with O
45 O
mg O
/ O
kg O

12 B
- I
Hydroxystearic I
acid I
( O
12 B
- I
HSA I
) O
xerogels O
derived O
from O
12 B
- I
HSA I
- O
acetronitrile B
organogels O
are O
highly O
effective O
sorbent O
materials O
capable O
of O
adsorbing O
apolar O
, O
spilled O
materials O
in O
aqueous O
environments O
. O

Invertebrate O
gamma B
- I
aminobutyric I
acid I
( O
GABA B
) O
- O
gated O
chloride B
channels O
( O
GABACls O
) O
and O
glutamate B
- O
gated O
chloride B
channels O
( O
GluCls O
) O
, O
which O
function O
as O
inhibitory O
neurotransmitter O
receptors O
, O
are O
important O
targets O
of O
insecticides O
and O
antiparasitic O
agents O
. O

Synthesis O
and O
antibacterial O
evaluation O
of O
a O
novel O
series O
of O
10 B
- I
hydroxyl I
ketolide I
derivatives O
. O

A O
novel O
series O
of O
10 B
- I
hydroxyl I
ketolide I
derivatives O
were O
synthesized O
, O
during O
which O
a O
distinctive O
intermediate O
, O
3 B
- I
O I
- I
descladinosyl I
- I
3 I
- I
oxo I
- I
11 I
- I
deoxy I
- I
10 I
, I
11 I
- I
epoxy I
- I
6 I
- I
O I
- I
methylerythromycin I
A I
, O
was O
obtained O
from O
6 B
- I
O I
- I
methylerythromycin I
A I
. O

The O
increase O
in O
free O
silver B
ion O
- O
to O
- O
seed O
ratio O
( O
Ag B
( I
+ I
) I
/ O
Ag B
( I
0 I
) I
) O
resulted O
in O
changes O
of O
particle O
shape O
from O
spherical O
to O
pseudo O
- O
spherical O
and O
minor O
cylindrical O
shape O
. O

The O
increase O
in O
free O
silver B
ion O
- O
to O
- O
seed O
ratio O
( O
Ag B
( I
+ I
) I
/ O
Ag B
( I
0 I
) I
) O
resulted O
in O
changes O
of O
particle O
shape O
from O
spherical O
to O
pseudo O
- O
spherical O
and O
minor O
cylindrical O
shape O
. O

The O
mechanism O
of O
formation O
of O
benzene B
rings O
during O
the O
pyrolysis O
of O
dichloro B
- I
and I
trichloroethylene I
has O
been O
investigated O
by O
the O
method O
of O
Laser O
Powered O
Homogeneous O
Pyrolysis O
coupled O
with O
product O
analysis O
by O
gas O
chromatography O
. O

Eleven O
new O
diterpenes B
, O
named O
decandrins B
A I
- I
K I
( O
1 O
- O
11 O
) O
, O
including O
nine O
abietanes B
( O
1 O
- O
9 O
) O
and O
two O
podocarpanes B
( O
10 O
- O
11 O
) O
, O
were O
isolated O
from O
the O
barks O
of O
an O
Indian O
mangrove O
, O
Ceriops O
decandra O
, O
collected O
in O
the O
mangrove O
swamp O
of O
Godavari O
estuary O
, O
Andhra O
Pradesh O
, O
together O
with O
four O
known O
abietanes B
. O

Two O
spin O
states O
of O
such O
Mn6 B
complexes O
are O
explored O
, O
namely O
the O
ferromagnetically O
coupled O
configuration O
of O
the O
six O
Mn B
( I
III I
) I
cations O
, O
leading O
to O
the O
S O
= O
12 O
ground O
state O
, O
and O
the O
low O
S O
= O
4 O
spin O
state O
. O

Two O
new O
isoflavone B
glycosides I
, O
ammopiptanosides B
A I
and I
B I
, O
have O
been O
isolated O
from O
the O
95 O
% O
EtOH B
extract O
of O
the O
twigs O
of O
Ammopiptanthus O
nanus O
( O
M O
. O
Pop O
. O
) O
Cheng O
f O
. O
, O
together O
with O
six O
known O
compounds O
, O
and O
their O
structures O
were O
characterized O
by O
spectroscopic O
methods O
and O
compared O
with O
the O
data O
in O
the O
literature O
. O

Three O
new O
sulfated B
triterpene I
glycosides I
, O
asprellanosides B
C I
- I
E I
( O
1 O
- O
3 O
) O
, O
were O
isolated O
from O
the O
roots O
of O
Ilex O
asprella O
. O

Finally O
, O
EDTA B
- I
bis I
( I
tyramide I
) I
labeled O
with O
( B
99m I
) I
Tc I
to O
investigate O
its O
in O
- O
vivo O
radiopharmaceutical O
efficiency O
, O
having O
97 O
% O
binding O
affinity O
with O
98 O
% O
radiochemical O
purity O
. O

This O
paper O
reviews O
our O
current O
knowledge O
of O
the O
beneficial O
nutrient O
composition O
of O
seafood O
, O
in O
particular O
omega B
- I
3 I
fatty I
acids I
, O
selenium B
, O
taurine B
, O
vitamins B
D I
and I
B12 I
, O
in O
the O
context O
of O
the O
development O
of O
environmentally O
sustainable O
aquaculture O
. O

Adding O
ethylene B
glycol I
( O
EG O
) O
to O
poly B
( I
3 I
, I
4 I
- I
ethylenedioxythiophe I
) I
: O
poly B
( I
styrenesulfonate I
) I
( O
PEDOT B
: O
PSS B
) O
solution O
improves O
the O
crystallinity O
of O
the O
PEDOT B
and O
the O
ordering O
of O
the O
PEDOT B
nanocrystals O
in O
solid O
films O
. O

Synaptotagmin O
1 O
is O
required O
for O
vesicular O
Ca B
( I
2 I
+ I
) I
/ O
H B
( I
+ I
) I
- O
antiport O
activity O
. O

A O
low O
- O
affinity O
Ca B
( I
2 I
+ I
) I
/ O
H B
( I
+ I
) I
- O
antiport O
was O
described O
in O
the O
membrane O
of O
mammalian O
brain O
synaptic O
vesicles O
. O

Here O
, O
we O
report O
that O
synaptotagmin O
- O
1 O
is O
necessary O
for O
expression O
of O
the O
vesicular O
Ca B
( I
2 I
+ I
) I
/ O
H B
( I
+ I
) I
- O
antiport O
. O

We O
measured O
Ca B
( I
2 I
+ I
) I
/ O
H B
( I
+ I
) I
- O
antiport O
activity O
in O
vesicles O
and O
granules O
of O
pheochromocytoma O
PC12 O
cells O
by O
three O
methods O
: O
( O
1 O
) O
Ca B
( I
2 I
+ I
) I
- O
induced O
dissipation O
of O
the O
vesicular O
H B
( I
+ I
) I
- O
gradient O
; O
( O
2 O
) O
bafilomycin B
- O
sensitive O
calcium B
accumulation O
and O
( O
3 O
) O
pH O
- O
jump O
- O
induced O
calcium B
accumulation O
. O

We O
measured O
Ca B
( I
2 I
+ I
) I
/ O
H B
( I
+ I
) I
- O
antiport O
activity O
in O
vesicles O
and O
granules O
of O
pheochromocytoma O
PC12 O
cells O
by O
three O
methods O
: O
( O
1 O
) O
Ca B
( I
2 I
+ I
) I
- O
induced O
dissipation O
of O
the O
vesicular O
H B
( I
+ I
) I
- O
gradient O
; O
( O
2 O
) O
bafilomycin B
- O
sensitive O
calcium B
accumulation O
and O
( O
3 O
) O
pH O
- O
jump O
- O
induced O
calcium B
accumulation O
. O

The O
results O
were O
congruent O
and O
highly O
significant O
: O
Ca B
( I
2 I
+ I
) I
/ O
H B
( I
+ I
) I
- O
antiport O
activity O
is O
detectable O
only O
in O
acidic O
organelles O
expressing O
functional O
synaptotagmin O
- O
1 O
. O

In O
contrast O
, O
synaptotagmin O
- O
1 O
- O
deficient O
cells O
- O
and O
cells O
where O
transgenically O
encoded O
synaptotagmin O
- O
1 O
was O
acutely O
photo O
- O
inactivated O
- O
were O
devoid O
of O
any O
Ca B
( I
2 I
+ I
) I
/ O
H B
( I
+ I
) I
- O
antiport O
activity O
. O

Therefore O
, O
in O
addition O
to O
its O
previously O
described O
functions O
, O
synaptotagmin O
- O
1 O
is O
involved O
in O
a O
rapid O
vesicular O
Ca B
( I
2 I
+ I
) I
sequestration O
through O
a O
Ca B
( I
2 I
+ I
) I
/ O
H B
( I
+ I
) I
antiport O
. O

Antimicrobial O
and O
demelanizing O
activity O
of O
Ganoderma O
lucidum O
extract O
, O
p B
- I
hydroxybenzoic I
and I
cinnamic I
acids I
and O
their O
synthetic O
acetylated B
glucuronide I
methyl I
esters I
. O

Synthesis O
and O
antiprogestational O
properties O
of O
novel O
17 B
- I
fluorinated I
steroids I
. O

In O
the O
present O
study O
, O
we O
chemically O
synthesized O
novel O
17 B
- I
fluorinated I
steroids I
and O
evaluated O
the O
cytotoxicity O
profiles O
of O
these O
compounds O
in O
T47D O
breast O
cancer O
cells O
compared O
to O
the O
activity O
of O
known O
antiprogestins B
, O
including O
ZK230 B
211 I
, O
RU B
- I
486 I
, O
CDB2914 B
, O
CDB4124 B
and O
ORG33628 B
. O

Proteins O
identified O
of O
the O
naphthalene B
degradation O
pathway O
showed O
a O
relative O
( B
13 I
) I
C I
isotope O
abundance O
of O
approximately O
50 O
atom O
% O
demonstrating O
that O
the O
identified O
naphthalene B
degrading O
bacteria O
gained O
at O
least O
80 O
% O
of O
their O
carbon B
by O
PAH B
degradation O
. O

More O
generally O
, O
our O
proposed O
mechanism O
for O
the O
reactivity O
of O
the O
gold O
/ O
TiO2 B
interface O
should O
hold O
for O
oxidation O
of O
organic O
molecules O
with O
the O
structure O
of O
R B
- I
O I
- I
R I
' I
, O
where O
R O
and O
R O
' O
are O
( B
saturated I
) I
hydrocarbons I
. O

The O
plasma O
levels O
of O
linoleic B
acid I
, O
alpha B
- I
linolenic I
acid I
, O
palmitic B
acid I
and O
oleic B
acid I
were O
higher O
in O
the O
pregnant O
control O
mPPARa O
mice O
than O
in O
Ppara O
- O
null O
and O
hPPARa O
mice O
. O

DEHP B
exposure O
slightly O
increased O
hepatic O
arachidonic B
acid I
, O
alpha B
- I
linolenic I
acid I
, O
palmitoleic B
acid I
and O
oleic B
acid I
in O
fetuses O
, O
but O
not O
in O
pups O
. O

Two O
new O
vinblastine B
- O
type O
N B
- I
oxide I
alkaloids I
from O
Catharanthus O
roseus O
. O

Two O
new O
vinblastine B
- O
type O
N B
- I
oxide I
alkaloids I
, O
17 B
- I
desacetoxyvinblastin I
[ O
Formula O
: O
see O
text O
] O
- O
oxide B
( O
1 O
) O
and O
20 B
' I
- I
deoxyvinblastine I
[ O
Formula O
: O
see O
text O
] O
- O
oxide B
( O
2 O
) O
, O
were O
isolated O
from O
the O
leaves O
of O
Catharanthus O
roseus O
. O

Two O
new O
vinblastine B
- O
type O
N B
- I
oxide I
alkaloids I
, O
17 B
- I
desacetoxyvinblastin I
[ O
Formula O
: O
see O
text O
] O
- O
oxide B
( O
1 O
) O
and O
20 B
' I
- I
deoxyvinblastine I
[ O
Formula O
: O
see O
text O
] O
- O
oxide B
( O
2 O
) O
, O
were O
isolated O
from O
the O
leaves O
of O
Catharanthus O
roseus O
. O

A O
redox O
- O
active O
phospholipid O
polymer O
with O
a O
phospholipid O
- O
mimicking O
structure O
( O
2 B
- I
methacryloyloxyethyl I
phosphorylcholine I
; O
MPC B
) O
was O
synthesized O
to O
construct O
a O
biocompatible O
electron O
mediator O
between O
bacteria O
and O
an O
electrode O
. O

X O
- O
ray O
structure O
analysis O
of O
a O
solid O
solution O
of O
milbemycins B
A3 I
and I
A4 I
. O

Milbemycins B
A3 I
and I
A4 I
are O
pharmaceutically O
and O
agriculturally O
useful O
macrolides O
isolated O
from O
Streptomyces O
species O
. O

Site O
- O
specific O
and O
Far O
- O
Red O
Light O
- O
Activatable O
Prodrug O
of O
Combretastain B
A I
- I
4 I
Using O
Photo O
- O
Unclick O
Chemistry O
. O

A O
prodrug O
of O
combretastatin B
A I
- I
4 I
( O
CA4 B
) O
was O
prepared O
, O
CMP B
- I
L I
- I
CA4 I
: O
CMP B
( O
dithiaporphyrin B
, O
a O
photosensitizer O
) O
and O
L O
( O
aminoacrylate B
linker O
) O
. O

This O
extract O
afforded O
six O
new O
isoflavonoids B
, O
sedonans B
A I
- I
F I
( O
1 O
- O
6 O
) O
, O
a O
new O
but B
- I
2 I
- I
enolide I
, O
4 B
' I
- I
O I
- I
methylpuerol I
A I
( O
7 O
) O
, O
and O
the O
new O
pterocarpan O
ent B
- I
sandwicensin I
( O
8 O
) O
. O

Sedonans B
A I
- I
F I
and O
ent B
- I
sandwicensin I
were O
also O
active O
against O
Saccharomyces O
cerevisiae O
strains O
that O
express O
differing O
ABC O
transporter O
- O
associated O
resistance O
mechanisms O
but O
differed O
in O
their O
susceptibility O
to O
Cdr1p O
- O
mediated O
detoxification O
. O

Anti O
- O
HIV O
and O
NO B
production O
inhibition O
activities O
of O
epi B
- I
aleuritolic I
acid I
derivatives O
. O

Fifteen O
epi B
- I
aleuritolic I
acid I
derivatives O
were O
synthesized O
and O
evaluated O
for O
anti O
- O
HIV O
activity O
in O
293 O
T O
cells O
and O
NO B
production O
inhibition O
activity O
. O

Increased O
levels O
of O
free B
fatty I
acids I
( O
FFAs B
) O
, O
specifically O
saturated B
free I
fatty I
acids I
such O
as O
palmitate B
are O
associated O
with O
insulin O
resistance O
of O
muscle O
, O
fat O
and O
liver O
. O

Rooibos O
( O
Aspalathus O
linearis O
) O
and O
its O
unique O
dihydrochalcone B
C I
- I
glucoside I
, O
aspalathin B
, O
shown O
to O
reduce O
hyperglycemia O
in O
diabetic O
rats O
, O
could O
play O
a O
role O
in O
preventing O
or O
ameliorating O
the O
development O
of O
insulin O
resistance O
. O

The O
newly O
synthesized O
compounds O
were O
characterized O
by O
IR O
, O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
NMR O
and O
LC O
- O
mass O
spectra O
. O

The O
newly O
synthesized O
compounds O
were O
characterized O
by O
IR O
, O
( B
1 I
) I
H I
, O
( B
13 I
) I
C I
NMR O
and O
LC O
- O
mass O
spectra O
. O

Based O
on O
the O
( B
1 I
) I
H I
NMR O
analysis O
, O
all O
the O
compounds O
were O
found O
to O
adopt O
normal O
chair O
conformation O
with O
equatorial O
orientation O
of O
all O
the O
substituents O
. O

The O
resulting O
epoxy B
- I
functionalized I
polyester I
was O
further O
modified O
by O
covalent O
immobilization O
of O
heparin O
. O

Apoptosis O
inducing O
activity O
of O
benzophenanthridine B
- I
type I
alkaloids I
and O
2 B
- I
arylbenzofuran I
neolignans I
in O
HCT116 O
colon O
carcinoma O
cells O
. O

Apoptosis O
inducing O
activity O
of O
benzophenanthridine B
- I
type I
alkaloids I
and O
2 B
- I
arylbenzofuran I
neolignans I
in O
HCT116 O
colon O
carcinoma O
cells O
. O

Out O
of O
the O
tested O
compounds O
, O
three O
benzophenanthridine B
alkaloids I
( O
1 O
, O
4 O
, O
and O
7 O
) O
, O
a O
dibenzyl B
butyrolactone I
lignan I
( O
10 O
) O
, O
and O
two O
2 B
- I
arylbenzofuran I
neolignans I
( O
12 O
and O
13 O
) O
displayed O
significant O
cytotoxicity O
to O
HCT116 O
cells O
, O
confirmed O
by O
the O
Guava O
ViaCount O
viability O
assay O
. O

These O
results O
suggested O
that O
specific O
benzophenanthridine B
alkaloids I
and O
2 B
- I
arylbenzofuran I
neolignans I
isolated O
from O
Zanthoxylum O
capense O
show O
strong O
anticancer O
activity O
in O
HCT116 O
colon O
carcinoma O
cells O
. O

The O
remaining O
two O
nitriles B
( O
benzonitrile B
and O
alpha B
- I
cyclohexylidene I
benzeneacetonitrile I
) O
were O
negative O
in O
the O
in O
- O
vivo O
micronucleus O
test O
. O

Designing O
, O
structural O
elucidation O
, O
comparison O
of O
DNA O
binding O
, O
cleavage O
, O
radical O
scavenging O
activity O
and O
anticancer O
activity O
of O
copper B
( I
I I
) I
complex O
with O
5 B
- I
dimethyl I
- I
2 I
- I
phenyl I
- I
4 I
- I
[ I
( I
pyridin I
- I
2 I
- I
ylmethylene I
) I
- I
amino I
] I
- I
1 I
, I
2 I
- I
dihydro I
- I
pyrazol I
- I
3 I
- I
one I
Schiff B
base I
ligand O
. O

Single O
crystal O
X O
- O
ray O
diffraction O
studies O
revealed O
that O
the O
copper B
( I
I I
) I
complex O
[ B
CuCl I
( I
PPh3 I
) I
L I
] I
has O
a O
distorted O
tetrahedral O
geometry O
around O
the O
central O
copper B
( I
I I
) I
ion O
. O

Single O
crystal O
X O
- O
ray O
diffraction O
studies O
revealed O
that O
the O
copper B
( I
I I
) I
complex O
[ B
CuCl I
( I
PPh3 I
) I
L I
] I
has O
a O
distorted O
tetrahedral O
geometry O
around O
the O
central O
copper B
( I
I I
) I
ion O
. O

The O
antioxidative O
properties O
showed O
that O
the O
copper B
( I
I I
) I
complex O
has O
a O
strong O
radical O
- O
scavenging O
potency O
than O
ligands O
. O

Synthesis O
and O
biological O
evaluation O
of O
novel O
phosphatidylinositol B
3 O
- O
kinase O
inhibitors O
: O
Solubilized O
4 B
- I
substituted I
benzimidazole I
analogs O
of O
2 B
- I
( I
difluoromethyl I
) I
- I
1 I
- I
[ I
4 I
, I
6 I
- I
di I
( I
4 I
- I
morpholinyl I
) I
- I
1 I
, I
3 I
, I
5 I
- I
triazin I
- I
2 I
- I
yl I
] I
- I
1H I
- I
benzimidazole I
( O
ZSTK474 B
) O
. O

